"STUDYID","STUDYIDN","USUBJID","USUBJIDN","SUBJID","SUBJIDN","SITEID","SITEIDN","ARM","ARMN","ACTARM","ACTARMN","TRT01P","TRT01PN","TRT01A","TRT01AN","TRTSDT","TRTEDT","TRTDURD","AGE","AGEGR1","AGEGR1N","SEX","SEXN","RACE","RACEN","ETHNIC","ETHNICN","PARAMCD","PARAM","PARAMN","PARCAT1","PARCAT2","AVAL","AVALU","AVALC","STARTDT","ADT","CNSR","EVENT","EVNTDESC","SRCDOM","SRCVAR","SRCSEQ","ATPT","ATPTN","AVISIT","AVISITN","DOSE","AUCSS","CMAXSS","CAVGSS","CMINSS","CLSS","AUCSSLOG","AUCSSSTD","AUCSSN","AUCSSDOSE","CMAXSSLOG","CMAXSSSTD","CMAXSSDOSE","CAVGSSLOG","AUCSSCAT","AUCSSCATN","AUCSSQ","AUCSSQN","AUCSSMED","WTBL","WTBLGR1","HTBL","BMIBL","BSABL","CREATBL","CRCLBL","EGFRBL","ALTBL","ASTBL","TBILBL","ALBBL","ANL01FL","ANL02FL","ANL03FL","ANL04FL","ASEQ"
"CDISCPILOT01",1,"01-701-1015",1015,"1015",1015,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-02,2014-07-02,182,63,"<65",1,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",64,"DAYS","CENSORED",2014-01-02,2014-03-06,1,0,"Last Tumor Assessment","ADRS","ADT",9,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.43,"<70 kg",147.32,25.0792713238221,1.49244650006476,79.56,54.7857516339869,71.8538279993146,27,40,10.26,38,"Y","","","",1
"CDISCPILOT01",1,"01-701-1015",1015,"1015",1015,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-02,2014-07-02,182,63,"<65",1,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2014-01-02,2014-07-02,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.43,"<70 kg",147.32,25.0792713238221,1.49244650006476,79.56,54.7857516339869,71.8538279993146,27,40,10.26,38,"","Y","","",2
"CDISCPILOT01",1,"01-701-1023",1023,"1023",1023,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-08-05,2012-09-01,28,64,"<65",1,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-08-05,2012-08-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,80.29,">=70 kg",162.56,30.3832394774165,1.90408496542448,123.76,60.6456787330317,56.1408678383307,23,21,11.97,40,"Y","","","",1
"CDISCPILOT01",1,"01-701-1023",1023,"1023",1023,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-08-05,2012-09-01,28,64,"<65",1,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",29,"DAYS","CENSORED",2012-08-05,2012-09-02,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,80.29,">=70 kg",162.56,30.3832394774165,1.90408496542448,123.76,60.6456787330317,56.1408678383307,23,21,11.97,40,"","Y","","",2
"CDISCPILOT01",1,"01-701-1028",1028,"1028",1028,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-07-19,2014-01-14,180,71,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",43,"DAYS","EVENT",2013-07-19,2013-08-30,0,1,"Disease Progression","ADRS","ADT",14,"BASELINE",0,"BASELINE",0,81,22.8195487789334,3.78312693625524,0.95081453245556,0.583864543826757,3.5495881528901,3.12805569595451,-0.223393989821081,0.938279971510278,0.281722824431277,1.33319072807224,-0.445357725934204,0.0467052708179659,-0.0399738829606836,"Medium",2,"Q2",2,"Below Median",99.34,">=70 kg",177.8,31.4239403989012,2.21501517426455,123.76,68.1236732385262,53.7492079230433,26,24,18.81,44,"Y","","","",1
"CDISCPILOT01",1,"01-701-1028",1028,"1028",1028,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-07-19,2014-01-14,180,71,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",180,"DAYS","CENSORED",2013-07-19,2014-01-14,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,22.8195487789334,3.78312693625524,0.95081453245556,0.583864543826757,3.5495881528901,3.12805569595451,-0.223393989821081,0.938279971510278,0.281722824431277,1.33319072807224,-0.445357725934204,0.0467052708179659,-0.0399738829606836,"Medium",2,"Q2",2,"Below Median",99.34,">=70 kg",177.8,31.4239403989012,2.21501517426455,123.76,68.1236732385262,53.7492079230433,26,24,18.81,44,"","Y","","",2
"CDISCPILOT01",1,"01-701-1033",1033,"1033",1033,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-03-18,2014-03-31,14,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-03-18,2014-03-18,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,15.8320002726693,4.32732373835898,0.659666678027888,0.524224928545608,3.41081348344971,2.76266465825389,-0.949130916709881,0.650970310968839,0.293185190234617,1.46725750775771,-0.205017331149849,0.0801356247844256,-0.400975185869825,"Low",1,"Q1",1,"Below Median",88.45,">=70 kg",175.26,28.7960038217913,2.075100198384,132.6,54.1506108597285,48.5638576919488,16,20,13.68,38,"Y","","","",1
"CDISCPILOT01",1,"01-701-1033",1033,"1033",1033,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-03-18,2014-03-31,14,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",28,"DAYS","CENSORED",2014-03-18,2014-04-14,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,15.8320002726693,4.32732373835898,0.659666678027888,0.524224928545608,3.41081348344971,2.76266465825389,-0.949130916709881,0.650970310968839,0.293185190234617,1.46725750775771,-0.205017331149849,0.0801356247844256,-0.400975185869825,"Low",1,"Q1",1,"Below Median",88.45,">=70 kg",175.26,28.7960038217913,2.075100198384,132.6,54.1506108597285,48.5638576919488,16,20,13.68,38,"","Y","","",2
"CDISCPILOT01",1,"01-701-1034",1034,"1034",1034,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-07-01,2014-12-30,183,77,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",43,"DAYS","CENSORED",2014-07-01,2014-08-12,1,0,"Last Tumor Assessment","ADRS","ADT",9,"BASELINE",0,"BASELINE",0,81,33.6087371196828,4.80892269786072,1.40036404665345,0.82260657599123,2.4100875826293,3.51508356391037,0.897186766508617,1.38190308724528,0.414922680489911,1.57255039641327,0.00767720069401347,0.0593694160229718,0.343847860180925,"High",3,"Q4",4,"Above Median",62.6,"<70 kg",154.94,26.0763757216845,1.64141233224454,88.4,46.3976470588235,58.0399213301922,15,23,10.26,43,"Y","","","",1
"CDISCPILOT01",1,"01-701-1034",1034,"1034",1034,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-07-01,2014-12-30,183,77,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2014-07-01,2014-12-30,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,33.6087371196828,4.80892269786072,1.40036404665345,0.82260657599123,2.4100875826293,3.51508356391037,0.897186766508617,1.38190308724528,0.414922680489911,1.57255039641327,0.00767720069401347,0.0593694160229718,0.343847860180925,"High",3,"Q4",4,"Above Median",62.6,"<70 kg",154.94,26.0763757216845,1.64141233224454,88.4,46.3976470588235,58.0399213301922,15,23,10.26,43,"","Y","","",2
"CDISCPILOT01",1,"01-701-1047",1047,"1047",1047,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-12,2013-03-09,26,85,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-12,2013-02-12,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,67.13,"<70 kg",148.59,30.4044731107944,1.66456923857195,88.4,43.4370588235294,55.2228421118293,22,25,6.84,42,"Y","","","",1
"CDISCPILOT01",1,"01-701-1047",1047,"1047",1047,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-12,2013-03-09,26,85,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",55,"DAYS","CENSORED",2013-02-12,2013-04-07,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,67.13,"<70 kg",148.59,30.4044731107944,1.66456923857195,88.4,43.4370588235294,55.2228421118293,22,25,6.84,42,"","Y","","",2
"CDISCPILOT01",1,"01-701-1097",1097,"1097",1097,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-01-01,2014-07-09,190,68,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",22,"DAYS","CENSORED",2014-01-01,2014-01-22,1,0,"Last Tumor Assessment","ADRS","ADT",9,"BASELINE",0,"BASELINE",0,54,15.8150191542349,4.38793255704628,0.658959131426453,0.289698197084258,3.41447578870242,2.7615921784077,-0.950894600310318,0.650272091934131,0.292870725078423,1.48113455710055,-0.178249905552331,0.0812580103156719,-0.402032309768571,"Low",1,"Q1",1,"Below Median",78.02,">=70 kg",168.91,27.3460889507567,1.9132838408233,123.76,55.8294376212023,54.7614692088909,16,19,6.84,43,"Y","","","",1
"CDISCPILOT01",1,"01-701-1097",1097,"1097",1097,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-01-01,2014-07-09,190,68,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",190,"DAYS","CENSORED",2014-01-01,2014-07-09,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,15.8150191542349,4.38793255704628,0.658959131426453,0.289698197084258,3.41447578870242,2.7615921784077,-0.950894600310318,0.650272091934131,0.292870725078423,1.48113455710055,-0.178249905552331,0.0812580103156719,-0.402032309768571,"Low",1,"Q1",1,"Below Median",78.02,">=70 kg",168.91,27.3460889507567,1.9132838408233,123.76,55.8294376212023,54.7614692088909,16,19,6.84,43,"","Y","","",2
"CDISCPILOT01",1,"01-701-1111",1111,"1111",1111,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-07,2012-09-16,10,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-07,2012-09-07,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,17.0252192971972,5.26218491837159,0.709384137383215,0.706823406896343,3.17176531223242,2.83528292436128,-0.825201457445337,0.700032346471183,0.315281838836984,1.66244487214873,0.207857026443249,0.0974478688587332,-0.329359797750738,"Low",1,"Q1",1,"Below Median",59.88,"<70 kg",158.24,23.9138358137695,1.62236206398777,79.56,46.1819607843137,64.243881656682,23,28,6.84,36,"Y","","","",1
"CDISCPILOT01",1,"01-701-1111",1111,"1111",1111,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-07,2012-09-16,10,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",11,"DAYS","CENSORED",2012-09-07,2012-09-17,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,17.0252192971972,5.26218491837159,0.709384137383215,0.706823406896343,3.17176531223242,2.83528292436128,-0.825201457445337,0.700032346471183,0.315281838836984,1.66244487214873,0.207857026443249,0.0974478688587332,-0.329359797750738,"Low",1,"Q1",1,"Below Median",59.88,"<70 kg",158.24,23.9138358137695,1.62236206398777,79.56,46.1819607843137,64.243881656682,23,28,6.84,36,"","Y","","",2
"CDISCPILOT01",1,"01-701-1115",1115,"1115",1115,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-11-30,2013-01-23,55,84,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",64,"DAYS","CENSORED",2012-11-30,2013-02-01,1,0,"Last Tumor Assessment","ADRS","ADT",9,"BASELINE",0,"BASELINE",0,54,14.8073762369332,2.46303395007019,0.616974009872218,0.397792272650676,3.64683108850241,2.69580056215186,-1.05554985580488,0.608840459043514,0.274210671054319,0.905445716738695,-1.02836679218611,0.0456117398161147,-0.466850190767816,"Low",1,"Q1",1,"Below Median",78.93,">=70 kg",181.61,23.9310958351977,1.99544462463883,114.92,47.3085485555169,54.1851886840024,18,26,8.55,39,"Y","","","",1
"CDISCPILOT01",1,"01-701-1115",1115,"1115",1115,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-11-30,2013-01-23,55,84,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",55,"DAYS","CENSORED",2012-11-30,2013-01-23,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,14.8073762369332,2.46303395007019,0.616974009872218,0.397792272650676,3.64683108850241,2.69580056215186,-1.05554985580488,0.608840459043514,0.274210671054319,0.905445716738695,-1.02836679218611,0.0456117398161147,-0.466850190767816,"Low",1,"Q1",1,"Below Median",78.93,">=70 kg",181.61,23.9310958351977,1.99544462463883,114.92,47.3085485555169,54.1851886840024,18,26,8.55,39,"","Y","","",2
"CDISCPILOT01",1,"01-701-1118",1118,"1118",1118,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-03-12,2014-09-09,182,52,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",85,"DAYS","CENSORED",2014-03-12,2014-06-04,1,0,"Last Tumor Assessment","ADRS","ADT",9,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,71.22,">=70 kg",180.34,21.8986750213135,1.88884259093587,88.4,87.2042171945701,90.5826153419153,15,15,11.97,39,"Y","","","",1
"CDISCPILOT01",1,"01-701-1118",1118,"1118",1118,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-03-12,2014-09-09,182,52,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2014-03-12,2014-09-09,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,71.22,">=70 kg",180.34,21.8986750213135,1.88884259093587,88.4,87.2042171945701,90.5826153419153,15,15,11.97,39,"","Y","","",2
"CDISCPILOT01",1,"01-701-1130",1130,"1130",1130,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-02-15,2014-08-16,183,84,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",64,"DAYS","EVENT",2014-02-15,2014-04-19,0,1,"Disease Progression","ADRS","ADT",14,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,79.38,">=70 kg",169.67,27.574076420674,1.93422426310912,123.76,44.1798190045249,49.5745716042942,15,24,8.55,37,"Y","","","",1
"CDISCPILOT01",1,"01-701-1130",1130,"1130",1130,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-02-15,2014-08-16,183,84,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2014-02-15,2014-08-16,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,79.38,">=70 kg",169.67,27.574076420674,1.93422426310912,123.76,44.1798190045249,49.5745716042942,15,24,8.55,37,"","Y","","",2
"CDISCPILOT01",1,"01-701-1133",1133,"1133",1133,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-10-28,2013-04-28,183,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",64,"DAYS","EVENT",2012-10-28,2012-12-30,0,1,"Disease Progression","ADRS","ADT",14,"BASELINE",0,"BASELINE",0,81,32.4146558860524,10.2859326333961,1.35061066191885,1.04180476291915,2.49886965589702,3.47891911753408,0.773167756955601,1.33280559996692,0.400180936864844,2.33174892728447,2.42655714459614,0.12698682263452,0.307933615087191,"High",3,"Q4",4,"Above Median",74.39,">=70 kg",162.56,28.1505689964505,1.83279070757623,97.24,46.9412834224599,50.4953704364397,23,27,15.39,45,"Y","","","",1
"CDISCPILOT01",1,"01-701-1133",1133,"1133",1133,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-10-28,2013-04-28,183,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2012-10-28,2013-04-29,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,32.4146558860524,10.2859326333961,1.35061066191885,1.04180476291915,2.49886965589702,3.47891911753408,0.773167756955601,1.33280559996692,0.400180936864844,2.33174892728447,2.42655714459614,0.12698682263452,0.307933615087191,"High",3,"Q4",4,"Above Median",74.39,">=70 kg",162.56,28.1505689964505,1.83279070757623,97.24,46.9412834224599,50.4953704364397,23,27,15.39,45,"","Y","","",2
"CDISCPILOT01",1,"01-701-1146",1146,"1146",1146,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-20,2013-06-26,38,75,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-20,2013-05-20,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,21.7470099011336,4.30491231041539,0.906125412547233,0.569467922575845,3.7246499803073,3.07993599991403,-0.334789433937917,0.894179986998983,0.268481603717699,1.46207700229307,-0.214915168510931,0.0531470655606838,-0.0876020104186003,"Medium",2,"Q2",2,"Below Median",53.98,"<70 kg",147.32,24.8719284596714,1.4862642953242,79.56,45.8653594771242,66.68648381889,15,14,5.13,37,"Y","","","",1
"CDISCPILOT01",1,"01-701-1146",1146,"1146",1146,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-20,2013-06-26,38,75,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",42,"DAYS","CENSORED",2013-05-20,2013-06-30,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,21.7470099011336,4.30491231041539,0.906125412547233,0.569467922575845,3.7246499803073,3.07993599991403,-0.334789433937917,0.894179986998983,0.268481603717699,1.46207700229307,-0.214915168510931,0.0531470655606838,-0.0876020104186003,"Medium",2,"Q2",2,"Below Median",53.98,"<70 kg",147.32,24.8719284596714,1.4862642953242,79.56,45.8653594771242,66.68648381889,15,14,5.13,37,"","Y","","",2
"CDISCPILOT01",1,"01-701-1148",1148,"1148",1148,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-08-23,2014-02-20,182,57,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-23,2013-08-23,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,24.956094269343,5.22577868181896,1.03983726122263,0.631529185026915,3.24570019353963,3.21751867513069,-0.00148927503048877,1.02612911617534,0.308099929251148,1.65551557859414,0.191778487885419,0.0645157861952958,0.0486351628455626,"Medium",2,"Q3",3,"Above Median",87.09,">=70 kg",175.26,28.3532388110775,2.05908511237394,106.08,83.8142731900452,70.5541107488369,34,25,8.55,41,"Y","","","",1
"CDISCPILOT01",1,"01-701-1148",1148,"1148",1148,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-08-23,2014-02-20,182,57,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2013-08-23,2014-02-20,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,24.956094269343,5.22577868181896,1.03983726122263,0.631529185026915,3.24570019353963,3.21751867513069,-0.00148927503048877,1.02612911617534,0.308099929251148,1.65551557859414,0.191778487885419,0.0645157861952958,0.0486351628455626,"Medium",2,"Q3",3,"Above Median",87.09,">=70 kg",175.26,28.3532388110775,2.05908511237394,106.08,83.8142731900452,70.5541107488369,34,25,8.55,41,"","Y","","",2
"CDISCPILOT01",1,"01-701-1153",1153,"1153",1153,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-23,2014-03-16,175,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-23,2013-09-23,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.06,"<70 kg",156.21,23.7935567417172,1.58723664482227,88.4,41.6665882352941,57.3224573602738,13,24,5.13,39,"Y","","","",1
"CDISCPILOT01",1,"01-701-1153",1153,"1153",1153,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-23,2014-03-16,175,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",191,"DAYS","CENSORED",2013-09-23,2014-04-01,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.06,"<70 kg",156.21,23.7935567417172,1.58723664482227,88.4,41.6665882352941,57.3224573602738,13,24,5.13,39,"","Y","","",2
"CDISCPILOT01",1,"01-701-1180",1180,"1180",1180,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-12,2013-03-18,35,56,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-12,2013-02-12,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,22.1389381752977,5.03210094706952,0.922455757304072,0.513600565468247,3.65871205559346,3.09778955743228,-0.294083194689958,0.91029504928524,0.273320224386392,1.61782284980083,0.106242183646449,0.062124703050241,-0.0699335738400528,"Medium",2,"Q2",2,"Below Median",89.81,">=70 kg",180.34,27.6147150191543,2.12108039818286,114.92,80.7445979812043,64.492439145287,29,21,11.97,41,"Y","","","",1
"CDISCPILOT01",1,"01-701-1180",1180,"1180",1180,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-12,2013-03-18,35,56,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",40,"DAYS","CENSORED",2013-02-12,2013-03-23,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,22.1389381752977,5.03210094706952,0.922455757304072,0.513600565468247,3.65871205559346,3.09778955743228,-0.294083194689958,0.91029504928524,0.273320224386392,1.61782284980083,0.106242183646449,0.062124703050241,-0.0699335738400528,"Medium",2,"Q2",2,"Below Median",89.81,">=70 kg",180.34,27.6147150191543,2.12108039818286,114.92,80.7445979812043,64.492439145287,29,21,11.97,41,"","Y","","",2
"CDISCPILOT01",1,"01-701-1181",1181,"1181",1181,"701",701,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-12-05,2013-12-09,5,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-05,2013-12-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,40.2968511826968,8.16889589764033,1.6790354659457,1.8770011199345,2.01008261496076,3.69652145903692,1.591823997638,1.65690078914093,0.497491989909837,2.10155716566601,1.4915839090358,0.100850566637535,0.524157635796856,"High",3,"Q4",4,"Above Median",66.68,"<70 kg",154.94,27.7759222543438,1.69405817819552,106.08,39.8772549019608,46.0582364148218,18,20,5.13,32,"Y","","","",1
"CDISCPILOT01",1,"01-701-1181",1181,"1181",1181,"701",701,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-12-05,2013-12-09,5,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",8,"DAYS","CENSORED",2013-12-05,2013-12-12,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,40.2968511826968,8.16889589764033,1.6790354659457,1.8770011199345,2.01008261496076,3.69652145903692,1.591823997638,1.65690078914093,0.497491989909837,2.10155716566601,1.4915839090358,0.100850566637535,0.524157635796856,"High",3,"Q4",4,"Above Median",66.68,"<70 kg",154.94,27.7759222543438,1.69405817819552,106.08,39.8772549019608,46.0582364148218,18,20,5.13,32,"","Y","","",2
"CDISCPILOT01",1,"01-701-1188",1188,"1188",1188,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-15,2013-03-24,38,71,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-15,2013-02-15,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,21.4781866435793,4.26230382164182,0.89492444348247,0.895375310659733,2.51417872914997,3.06750332568784,-0.362709807533721,0.883126679990906,0.39774419710332,1.45215321842722,-0.233732884773535,0.0789315522526263,-0.0999038266321902,"Medium",2,"Q2",2,"Below Median",101.15,">=70 kg",177.8,31.9964925644137,2.23510315446762,106.08,80.9257211538462,64.6707974453789,21,17,6.84,39,"Y","","","",1
"CDISCPILOT01",1,"01-701-1188",1188,"1188",1188,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-15,2013-03-24,38,71,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",39,"DAYS","CENSORED",2013-02-15,2013-03-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,21.4781866435793,4.26230382164182,0.89492444348247,0.895375310659733,2.51417872914997,3.06750332568784,-0.362709807533721,0.883126679990906,0.39774419710332,1.45215321842722,-0.233732884773535,0.0789315522526263,-0.0999038266321902,"Medium",2,"Q2",2,"Below Median",101.15,">=70 kg",177.8,31.9964925644137,2.23510315446762,106.08,80.9257211538462,64.6707974453789,21,17,6.84,39,"","Y","","",2
"CDISCPILOT01",1,"01-701-1192",1192,"1192",1192,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-07-22,2013-01-20,183,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-07-22,2012-07-22,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,14.6536743860257,2.1991274092927,0.610569766084402,0.322458405367748,3.68508256546881,2.6853733053008,-1.07151355306363,0.60252064221945,0.271364340481957,0.792597600136725,-1.14491911655009,0.0407245816535686,-0.477117245388866,"Low",1,"Q1",1,"Below Median",63.5,"<70 kg",151.13,27.8017645223907,1.63271714567398,79.56,49.8039215686275,64.6446786644013,17,18,11.97,41,"Y","","","",1
"CDISCPILOT01",1,"01-701-1192",1192,"1192",1192,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-07-22,2013-01-20,183,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2012-07-22,2013-01-20,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,14.6536743860257,2.1991274092927,0.610569766084402,0.322458405367748,3.68508256546881,2.6853733053008,-1.07151355306363,0.60252064221945,0.271364340481957,0.792597600136725,-1.14491911655009,0.0407245816535686,-0.477117245388866,"Low",1,"Q1",1,"Below Median",63.5,"<70 kg",151.13,27.8017645223907,1.63271714567398,79.56,49.8039215686275,64.6446786644013,17,18,11.97,41,"","Y","","",2
"CDISCPILOT01",1,"01-701-1203",1203,"1203",1203,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-02,2013-08-03,183,81,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-02,2013-02-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,66.23,"<70 kg",160.02,25.8646271890679,1.71578655432428,88.4,45.9714117647059,56.6138623642673,13,20,5.13,38,"Y","","","",1
"CDISCPILOT01",1,"01-701-1203",1203,"1203",1203,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-02,2013-08-03,183,81,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-02-02,2013-08-03,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,66.23,"<70 kg",160.02,25.8646271890679,1.71578655432428,88.4,45.9714117647059,56.6138623642673,13,20,5.13,38,"","Y","","",2
"CDISCPILOT01",1,"01-701-1211",1211,"1211",1211,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-11-15,2013-01-12,59,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",61,"DAYS","EVENT",2012-11-15,2013-01-14,0,1,"Death","ADRS","ADT",8,"BASELINE",0,"BASELINE",0,54,14.4252557675764,3.70683352421608,0.601052323649015,0.428985766953856,3.74343449225876,2.6696735315292,-1.0952374422143,0.593128667957064,0.267134366066229,1.31287210263821,-0.479052133358235,0.0686450652632607,-0.492572687390334,"Low",1,"Q1",1,"Below Median",45.36,"<70 kg",160.02,17.714321142928,1.41994788636767,97.24,31.0485561497326,52.0902690385379,19,20,18.81,42,"Y","","","",1
"CDISCPILOT01",1,"01-701-1211",1211,"1211",1211,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-11-15,2013-01-12,59,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",61,"DAYS","EVENT",2012-11-15,2013-01-14,0,1,"Death","ADRS","ADT",8,"BASELINE",0,"BASELINE",0,54,14.4252557675764,3.70683352421608,0.601052323649015,0.428985766953856,3.74343449225876,2.6696735315292,-1.0952374422143,0.593128667957064,0.267134366066229,1.31287210263821,-0.479052133358235,0.0686450652632607,-0.492572687390334,"Low",1,"Q1",1,"Below Median",45.36,"<70 kg",160.02,17.714321142928,1.41994788636767,97.24,31.0485561497326,52.0902690385379,19,20,18.81,42,"","Y","","",2
"CDISCPILOT01",1,"01-701-1234",1234,"1234",1234,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-30,2013-09-22,177,69,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-30,2013-03-30,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,77.11,">=70 kg",181.61,23.3792829070327,1.97230456713854,97.24,69.2515045248869,72.6869597967163,18,24,5.13,41,"Y","","","",1
"CDISCPILOT01",1,"01-701-1234",1234,"1234",1234,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-30,2013-09-22,177,69,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",177,"DAYS","CENSORED",2013-03-30,2013-09-22,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,77.11,">=70 kg",181.61,23.3792829070327,1.97230456713854,97.24,69.2515045248869,72.6869597967163,18,24,5.13,41,"","Y","","",2
"CDISCPILOT01",1,"01-701-1239",1239,"1239",1239,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-11,2014-07-10,181,56,"<65",1,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-11,2014-01-11,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,16.9490759053917,3.32917323995194,0.706211496057986,0.40517637045289,4.77902160873756,2.83080314216891,-0.833109820603354,0.696901529986332,0.209247850683848,1.20572324339875,-0.645842936728504,0.0411009041969376,-0.333779770083369,"Low",1,"Q1",1,"Below Median",95.94,">=70 kg",168.91,33.6270670845372,2.12166243780673,114.92,86.2558371040724,64.492439145287,61,36,34.2,42,"Y","","","",1
"CDISCPILOT01",1,"01-701-1239",1239,"1239",1239,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-11,2014-07-10,181,56,"<65",1,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2014-01-11,2014-07-11,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,16.9490759053917,3.32917323995194,0.706211496057986,0.40517637045289,4.77902160873756,2.83080314216891,-0.833109820603354,0.696901529986332,0.209247850683848,1.20572324339875,-0.645842936728504,0.0411009041969376,-0.333779770083369,"Low",1,"Q1",1,"Below Median",95.94,">=70 kg",168.91,33.6270670845372,2.12166243780673,114.92,86.2558371040724,64.492439145287,61,36,34.2,42,"","Y","","",2
"CDISCPILOT01",1,"01-701-1275",1275,"1275",1275,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-02-07,2014-05-31,114,61,"<65",1,"M",1,"AMERICAN INDIAN OR ALASKA NATIVE",1,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-02-07,2014-02-07,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,25.6425072155612,5.10696743268659,1.06843780064839,1.13586536312478,3.15881747908195,3.2446413140352,0.0698025695582846,1.05435261550309,0.316574163155077,1.63256196527008,0.139306399826634,0.0630489806504517,0.0755135130916106,"Medium",2,"Q3",3,"Above Median",68.95,"<70 kg",167.64,24.5345991151119,1.79186262494273,97.24,68.9003650761004,76.3949349037317,19,28,10.26,38,"Y","","","",1
"CDISCPILOT01",1,"01-701-1275",1275,"1275",1275,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-02-07,2014-05-31,114,61,"<65",1,"M",1,"AMERICAN INDIAN OR ALASKA NATIVE",1,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",128,"DAYS","CENSORED",2014-02-07,2014-06-14,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,25.6425072155612,5.10696743268659,1.06843780064839,1.13586536312478,3.15881747908195,3.2446413140352,0.0698025695582846,1.05435261550309,0.316574163155077,1.63256196527008,0.139306399826634,0.0630489806504517,0.0755135130916106,"Medium",2,"Q3",3,"Above Median",68.95,"<70 kg",167.64,24.5345991151119,1.79186262494273,97.24,68.9003650761004,76.3949349037317,19,28,10.26,38,"","Y","","",2
"CDISCPILOT01",1,"01-701-1287",1287,"1287",1287,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-25,2014-07-26,183,56,"<65",1,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-25,2014-01-25,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,19.1957123184791,3.78728627275228,0.799821346603297,0.675170519023305,4.21969232795929,2.95520775137191,-0.599770902840007,0.789277324533667,0.236984102697273,1.3342866728644,-0.443520786481647,0.0467566206512628,-0.210941615391547,"Medium",2,"Q2",2,"Below Median",56.25,"<70 kg",154.94,23.4312481524721,1.55593621334552,70.72,69.4852941176471,86.4450221892608,21,25,8.55,39,"Y","","","",1
"CDISCPILOT01",1,"01-701-1287",1287,"1287",1287,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-25,2014-07-26,183,56,"<65",1,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2014-01-25,2014-07-26,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,19.1957123184791,3.78728627275228,0.799821346603297,0.675170519023305,4.21969232795929,2.95520775137191,-0.599770902840007,0.789277324533667,0.236984102697273,1.3342866728644,-0.443520786481647,0.0467566206512628,-0.210941615391547,"Medium",2,"Q2",2,"Below Median",56.25,"<70 kg",154.94,23.4312481524721,1.55593621334552,70.72,69.4852941176471,86.4450221892608,21,25,8.55,39,"","Y","","",2
"CDISCPILOT01",1,"01-701-1294",1294,"1294",1294,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-03-24,2013-06-14,83,67,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-24,2013-03-24,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,26.1184638550169,3.21569754887462,1.08826932729237,0.954268992649968,2.0675029090437,3.26302528924784,0.119236116751723,1.07392270369523,0.483675256574386,1.1711492210842,-0.695958615994759,0.0595499546087892,0.0937356019819315,"Medium",2,"Q3",3,"Above Median",78.47,">=70 kg",170.18,27.094841447424,1.92599358196692,159.12,44.2799226998492,40.7570493904495,20,23,6.84,36,"Y","","","",1
"CDISCPILOT01",1,"01-701-1294",1294,"1294",1294,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-03-24,2013-06-14,83,67,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",83,"DAYS","CENSORED",2013-03-24,2013-06-14,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,26.1184638550169,3.21569754887462,1.08826932729237,0.954268992649968,2.0675029090437,3.26302528924784,0.119236116751723,1.07392270369523,0.483675256574386,1.1711492210842,-0.695958615994759,0.0595499546087892,0.0937356019819315,"Medium",2,"Q3",3,"Above Median",78.47,">=70 kg",170.18,27.094841447424,1.92599358196692,159.12,44.2799226998492,40.7570493904495,20,23,6.84,36,"","Y","","",2
"CDISCPILOT01",1,"01-701-1302",1302,"1302",1302,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-08-29,2013-11-05,69,61,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-29,2013-08-29,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,42.8487634115425,11.362621937165,1.78536514214761,0.9446052033267,1.89036960581645,3.75791013782199,1.85686930458537,1.76182872424491,0.528997079154846,2.43120888251181,2.90206881854855,0.140279283174876,0.585208423062082,"High",3,"Q4",4,"Above Median",82.1,">=70 kg",177.8,25.9704601041855,2.01366029353955,114.92,69.4192220675252,62.5178111977403,62,52,10.26,43,"Y","","","",1
"CDISCPILOT01",1,"01-701-1302",1302,"1302",1302,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-08-29,2013-11-05,69,61,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",69,"DAYS","CENSORED",2013-08-29,2013-11-05,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,42.8487634115425,11.362621937165,1.78536514214761,0.9446052033267,1.89036960581645,3.75791013782199,1.85686930458537,1.76182872424491,0.528997079154846,2.43120888251181,2.90206881854855,0.140279283174876,0.585208423062082,"High",3,"Q4",4,"Above Median",82.1,">=70 kg",177.8,25.9704601041855,2.01366029353955,114.92,69.4192220675252,62.5178111977403,62,52,10.26,43,"","Y","","",2
"CDISCPILOT01",1,"01-701-1317",1317,"1317",1317,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-05-22,2014-11-20,183,68,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-05-22,2014-05-22,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,27.0169934359299,5.45692715568457,1.12570805983041,1.07790475596656,1.99874201872461,3.29683612346655,0.212558702804029,1.11086788248678,0.500314693257961,1.6987166954569,0.293863460174676,0.101054206586751,0.127256297685572,"Medium",2,"Q3",3,"Above Median",66.68,"<70 kg",176.53,21.3972789624581,1.80823889154306,106.08,55.6672398190045,65.8887455251456,9,17,22.23,38,"Y","","","",1
"CDISCPILOT01",1,"01-701-1317",1317,"1317",1317,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-05-22,2014-11-20,183,68,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2014-05-22,2014-11-20,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,27.0169934359299,5.45692715568457,1.12570805983041,1.07790475596656,1.99874201872461,3.29683612346655,0.212558702804029,1.11086788248678,0.500314693257961,1.6987166954569,0.293863460174676,0.101054206586751,0.127256297685572,"Medium",2,"Q3",3,"Above Median",66.68,"<70 kg",176.53,21.3972789624581,1.80823889154306,106.08,55.6672398190045,65.8887455251456,9,17,22.23,38,"","Y","","",2
"CDISCPILOT01",1,"01-701-1324",1324,"1324",1324,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-10-02,2013-04-02,183,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-10-02,2012-10-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,16.4110154985174,4.96459558656458,0.683792312438224,0.388534439928472,3.29047279279448,2.79856194733225,-0.88899355519431,0.674777897826747,0.303907694416989,1.60434407817367,0.0764289526037466,0.0919369553067514,-0.365582624879418,"Low",1,"Q1",1,"Below Median",77.11,">=70 kg",166.37,27.8586886641753,1.88773752736503,88.4,65.4475486425339,76.5804035752657,11,20,6.84,37,"Y","","","",1
"CDISCPILOT01",1,"01-701-1324",1324,"1324",1324,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-10-02,2013-04-02,183,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2012-10-02,2013-04-02,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,16.4110154985174,4.96459558656458,0.683792312438224,0.388534439928472,3.29047279279448,2.79856194733225,-0.88899355519431,0.674777897826747,0.303907694416989,1.60434407817367,0.0764289526037466,0.0919369553067514,-0.365582624879418,"Low",1,"Q1",1,"Below Median",77.11,">=70 kg",166.37,27.8586886641753,1.88773752736503,88.4,65.4475486425339,76.5804035752657,11,20,6.84,37,"","Y","","",2
"CDISCPILOT01",1,"01-701-1341",1341,"1341",1341,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-01-05,2013-01-26,22,51,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-05,2013-01-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,15.8856590031201,2.64773798058303,0.661902458463336,0.549278474243362,3.39929240514315,2.76604605327811,-0.943557843105717,0.653176617174379,0.294178870428149,0.977475377773202,-0.946793656437959,0.0490321848256117,-0.397642100090653,"Low",1,"Q1",1,"Below Median",70.76,">=70 kg",157.48,28.5323151291464,1.75936263711859,106.08,73.021278280543,73.2366327108306,43,51,5.13,46,"Y","","","",1
"CDISCPILOT01",1,"01-701-1341",1341,"1341",1341,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-01-05,2013-01-26,22,51,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",34,"DAYS","CENSORED",2013-01-05,2013-02-07,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,15.8856590031201,2.64773798058303,0.661902458463336,0.549278474243362,3.39929240514315,2.76604605327811,-0.943557843105717,0.653176617174379,0.294178870428149,0.977475377773202,-0.946793656437959,0.0490321848256117,-0.397642100090653,"Low",1,"Q1",1,"Below Median",70.76,">=70 kg",157.48,28.5323151291464,1.75936263711859,106.08,73.021278280543,73.2366327108306,43,51,5.13,46,"","Y","","",2
"CDISCPILOT01",1,"01-701-1345",1345,"1345",1345,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-08,2014-03-18,162,63,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-08,2013-10-08,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,56.25,"<70 kg",173.99,18.5812082423888,1.64881586297561,97.24,46.3235294117647,56.4767502918193,13,22,8.55,45,"Y","","","",1
"CDISCPILOT01",1,"01-701-1345",1345,"1345",1345,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-08,2014-03-18,162,63,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",162,"DAYS","CENSORED",2013-10-08,2014-03-18,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,56.25,"<70 kg",173.99,18.5812082423888,1.64881586297561,97.24,46.3235294117647,56.4767502918193,13,22,8.55,45,"","Y","","",2
"CDISCPILOT01",1,"01-701-1360",1360,"1360",1360,"701",701,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-07-31,2013-08-05,6,67,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-07-31,2013-07-31,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,35.6605162939271,6.26738207390396,1.4858548455803,0.669407904000321,2.27141972181132,3.57432447344399,1.1102875287052,1.46626686340078,0.440253287579347,1.83695302635407,0.651794734755446,0.0773750873321477,0.402697846489313,"High",3,"Q4",4,"Above Median",80.29,">=70 kg",166.37,29.0075750596114,1.92626922803872,97.24,74.1386168243521,73.5967301927983,16,14,17.1,43,"Y","","","",1
"CDISCPILOT01",1,"01-701-1360",1360,"1360",1360,"701",701,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-07-31,2013-08-05,6,67,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",15,"DAYS","CENSORED",2013-07-31,2013-08-14,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,35.6605162939271,6.26738207390396,1.4858548455803,0.669407904000321,2.27141972181132,3.57432447344399,1.1102875287052,1.46626686340078,0.440253287579347,1.83695302635407,0.651794734755446,0.0773750873321477,0.402697846489313,"High",3,"Q4",4,"Above Median",80.29,">=70 kg",166.37,29.0075750596114,1.92626922803872,97.24,74.1386168243521,73.5967301927983,16,14,17.1,43,"","Y","","",2
"CDISCPILOT01",1,"01-701-1363",1363,"1363",1363,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-05-30,2013-11-27,182,81,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-30,2013-05-30,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,64.86,"<70 kg",161.29,24.9322837290352,1.70467245143067,106.08,37.5170588235294,45.4888847618858,9,20,8.55,41,"Y","","","",1
"CDISCPILOT01",1,"01-701-1363",1363,"1363",1363,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-05-30,2013-11-27,182,81,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2013-05-30,2013-11-27,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,64.86,"<70 kg",161.29,24.9322837290352,1.70467245143067,106.08,37.5170588235294,45.4888847618858,9,20,8.55,41,"","Y","","",2
"CDISCPILOT01",1,"01-701-1383",1383,"1383",1383,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-04,2013-08-06,184,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-04,2013-02-04,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,10.2854394299656,2.12179074210958,0.428559976248565,0.26174181534064,7.87521044205606,2.33170102339258,-1.52520477396854,0.422910282267634,0.126980733703279,0.756962350505977,-1.17907426970469,0.0261949474334516,-0.82425870058544,"Low",1,"Q1",1,"Below Median",84.82,">=70 kg",163.83,31.6017698317471,1.96469255440472,79.56,75.3955555555556,67.9423934121219,17,20,8.55,39,"Y","","","",1
"CDISCPILOT01",1,"01-701-1383",1383,"1383",1383,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-04,2013-08-06,184,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2013-02-04,2013-08-06,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,10.2854394299656,2.12179074210958,0.428559976248565,0.26174181534064,7.87521044205606,2.33170102339258,-1.52520477396854,0.422910282267634,0.126980733703279,0.756962350505977,-1.17907426970469,0.0261949474334516,-0.82425870058544,"Low",1,"Q1",1,"Below Median",84.82,">=70 kg",163.83,31.6017698317471,1.96469255440472,79.56,75.3955555555556,67.9423934121219,17,20,8.55,39,"","Y","","",2
"CDISCPILOT01",1,"01-701-1387",1387,"1387",1387,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-03-12,2014-03-25,14,87,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-03-12,2014-03-12,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,59.42,"<70 kg",162.56,22.4856406744064,1.63803025341753,106.08,30.8750980392157,43.8227113199395,12,18,6.84,40,"Y","","","",1
"CDISCPILOT01",1,"01-701-1387",1387,"1387",1387,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-03-12,2014-03-25,14,87,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",14,"DAYS","CENSORED",2014-03-12,2014-03-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,59.42,"<70 kg",162.56,22.4856406744064,1.63803025341753,106.08,30.8750980392157,43.8227113199395,12,18,6.84,40,"","Y","","",2
"CDISCPILOT01",1,"01-701-1392",1392,"1392",1392,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-10-28,2013-04-28,183,78,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-10-28,2012-10-28,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,81.19,">=70 kg",167.64,28.8899797266996,1.94441447913419,114.92,53.8770396797772,56.2453515450587,23,25,6.84,42,"Y","","","",1
"CDISCPILOT01",1,"01-701-1392",1392,"1392",1392,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-10-28,2013-04-28,183,78,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2012-10-28,2013-04-28,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,81.19,">=70 kg",167.64,28.8899797266996,1.94441447913419,114.92,53.8770396797772,56.2453515450587,23,25,6.84,42,"","Y","","",2
"CDISCPILOT01",1,"01-701-1415",1415,"1415",1415,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-23,2014-03-24,183,85,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-23,2013-09-23,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,76.66,">=70 kg",175.26,24.9576218539121,1.93185515330041,123.76,41.9040804783452,49.2672092603476,13,15,13.68,41,"Y","","","",1
"CDISCPILOT01",1,"01-701-1415",1415,"1415",1415,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-23,2014-03-24,183,85,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-09-23,2014-03-24,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,76.66,">=70 kg",175.26,24.9576218539121,1.93185515330041,123.76,41.9040804783452,49.2672092603476,13,15,13.68,41,"","Y","","",2
"CDISCPILOT01",1,"01-701-1429",1429,"1429",1429,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-03-19,2013-04-30,43,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-19,2013-03-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,21.5042554746151,2.95251560469715,0.896010644775629,1.03988605892627,2.51113088122231,3.06871576074711,-0.360002260916112,0.884198561923302,0.398226953233613,1.0860387738557,-0.812190927759922,0.054676214901799,-0.0987042238077052,"Medium",2,"Q2",2,"Below Median",56.7,"<70 kg",148.59,25.6805247338305,1.5298014577062,70.72,46.6941176470588,72.6292864744312,28,26,8.55,40,"Y","","","",1
"CDISCPILOT01",1,"01-701-1429",1429,"1429",1429,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-03-19,2013-04-30,43,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",43,"DAYS","CENSORED",2013-03-19,2013-04-30,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,21.5042554746151,2.95251560469715,0.896010644775629,1.03988605892627,2.51113088122231,3.06871576074711,-0.360002260916112,0.884198561923302,0.398226953233613,1.0860387738557,-0.812190927759922,0.054676214901799,-0.0987042238077052,"Medium",2,"Q2",2,"Below Median",56.7,"<70 kg",148.59,25.6805247338305,1.5298014577062,70.72,46.6941176470588,72.6292864744312,28,26,8.55,40,"","Y","","",2
"CDISCPILOT01",1,"01-701-1440",1440,"1440",1440,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-08-08,2014-02-05,182,70,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-08,2013-08-08,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,49.44,"<70 kg",156.21,20.2609963022821,1.46467880437999,88.4,48.153665158371,80.989127263119,21,31,8.55,38,"Y","","","",1
"CDISCPILOT01",1,"01-701-1440",1440,"1440",1440,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-08-08,2014-02-05,182,70,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2013-08-08,2014-02-05,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,49.44,"<70 kg",156.21,20.2609963022821,1.46467880437999,88.4,48.153665158371,80.989127263119,21,31,8.55,38,"","Y","","",2
"CDISCPILOT01",1,"01-701-1442",1442,"1442",1442,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-10-26,2014-04-26,183,57,"<65",1,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-26,2013-10-26,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,7.28427870778865,1.19822320366471,0.303511612824527,0.220296285608799,7.41322540861334,1.98709030221155,-1.83690968129899,0.299510427862908,0.134894050144234,0.189150853690136,-1.58696087606064,0.0221893185863834,-1.15991887709274,"Low",1,"Q1",1,"Below Median",106.14,">=70 kg",162.56,40.1653635338521,2.18924888184662,79.56,115.158431372549,74.5857662183029,23,14,8.55,46,"Y","","","",1
"CDISCPILOT01",1,"01-701-1442",1442,"1442",1442,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-10-26,2014-04-26,183,57,"<65",1,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-10-26,2014-04-26,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,7.28427870778865,1.19822320366471,0.303511612824527,0.220296285608799,7.41322540861334,1.98709030221155,-1.83690968129899,0.299510427862908,0.134894050144234,0.189150853690136,-1.58696087606064,0.0221893185863834,-1.15991887709274,"Low",1,"Q1",1,"Below Median",106.14,">=70 kg",162.56,40.1653635338521,2.18924888184662,79.56,115.158431372549,74.5857662183029,23,14,8.55,46,"","Y","","",2
"CDISCPILOT01",1,"01-701-1444",1444,"1444",1444,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-01-05,2013-02-12,39,63,"<65",1,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-05,2013-01-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,15.238882030165,2.99426922399533,0.63495341792354,0.247006698550052,5.31535055128471,2.72450619086877,-1.01073303799904,0.626582845069733,0.188134346051419,1.10003435172209,-0.793750758124583,0.0369662867159918,-0.438577185067956,"Low",1,"Q1",1,"Below Median",101.61,">=70 kg",171.45,34.5669827142123,2.19981277612437,97.24,98.9663009049774,75.4505743322231,19,19,13.68,39,"Y","","","",1
"CDISCPILOT01",1,"01-701-1444",1444,"1444",1444,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-01-05,2013-02-12,39,63,"<65",1,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",40,"DAYS","CENSORED",2013-01-05,2013-02-13,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,15.238882030165,2.99426922399533,0.63495341792354,0.247006698550052,5.31535055128471,2.72450619086877,-1.01073303799904,0.626582845069733,0.188134346051419,1.10003435172209,-0.793750758124583,0.0369662867159918,-0.438577185067956,"Low",1,"Q1",1,"Below Median",101.61,">=70 kg",171.45,34.5669827142123,2.19981277612437,97.24,98.9663009049774,75.4505743322231,19,19,13.68,39,"","Y","","",2
"CDISCPILOT01",1,"01-702-1082",1082,"1082",1082,"702",702,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-26,2013-10-13,80,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-07-26,2013-07-26,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,42.1657101678204,7.64363535208652,1.75690459032585,2.03343036377241,1.28066146129352,3.74184446688707,1.78592640357282,1.73374336706855,0.780846484589267,2.03518074438528,1.2596065684946,0.141548802816417,0.569229196591617,"High",3,"Q4",4,"Above Median",54.43,"<70 kg",154.94,22.6731171011388,1.5305576507346,97.24,32.5997860962567,49.56196763798,37,44,8.55,40,"Y","","","",1
"CDISCPILOT01",1,"01-702-1082",1082,"1082",1082,"702",702,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-26,2013-10-13,80,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",115,"DAYS","CENSORED",2013-07-26,2013-11-17,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,42.1657101678204,7.64363535208652,1.75690459032585,2.03343036377241,1.28066146129352,3.74184446688707,1.78592640357282,1.73374336706855,0.780846484589267,2.03518074438528,1.2596065684946,0.141548802816417,0.569229196591617,"High",3,"Q4",4,"Above Median",54.43,"<70 kg",154.94,22.6731171011388,1.5305576507346,97.24,32.5997860962567,49.56196763798,37,44,8.55,40,"","Y","","",2
"CDISCPILOT01",1,"01-703-1042",1042,"1042",1042,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-02,2013-08-31,183,64,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-02,2013-03-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,74.39,">=70 kg",177.8,23.5315776754002,1.91677840254017,70.72,98.3311255656109,98.8329117678639,19,29,10.26,38,"Y","","","",1
"CDISCPILOT01",1,"01-703-1042",1042,"1042",1042,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-02,2013-08-31,183,64,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-03-02,2013-08-31,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,74.39,">=70 kg",177.8,23.5315776754002,1.91677840254017,70.72,98.3311255656109,98.8329117678639,19,29,10.26,38,"","Y","","",2
"CDISCPILOT01",1,"01-703-1076",1076,"1076",1076,"703",703,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-25,2013-12-24,61,69,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-25,2013-10-25,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,24.4020586597236,3.49062355751661,1.01675244415515,0.578168145615963,3.31939206972291,3.19507721758464,-0.0590322173587857,1.00334862559486,0.301259983453378,1.25294111191735,-0.57453962713251,0.0430941179940323,0.0264008543290793,"Medium",2,"Q3",3,"Above Median",87.09,">=70 kg",165.1,31.9502414152757,1.99851048700443,106.08,71.6965469457014,65.4802353028897,19,24,10.26,49,"Y","","","",1
"CDISCPILOT01",1,"01-703-1076",1076,"1076",1076,"703",703,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-25,2013-12-24,61,69,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",61,"DAYS","CENSORED",2013-10-25,2013-12-24,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,24.4020586597236,3.49062355751661,1.01675244415515,0.578168145615963,3.31939206972291,3.19507721758464,-0.0590322173587857,1.00334862559486,0.301259983453378,1.25294111191735,-0.57453962713251,0.0430941179940323,0.0264008543290793,"Medium",2,"Q3",3,"Above Median",87.09,">=70 kg",165.1,31.9502414152757,1.99851048700443,106.08,71.6965469457014,65.4802353028897,19,24,10.26,49,"","Y","","",2
"CDISCPILOT01",1,"01-703-1086",1086,"1086",1086,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-02,2012-12-04,94,71,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-02,2012-09-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,10.9286929891615,1.79075519536247,0.455362207881731,0.196227857580302,4.94112150954868,2.39230631903044,-1.45839552594076,0.449359180843292,0.202383203502991,0.588206129893528,-1.32527361098213,0.0331621332474532,-0.764939234931261,"Low",1,"Q1",1,"Below Median",95.71,">=70 kg",195.58,25.0212171869781,2.28028761587461,97.24,83.5346328671329,71.7884355819716,20,32,11.97,42,"Y","","","",1
"CDISCPILOT01",1,"01-703-1086",1086,"1086",1086,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-02,2012-12-04,94,71,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",123,"DAYS","CENSORED",2012-09-02,2013-01-02,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,10.9286929891615,1.79075519536247,0.455362207881731,0.196227857580302,4.94112150954868,2.39230631903044,-1.45839552594076,0.449359180843292,0.202383203502991,0.588206129893528,-1.32527361098213,0.0331621332474532,-0.764939234931261,"Low",1,"Q1",1,"Below Median",95.71,">=70 kg",195.58,25.0212171869781,2.28028761587461,97.24,83.5346328671329,71.7884355819716,20,32,11.97,42,"","Y","","",2
"CDISCPILOT01",1,"01-703-1096",1096,"1096",1096,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-01-25,2013-03-16,51,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-25,2013-01-25,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,81.19,">=70 kg",160.02,31.7069165254481,1.89970931986975,70.72,70.4442647058824,73.9971171412954,11,17,5.13,36,"Y","","","",1
"CDISCPILOT01",1,"01-703-1096",1096,"1096",1096,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-01-25,2013-03-16,51,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",51,"DAYS","CENSORED",2013-01-25,2013-03-16,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,81.19,">=70 kg",160.02,31.7069165254481,1.89970931986975,70.72,70.4442647058824,73.9971171412954,11,17,5.13,36,"","Y","","",2
"CDISCPILOT01",1,"01-703-1100",1100,"1100",1100,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-13,2013-09-14,186,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-13,2013-03-13,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,61.24,"<70 kg",167.64,21.7911363279109,1.6887103560607,114.92,31.0356561085973,40.5590467389533,18,33,13.68,38,"Y","","","",1
"CDISCPILOT01",1,"01-703-1100",1100,"1100",1100,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-13,2013-09-14,186,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",186,"DAYS","CENSORED",2013-03-13,2013-09-14,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,61.24,"<70 kg",167.64,21.7911363279109,1.6887103560607,114.92,31.0356561085973,40.5590467389533,18,33,13.68,38,"","Y","","",2
"CDISCPILOT01",1,"01-703-1119",1119,"1119",1119,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-20,2013-06-13,114,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-20,2013-02-20,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,37.2536173425193,6.39518252572104,1.5522340559383,0.833988875968874,1.44952366648077,3.61801744426464,1.27574931522334,1.5317709985161,0.689881802639246,1.85710743232299,0.708236836077241,0.118429306031871,0.446116883942556,"High",3,"Q4",4,"Above Median",47.17,"<70 kg",160.02,18.4211756682521,1.44800086325941,123.76,23.3868067226891,37.8067322784909,20,31,6.84,39,"Y","","","",1
"CDISCPILOT01",1,"01-703-1119",1119,"1119",1119,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-20,2013-06-13,114,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",114,"DAYS","CENSORED",2013-02-20,2013-06-13,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,37.2536173425193,6.39518252572104,1.5522340559383,0.833988875968874,1.44952366648077,3.61801744426464,1.27574931522334,1.5317709985161,0.689881802639246,1.85710743232299,0.708236836077241,0.118429306031871,0.446116883942556,"High",3,"Q4",4,"Above Median",47.17,"<70 kg",160.02,18.4211756682521,1.44800086325941,123.76,23.3868067226891,37.8067322784909,20,31,6.84,39,"","Y","","",2
"CDISCPILOT01",1,"01-703-1175",1175,"1175",1175,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-12-20,2013-12-26,7,75,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-20,2013-12-20,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,77.11,">=70 kg",170.18,26.6252481714141,1.90923048780276,97.24,63.3992647058824,70.0245713336212,19,17,13.68,38,"Y","","","",1
"CDISCPILOT01",1,"01-703-1175",1175,"1175",1175,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-12-20,2013-12-26,7,75,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",12,"DAYS","CENSORED",2013-12-20,2013-12-31,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,77.11,">=70 kg",170.18,26.6252481714141,1.90923048780276,97.24,63.3992647058824,70.0245713336212,19,17,13.68,38,"","Y","","",2
"CDISCPILOT01",1,"01-703-1182",1182,"1182",1182,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-10-17,2013-12-11,56,84,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-17,2013-10-17,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,13.8140871934374,2.92559539882479,0.575586966393224,0.209439978860818,3.90905307342013,2.62641251943745,-1.15871429713832,0.567999019781877,0.255816429508099,1.07691029431623,-0.824080032734496,0.0541776925708294,-0.535140573424895,"Low",1,"Q1",1,"Below Median",68.04,"<70 kg",172.72,22.8075715667002,1.8067672788713,167.96,27.9030435818052,34.364362499692,16,21,17.1,37,"Y","","","",1
"CDISCPILOT01",1,"01-703-1182",1182,"1182",1182,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-10-17,2013-12-11,56,84,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",57,"DAYS","CENSORED",2013-10-17,2013-12-12,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,13.8140871934374,2.92559539882479,0.575586966393224,0.209439978860818,3.90905307342013,2.62641251943745,-1.15871429713832,0.567999019781877,0.255816429508099,1.07691029431623,-0.824080032734496,0.0541776925708294,-0.535140573424895,"Low",1,"Q1",1,"Below Median",68.04,"<70 kg",172.72,22.8075715667002,1.8067672788713,167.96,27.9030435818052,34.364362499692,16,21,17.1,37,"","Y","","",2
"CDISCPILOT01",1,"01-703-1197",1197,"1197",1197,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-06-16,2013-06-29,14,76,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-06-16,2013-06-16,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,16.2437120671376,3.15968140855988,0.676821336130734,0.568941661231043,3.32436328450111,2.78832131758924,-0.906369932336972,0.667898819701702,0.300809482724771,1.15363108080694,-0.720697719983416,0.0585126186770348,-0.375681084438539,"Low",1,"Q1",1,"Below Median",102.06,">=70 kg",162.56,38.6214151334553,2.14675941828608,97.24,69.8592513368984,52.0902690385379,18,17,6.84,40,"Y","","","",1
"CDISCPILOT01",1,"01-703-1197",1197,"1197",1197,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-06-16,2013-06-29,14,76,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",14,"DAYS","CENSORED",2013-06-16,2013-06-29,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,16.2437120671376,3.15968140855988,0.676821336130734,0.568941661231043,3.32436328450111,2.78832131758924,-0.906369932336972,0.667898819701702,0.300809482724771,1.15363108080694,-0.720697719983416,0.0585126186770348,-0.375681084438539,"Low",1,"Q1",1,"Below Median",102.06,">=70 kg",162.56,38.6214151334553,2.14675941828608,97.24,69.8592513368984,52.0902690385379,18,17,6.84,40,"","Y","","",2
"CDISCPILOT01",1,"01-703-1210",1210,"1210",1210,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-16,2013-09-06,175,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-16,2013-03-16,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,49.9,"<70 kg",144.78,23.8058340074821,1.41661980314644,97.24,36.2909090909091,53.4023822224413,16,25,8.55,41,"Y","","","",1
"CDISCPILOT01",1,"01-703-1210",1210,"1210",1210,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-16,2013-09-06,175,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",175,"DAYS","CENSORED",2013-03-16,2013-09-06,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,49.9,"<70 kg",144.78,23.8058340074821,1.41661980314644,97.24,36.2909090909091,53.4023822224413,16,25,8.55,41,"","Y","","",2
"CDISCPILOT01",1,"01-703-1258",1258,"1258",1258,"703",703,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-07-20,2013-01-11,176,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-07-20,2012-07-20,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,36.9128912826255,7.86101751265606,1.53803713677606,0.811141585720312,2.19435533726739,3.60883171866553,1.24036101224461,1.51776123693549,0.455714707192907,2.06318734411732,1.35561175281099,0.0970495989216798,0.43698776504519,"High",3,"Q4",4,"Above Median",59.42,"<70 kg",154.94,24.7517291594648,1.59917815698495,97.24,39.4014973262032,51.4463520524019,43,36,10.26,40,"Y","","","",1
"CDISCPILOT01",1,"01-703-1258",1258,"1258",1258,"703",703,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-07-20,2013-01-11,176,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",190,"DAYS","CENSORED",2012-07-20,2013-01-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,36.9128912826255,7.86101751265606,1.53803713677606,0.811141585720312,2.19435533726739,3.60883171866553,1.24036101224461,1.51776123693549,0.455714707192907,2.06318734411732,1.35561175281099,0.0970495989216798,0.43698776504519,"High",3,"Q4",4,"Above Median",59.42,"<70 kg",154.94,24.7517291594648,1.59917815698495,97.24,39.4014973262032,51.4463520524019,43,36,10.26,40,"","Y","","",2
"CDISCPILOT01",1,"01-703-1279",1279,"1279",1279,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-05-13,2013-06-03,22,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-13,2013-05-13,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,30.1097535801909,5.05648325803669,1.25457306584129,0.399917930575339,1.79343878906822,3.40518122162966,0.533777259024138,1.23803406478765,0.557588029262794,1.62264693945721,0.117010446563376,0.0936385788525313,0.234734567855767,"High",3,"Q3",3,"Above Median",55.79,"<70 kg",162.56,21.1119807005239,1.58720775087713,88.4,44.632,59.873114919928,11,17,6.84,40,"Y","","","",1
"CDISCPILOT01",1,"01-703-1279",1279,"1279",1279,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-05-13,2013-06-03,22,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",22,"DAYS","CENSORED",2013-05-13,2013-06-03,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,30.1097535801909,5.05648325803669,1.25457306584129,0.399917930575339,1.79343878906822,3.40518122162966,0.533777259024138,1.23803406478765,0.557588029262794,1.62264693945721,0.117010446563376,0.0936385788525313,0.234734567855767,"High",3,"Q3",3,"Above Median",55.79,"<70 kg",162.56,21.1119807005239,1.58720775087713,88.4,44.632,59.873114919928,11,17,6.84,40,"","Y","","",2
"CDISCPILOT01",1,"01-703-1295",1295,"1295",1295,"703",703,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-11-21,2014-04-19,150,88,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-11-21,2013-11-21,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,32.8218677646417,5.69614691993915,1.36757782352674,1.31866385703976,2.46786686793186,3.49139962190379,0.815461373535881,1.34954908396578,0.405208244007922,1.74154400078425,0.39951305671568,0.0703228014807302,0.32032675665724,"High",3,"Q4",4,"Above Median",56.25,"<70 kg",157.48,22.6814969758972,1.5686379442051,106.08,28.6764705882353,43.5510105097559,14,22,8.55,41,"Y","","","",1
"CDISCPILOT01",1,"01-703-1295",1295,"1295",1295,"703",703,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-11-21,2014-04-19,150,88,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",180,"DAYS","CENSORED",2013-11-21,2014-05-19,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,32.8218677646417,5.69614691993915,1.36757782352674,1.31866385703976,2.46786686793186,3.49139962190379,0.815461373535881,1.34954908396578,0.405208244007922,1.74154400078425,0.39951305671568,0.0703228014807302,0.32032675665724,"High",3,"Q4",4,"Above Median",56.25,"<70 kg",157.48,22.6814969758972,1.5686379442051,106.08,28.6764705882353,43.5510105097559,14,22,8.55,41,"","Y","","",2
"CDISCPILOT01",1,"01-703-1299",1299,"1299",1299,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-09-12,2013-03-13,183,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-12,2012-09-12,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,45.36,"<70 kg",153.67,19.2085624250478,1.39148913039233,61.88,44.9788235294118,86.8382212961208,9,19,5.13,37,"Y","","","",1
"CDISCPILOT01",1,"01-703-1299",1299,"1299",1299,"703",703,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-09-12,2013-03-13,183,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2012-09-12,2013-03-13,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,45.36,"<70 kg",153.67,19.2085624250478,1.39148913039233,61.88,44.9788235294118,86.8382212961208,9,19,5.13,37,"","Y","","",2
"CDISCPILOT01",1,"01-703-1335",1335,"1335",1335,"703",703,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-03-17,2014-05-07,52,67,"65-75",2,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-03-17,2014-03-17,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,39.938626684615,8.08802833448006,1.66410944519229,1.05774857755761,2.02811179862633,3.68759429576698,1.55461828147858,1.64217153769469,0.49306946524216,2.09162061655174,1.45586936242315,0.0998522016602476,0.515281349375954,"High",3,"Q4",4,"Above Median",55.34,"<70 kg",154.94,23.0521826268055,1.54329909969232,106.08,39.6060784313726,49.6271569256875,24,24,6.84,37,"Y","","","",1
"CDISCPILOT01",1,"01-703-1335",1335,"1335",1335,"703",703,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-03-17,2014-05-07,52,67,"65-75",2,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",69,"DAYS","CENSORED",2014-03-17,2014-05-24,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,39.938626684615,8.08802833448006,1.66410944519229,1.05774857755761,2.02811179862633,3.68759429576698,1.55461828147858,1.64217153769469,0.49306946524216,2.09162061655174,1.45586936242315,0.0998522016602476,0.515281349375954,"High",3,"Q4",4,"Above Median",55.34,"<70 kg",154.94,23.0521826268055,1.54329909969232,106.08,39.6060784313726,49.6271569256875,24,24,6.84,37,"","Y","","",2
"CDISCPILOT01",1,"01-703-1379",1379,"1379",1379,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-22,2014-03-21,181,81,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-22,2013-09-22,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,32.8924221187287,6.84739913638165,1.37051758828036,0.830983836021758,1.64171552356592,3.49354627569151,0.822789251126685,1.35245009388425,0.609118928124605,1.92532823520984,0.907954876157702,0.126803687710771,0.322458492821481,"High",3,"Q4",4,"Above Median",76.2,">=70 kg",157.48,30.7258679033487,1.82574003260778,106.08,44.0764705882353,45.4888847618858,9,20,6.84,37,"Y","","","",1
"CDISCPILOT01",1,"01-703-1379",1379,"1379",1379,"703",703,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-22,2014-03-21,181,81,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",181,"DAYS","CENSORED",2013-09-22,2014-03-21,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,32.8924221187287,6.84739913638165,1.37051758828036,0.830983836021758,1.64171552356592,3.49354627569151,0.822789251126685,1.35245009388425,0.609118928124605,1.92532823520984,0.907954876157702,0.126803687710771,0.322458492821481,"High",3,"Q4",4,"Above Median",76.2,">=70 kg",157.48,30.7258679033487,1.82574003260778,106.08,44.0764705882353,45.4888847618858,9,20,6.84,37,"","Y","","",2
"CDISCPILOT01",1,"01-703-1403",1403,"1403",1403,"703",703,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2012-12-12,2012-12-13,2,67,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-12,2012-12-12,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,17.0456318398533,2.52532556095535,0.710234659993886,0.634214469193699,4.75195057367244,2.83648046237601,-0.823081381146195,0.700871656666462,0.210439899257448,0.930322055209546,-1.00085617416333,0.0311768587772265,-0.328178203413158,"Low",1,"Q1",1,"Below Median",80.29,">=70 kg",177.8,25.397907938673,1.99133972211898,123.76,58.2517703619909,55.1031084814761,40,28,10.26,41,"Y","","","",1
"CDISCPILOT01",1,"01-703-1403",1403,"1403",1403,"703",703,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2012-12-12,2012-12-13,2,67,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",8,"DAYS","CENSORED",2012-12-12,2012-12-19,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,17.0456318398533,2.52532556095535,0.710234659993886,0.634214469193699,4.75195057367244,2.83648046237601,-0.823081381146195,0.700871656666462,0.210439899257448,0.930322055209546,-1.00085617416333,0.0311768587772265,-0.328178203413158,"Low",1,"Q1",1,"Below Median",80.29,">=70 kg",177.8,25.397907938673,1.99133972211898,123.76,58.2517703619909,55.1031084814761,40,28,10.26,41,"","Y","","",2
"CDISCPILOT01",1,"01-703-1439",1439,"1439",1439,"703",703,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-03-12,2014-09-11,184,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-03-12,2014-03-12,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,27.9510822760738,6.72941829014879,1.16462842816974,1.49308240491734,2.89791998749674,3.33081362463056,0.309574525117021,1.14927516471698,0.345075089828071,1.90797361409996,0.85584952924831,0.0830792381499851,0.160951866239545,"High",3,"Q3",3,"Above Median",63.5,"<70 kg",160.02,24.798487490651,1.68005208252602,88.4,47.8117647058824,58.4020138158505,23,29,10.26,40,"Y","","","",1
"CDISCPILOT01",1,"01-703-1439",1439,"1439",1439,"703",703,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-03-12,2014-09-11,184,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2014-03-12,2014-09-11,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,27.9510822760738,6.72941829014879,1.16462842816974,1.49308240491734,2.89791998749674,3.33081362463056,0.309574525117021,1.14927516471698,0.345075089828071,1.90797361409996,0.85584952924831,0.0830792381499851,0.160951866239545,"High",3,"Q3",3,"Above Median",63.5,"<70 kg",160.02,24.798487490651,1.68005208252602,88.4,47.8117647058824,58.4020138158505,23,29,10.26,40,"","Y","","",2
"CDISCPILOT01",1,"01-704-1008",1008,"1008",1008,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-01-13,2013-02-21,40,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-13,2013-01-13,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,25.3330589299638,2.79037429557603,1.05554412208182,0.432606826391419,3.19740305440153,3.23250488307565,0.0376628216024468,1.04162891393445,0.31275381395017,1.02975308523862,-0.88379940854183,0.0344490653774819,0.0634855814427917,"Medium",2,"Q3",3,"Above Median",46.72,"<70 kg",148,21.3294375456538,1.38589722241987,88.4,35.1774117647059,58.4020138158505,16,17,15.39,39,"Y","","","",1
"CDISCPILOT01",1,"01-704-1008",1008,"1008",1008,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-01-13,2013-02-21,40,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",44,"DAYS","CENSORED",2013-01-13,2013-02-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,25.3330589299638,2.79037429557603,1.05554412208182,0.432606826391419,3.19740305440153,3.23250488307565,0.0376628216024468,1.04162891393445,0.31275381395017,1.02975308523862,-0.88379940854183,0.0344490653774819,0.0634855814427917,"Medium",2,"Q3",3,"Above Median",46.72,"<70 kg",148,21.3294375456538,1.38589722241987,88.4,35.1774117647059,58.4020138158505,16,17,15.39,39,"","Y","","",2
"CDISCPILOT01",1,"01-704-1009",1009,"1009",1009,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-08-27,2013-09-25,30,83,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-27,2013-08-27,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,17.0218075473877,3.71355469924129,0.709241981141154,0.289286344682869,3.1724010419967,2.83508262805503,-0.825555806731044,0.699892064270818,0.315218658284957,1.31467877633629,-0.476083777328341,0.0687695314674312,-0.329557425530038,"Low",1,"Q1",1,"Below Median",66.68,"<70 kg",179.07,20.7945690273957,1.82120134343607,132.6,35.2559185520362,45.9202358007726,24,27,10.26,43,"Y","","","",1
"CDISCPILOT01",1,"01-704-1009",1009,"1009",1009,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-08-27,2013-09-25,30,83,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",32,"DAYS","CENSORED",2013-08-27,2013-09-27,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,17.0218075473877,3.71355469924129,0.709241981141154,0.289286344682869,3.1724010419967,2.83508262805503,-0.825555806731044,0.699892064270818,0.315218658284957,1.31467877633629,-0.476083777328341,0.0687695314674312,-0.329557425530038,"Low",1,"Q1",1,"Below Median",66.68,"<70 kg",179.07,20.7945690273957,1.82120134343607,132.6,35.2559185520362,45.9202358007726,24,27,10.26,43,"","Y","","",2
"CDISCPILOT01",1,"01-704-1010",1010,"1010",1010,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-02-21,2014-07-08,138,80,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-02-21,2014-02-21,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,80.97,">=70 kg",177.8,25.6130104096943,1.99975456827415,114.92,51.9977897667943,55.5500712572134,9,16,18.81,42,"Y","","","",1
"CDISCPILOT01",1,"01-704-1010",1010,"1010",1010,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-02-21,2014-07-08,138,80,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",139,"DAYS","CENSORED",2014-02-21,2014-07-09,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,80.97,">=70 kg",177.8,25.6130104096943,1.99975456827415,114.92,51.9977897667943,55.5500712572134,9,16,18.81,42,"","Y","","",2
"CDISCPILOT01",1,"01-704-1017",1017,"1017",1017,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-06,2013-11-18,44,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-06,2013-10-06,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,58.2791827815528,9.31036651140125,2.4282992825647,0.550984597591242,1.38986163041461,4.06541653208532,3.45949505010364,2.39628708217049,0.719496083722874,2.23220195318193,1.99570575775946,0.114942796437052,0.891300780934644,"High",3,"Q4",4,"Above Median",63.05,"<70 kg",170.18,21.7704823914883,1.72641640721789,159.12,30.7047794117647,38.2994608001766,10,13,11.97,37,"Y","","","",1
"CDISCPILOT01",1,"01-704-1017",1017,"1017",1017,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-06,2013-11-18,44,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",48,"DAYS","CENSORED",2013-10-06,2013-11-22,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,58.2791827815528,9.31036651140125,2.4282992825647,0.550984597591242,1.38986163041461,4.06541653208532,3.45949505010364,2.39628708217049,0.719496083722874,2.23220195318193,1.99570575775946,0.114942796437052,0.891300780934644,"High",3,"Q4",4,"Above Median",63.05,"<70 kg",170.18,21.7704823914883,1.72641640721789,159.12,30.7047794117647,38.2994608001766,10,13,11.97,37,"","Y","","",2
"CDISCPILOT01",1,"01-704-1025",1025,"1025",1025,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-27,2013-10-24,28,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-27,2013-09-27,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,25.5470929908939,4.48204751950291,1.06446220795391,0.719717233772305,2.11374343136606,3.24091489029065,0.0598927097369955,1.05042943293407,0.473094314646184,1.50230861551635,-0.136684745403468,0.0830008799907946,0.0718202647312256,"Medium",2,"Q3",3,"Above Median",55.52,"<70 kg",166,20.1480621280302,1.60002777753666,79.56,42.8193464052288,64.243881656682,19,30,8.55,38,"Y","","","",1
"CDISCPILOT01",1,"01-704-1025",1025,"1025",1025,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-27,2013-10-24,28,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",64,"DAYS","CENSORED",2013-09-27,2013-11-29,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,25.5470929908939,4.48204751950291,1.06446220795391,0.719717233772305,2.11374343136606,3.24091489029065,0.0598927097369955,1.05042943293407,0.473094314646184,1.50230861551635,-0.136684745403468,0.0830008799907946,0.0718202647312256,"Medium",2,"Q3",3,"Above Median",55.52,"<70 kg",166,20.1480621280302,1.60002777753666,79.56,42.8193464052288,64.243881656682,19,30,8.55,38,"","Y","","",2
"CDISCPILOT01",1,"01-704-1065",1065,"1065",1065,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-24,2013-12-22,60,75,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-24,2013-10-24,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,36.9098048005912,7.28525792856501,1.53790853335796,0.853299524456489,2.19453883426397,3.60874812252943,1.240040445742,1.5176343288926,0.455676602476434,1.9872245382469,1.10133189448331,0.0899414559082101,0.436904686443772,"High",3,"Q4",4,"Above Median",80.74,">=70 kg",180.34,24.8258778604445,2.01112541738312,132.6,48.6814705882353,48.2627617742587,16,23,8.55,35,"Y","","","",1
"CDISCPILOT01",1,"01-704-1065",1065,"1065",1065,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-24,2013-12-22,60,75,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",62,"DAYS","CENSORED",2013-10-24,2013-12-24,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,36.9098048005912,7.28525792856501,1.53790853335796,0.853299524456489,2.19453883426397,3.60874812252943,1.240040445742,1.5176343288926,0.455676602476434,1.9872245382469,1.10133189448331,0.0899414559082101,0.436904686443772,"High",3,"Q4",4,"Above Median",80.74,">=70 kg",180.34,24.8258778604445,2.01112541738312,132.6,48.6814705882353,48.2627617742587,16,23,8.55,35,"","Y","","",2
"CDISCPILOT01",1,"01-704-1074",1074,"1074",1074,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-22,2014-03-20,58,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-22,2014-01-22,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,25.2187287039488,3.97065172791759,1.05078036266453,0.588097463003283,3.21189862307836,3.22798337311347,0.0257883184338186,1.0369279550221,0.311342329678381,1.38144555662372,-0.362538822394614,0.0490203917026863,0.0590048284611232,"Medium",2,"Q3",3,"Above Median",75.75,">=70 kg",167.64,26.9542550104384,1.87814403068561,114.92,41.131221719457,41.5806974413785,14,19,8.55,43,"Y","","","",1
"CDISCPILOT01",1,"01-704-1074",1074,"1074",1074,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-22,2014-03-20,58,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",69,"DAYS","CENSORED",2014-01-22,2014-03-31,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,25.2187287039488,3.97065172791759,1.05078036266453,0.588097463003283,3.21189862307836,3.22798337311347,0.0257883184338186,1.0369279550221,0.311342329678381,1.38144555662372,-0.362538822394614,0.0490203917026863,0.0590048284611232,"Medium",2,"Q3",3,"Above Median",75.75,">=70 kg",167.64,26.9542550104384,1.87814403068561,114.92,41.131221719457,41.5806974413785,14,19,8.55,43,"","Y","","",2
"CDISCPILOT01",1,"01-704-1093",1093,"1093",1093,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-03-15,2013-06-17,95,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-15,2013-03-15,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,30.9032712788489,6.31365092141196,1.28763630328537,1.368395011658,2.62108173821193,3.43118558292363,0.616193158611761,1.27066143051265,0.381521867640109,1.84429671880599,0.67222902072203,0.0779463076717526,0.260544381242102,"High",3,"Q3",3,"Above Median",73.48,">=70 kg",173.99,24.2728387849018,1.88449707408163,106.08,51.9721380090498,61.5318759006393,14,18,10.26,40,"Y","","","",1
"CDISCPILOT01",1,"01-704-1093",1093,"1093",1093,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-03-15,2013-06-17,95,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",98,"DAYS","CENSORED",2013-03-15,2013-06-20,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,30.9032712788489,6.31365092141196,1.28763630328537,1.368395011658,2.62108173821193,3.43118558292363,0.616193158611761,1.27066143051265,0.381521867640109,1.84429671880599,0.67222902072203,0.0779463076717526,0.260544381242102,"High",3,"Q3",3,"Above Median",73.48,">=70 kg",173.99,24.2728387849018,1.88449707408163,106.08,51.9721380090498,61.5318759006393,14,18,10.26,40,"","Y","","",2
"CDISCPILOT01",1,"01-704-1114",1114,"1114",1114,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-01-23,2013-07-07,166,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-23,2013-01-23,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,23.0163426645496,3.98990256877716,0.959014277689568,0.299080512438062,2.34615902217915,3.1366388937767,-0.202954691310372,0.946371619736023,0.42622856786203,1.38627000301753,-0.354036834374408,0.0738870846069845,-0.0314759327421637,"Medium",2,"Q2",2,"Below Median",77.79,">=70 kg",166.37,28.104362484583,1.89604283091566,106.08,56.8245390271493,62.3020261348266,17,23,11.97,40,"Y","","","",1
"CDISCPILOT01",1,"01-704-1114",1114,"1114",1114,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-01-23,2013-07-07,166,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",167,"DAYS","CENSORED",2013-01-23,2013-07-08,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,23.0163426645496,3.98990256877716,0.959014277689568,0.299080512438062,2.34615902217915,3.1366388937767,-0.202954691310372,0.946371619736023,0.42622856786203,1.38627000301753,-0.354036834374408,0.0738870846069845,-0.0314759327421637,"Medium",2,"Q2",2,"Below Median",77.79,">=70 kg",166.37,28.104362484583,1.89604283091566,106.08,56.8245390271493,62.3020261348266,17,23,11.97,40,"","Y","","",2
"CDISCPILOT01",1,"01-704-1120",1120,"1120",1120,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-12-02,2014-02-01,62,71,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-02,2013-12-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,25.0276319109948,5.64766932892249,1.04281799629145,0.573251890397338,2.15761523871052,3.22037996951504,0.00594072823355757,1.02907055629851,0.463474665018422,1.73301202806838,0.378103295912055,0.10458646905412,0.0514703751846976,"Medium",2,"Q3",3,"Above Median",51.71,"<70 kg",147,23.9298440464621,1.45309726676044,97.24,38.160320855615,53.7355425864775,17,20,8.55,39,"Y","","","",1
"CDISCPILOT01",1,"01-704-1120",1120,"1120",1120,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-12-02,2014-02-01,62,71,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",64,"DAYS","CENSORED",2013-12-02,2014-02-03,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,25.0276319109948,5.64766932892249,1.04281799629145,0.573251890397338,2.15761523871052,3.22037996951504,0.00594072823355757,1.02907055629851,0.463474665018422,1.73301202806838,0.378103295912055,0.10458646905412,0.0514703751846976,"Medium",2,"Q3",3,"Above Median",51.71,"<70 kg",147,23.9298440464621,1.45309726676044,97.24,38.160320855615,53.7355425864775,17,20,8.55,39,"","Y","","",2
"CDISCPILOT01",1,"01-704-1127",1127,"1127",1127,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-02,2014-03-31,181,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-02,2013-10-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,41.05,"<70 kg",165.1,15.0597934331963,1.37207820881723,88.4,27.0447058823529,55.5673597422312,21,35,11.97,40,"Y","","","",1
"CDISCPILOT01",1,"01-704-1127",1127,"1127",1127,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-02,2014-03-31,181,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",181,"DAYS","CENSORED",2013-10-02,2014-03-31,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,41.05,"<70 kg",165.1,15.0597934331963,1.37207820881723,88.4,27.0447058823529,55.5673597422312,21,35,11.97,40,"","Y","","",2
"CDISCPILOT01",1,"01-704-1135",1135,"1135",1135,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-10-31,2014-05-16,198,74,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-31,2013-10-31,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,16.233908384172,2.16738855966018,0.676412849340501,0.674464899496891,3.32637087274989,2.78771796982859,-0.907388157075056,0.667495717981209,0.300627933040223,0.778126250322444,-1.15893633903503,0.0401368251788922,-0.376276011081937,"Low",1,"Q1",1,"Below Median",64.41,"<70 kg",161.8,24.6034644244829,1.70143223981053,88.4,50.0124705882353,59.1329898174584,16,16,10.26,40,"Y","","","",1
"CDISCPILOT01",1,"01-704-1135",1135,"1135",1135,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-10-31,2014-05-16,198,74,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",198,"DAYS","CENSORED",2013-10-31,2014-05-16,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,16.233908384172,2.16738855966018,0.676412849340501,0.674464899496891,3.32637087274989,2.78771796982859,-0.907388157075056,0.667495717981209,0.300627933040223,0.778126250322444,-1.15893633903503,0.0401368251788922,-0.376276011081937,"Low",1,"Q1",1,"Below Median",64.41,"<70 kg",161.8,24.6034644244829,1.70143223981053,88.4,50.0124705882353,59.1329898174584,16,16,10.26,40,"","Y","","",2
"CDISCPILOT01",1,"01-704-1164",1164,"1164",1164,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-09-19,2013-04-04,198,67,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-19,2012-09-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,49.9,"<70 kg",157.48,20.1210079839515,1.4774463705251,106.08,35.7127450980392,49.6271569256875,7,15,8.55,41,"Y","","","",1
"CDISCPILOT01",1,"01-704-1164",1164,"1164",1164,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-09-19,2013-04-04,198,67,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",198,"DAYS","CENSORED",2012-09-19,2013-04-04,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,49.9,"<70 kg",157.48,20.1210079839515,1.4774463705251,106.08,35.7127450980392,49.6271569256875,7,15,8.55,41,"","Y","","",2
"CDISCPILOT01",1,"01-704-1218",1218,"1218",1218,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-11-19,2013-05-27,190,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-11-19,2012-11-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,38.1735405293907,8.388880172676,1.59056418872461,0.779752902288724,1.41459239177524,3.64240454656475,1.3712938722329,1.56959582625179,0.706917417210939,2.12809838418566,1.58873829749239,0.155349632827333,0.470356185043519,"High",3,"Q4",4,"Above Median",54.43,"<70 kg",144,26.2490354938272,1.47553380171381,132.6,25.1872156862745,34.8027269237523,11,17,18.81,43,"Y","","","",1
"CDISCPILOT01",1,"01-704-1218",1218,"1218",1218,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-11-19,2013-05-27,190,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",190,"DAYS","CENSORED",2012-11-19,2013-05-27,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,38.1735405293907,8.388880172676,1.59056418872461,0.779752902288724,1.41459239177524,3.64240454656475,1.3712938722329,1.56959582625179,0.706917417210939,2.12809838418566,1.58873829749239,0.155349632827333,0.470356185043519,"High",3,"Q4",4,"Above Median",54.43,"<70 kg",144,26.2490354938272,1.47553380171381,132.6,25.1872156862745,34.8027269237523,11,17,18.81,43,"","Y","","",2
"CDISCPILOT01",1,"01-704-1233",1233,"1233",1233,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-21,2013-04-04,15,87,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-21,2013-03-21,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,46.27,"<70 kg",147.32,21.3194540538903,1.37603460066316,123.76,20.6076470588235,36.4219418273965,13,17,6.84,36,"Y","","","",1
"CDISCPILOT01",1,"01-704-1233",1233,"1233",1233,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-21,2013-04-04,15,87,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",113,"DAYS","CENSORED",2013-03-21,2013-07-11,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,46.27,"<70 kg",147.32,21.3194540538903,1.37603460066316,123.76,20.6076470588235,36.4219418273965,13,17,6.84,36,"","Y","","",2
"CDISCPILOT01",1,"01-704-1241",1241,"1241",1241,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-08-25,2013-10-09,46,86,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-25,2013-08-25,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,42.5826460456751,7.89743819847113,1.7742769185698,1.56442312141399,1.90218334278987,3.75168161033759,1.82922996882645,1.75088667640324,0.525711679576236,2.06780386060862,1.37169667277611,0.0974992370181621,0.579013245525473,"High",3,"Q4",4,"Above Median",73.03,">=70 kg",170.18,25.2164683433844,1.85803401176859,132.6,36.5810904977376,45.0714039923929,15,20,11.97,42,"Y","","","",1
"CDISCPILOT01",1,"01-704-1241",1241,"1241",1241,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-08-25,2013-10-09,46,86,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",68,"DAYS","CENSORED",2013-08-25,2013-10-31,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,42.5826460456751,7.89743819847113,1.7742769185698,1.56442312141399,1.90218334278987,3.75168161033759,1.82922996882645,1.75088667640324,0.525711679576236,2.06780386060862,1.37169667277611,0.0974992370181621,0.579013245525473,"High",3,"Q4",4,"Above Median",73.03,">=70 kg",170.18,25.2164683433844,1.85803401176859,132.6,36.5810904977376,45.0714039923929,15,20,11.97,42,"","Y","","",2
"CDISCPILOT01",1,"01-704-1260",1260,"1260",1260,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-08-30,2012-11-04,67,71,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-08-30,2012-08-30,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,48.76,"<70 kg",160.02,19.0421141739235,1.47220311098707,70.72,49.4770588235294,78.7453424948674,20,28,6.84,41,"Y","","","",1
"CDISCPILOT01",1,"01-704-1260",1260,"1260",1260,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-08-30,2012-11-04,67,71,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",67,"DAYS","CENSORED",2012-08-30,2012-11-04,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,48.76,"<70 kg",160.02,19.0421141739235,1.47220311098707,70.72,49.4770588235294,78.7453424948674,20,28,6.84,41,"","Y","","",2
"CDISCPILOT01",1,"01-704-1266",1266,"1266",1266,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-13,2013-12-06,55,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-13,2013-10-13,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,27.9047577528608,5.36331120341248,1.16269823970253,1.56234391126434,2.9027308073189,3.32915550069711,0.30476319291861,1.14737042186945,0.344503182134084,1.68144432993027,0.252518684093286,0.0662137185606479,0.15930728142,"Medium",2,"Q3",3,"Above Median",88.45,">=70 kg",173.99,29.2179176718096,2.06756804939738,97.24,64.8912278897573,67.0414510721731,12,20,11.97,46,"Y","","","",1
"CDISCPILOT01",1,"01-704-1266",1266,"1266",1266,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-13,2013-12-06,55,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",72,"DAYS","CENSORED",2013-10-13,2013-12-23,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,27.9047577528608,5.36331120341248,1.16269823970253,1.56234391126434,2.9027308073189,3.32915550069711,0.30476319291861,1.14737042186945,0.344503182134084,1.68144432993027,0.252518684093286,0.0662137185606479,0.15930728142,"Medium",2,"Q3",3,"Above Median",88.45,">=70 kg",173.99,29.2179176718096,2.06756804939738,97.24,64.8912278897573,67.0414510721731,12,20,11.97,46,"","Y","","",2
"CDISCPILOT01",1,"01-704-1323",1323,"1323",1323,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-08,2013-08-05,29,68,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-07-08,2013-07-08,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,25.3764029280827,4.87781477102913,1.05735012200345,1.28692265983139,2.12796116742933,3.23421371289875,0.0421645921398156,1.04341110541046,0.469933387557088,1.5867453265173,0.0381028628787259,0.0903299031672061,0.0651790553299701,"Medium",2,"Q3",3,"Above Median",59.88,"<70 kg",162.56,22.6597132881766,1.64435843618922,106.08,42.2682352941177,49.3194685527482,16,60,15.39,42,"Y","","","",1
"CDISCPILOT01",1,"01-704-1323",1323,"1323",1323,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-08,2013-08-05,29,68,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",29,"DAYS","CENSORED",2013-07-08,2013-08-05,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,25.3764029280827,4.87781477102913,1.05735012200345,1.28692265983139,2.12796116742933,3.23421371289875,0.0421645921398156,1.04341110541046,0.469933387557088,1.5867453265173,0.0381028628787259,0.0903299031672061,0.0651790553299701,"Medium",2,"Q3",3,"Above Median",59.88,"<70 kg",162.56,22.6597132881766,1.64435843618922,106.08,42.2682352941177,49.3194685527482,16,60,15.39,42,"","Y","","",2
"CDISCPILOT01",1,"01-704-1325",1325,"1325",1325,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-04-23,2014-07-04,73,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-04-23,2014-04-23,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,14.2039071711926,3.0008733743021,0.591829465466358,0.347976665014349,3.80177083313521,2.65422086358224,-1.11822702861455,0.58402739445158,0.263035317985048,1.10223019424867,-0.790834085175003,0.0555717291537426,-0.507781153760877,"Low",1,"Q1",1,"Below Median",68.49,"<70 kg",175.26,22.2977761645504,1.82601245888411,106.08,46.8544428733032,60.771245924781,17,21,8.55,35,"Y","","","",1
"CDISCPILOT01",1,"01-704-1325",1325,"1325",1325,"704",704,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-04-23,2014-07-04,73,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",106,"DAYS","CENSORED",2014-04-23,2014-08-06,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,14.2039071711926,3.0008733743021,0.591829465466358,0.347976665014349,3.80177083313521,2.65422086358224,-1.11822702861455,0.58402739445158,0.263035317985048,1.10223019424867,-0.790834085175003,0.0555717291537426,-0.507781153760877,"Low",1,"Q1",1,"Below Median",68.49,"<70 kg",175.26,22.2977761645504,1.82601245888411,106.08,46.8544428733032,60.771245924781,17,21,8.55,35,"","Y","","",2
"CDISCPILOT01",1,"01-704-1332",1332,"1332",1332,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-09,2014-02-14,68,80,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-09,2013-12-09,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,19.0249197993457,3.69774700937295,0.792704991639405,0.5552165370569,4.25757379554292,2.94627517649991,-0.617509661699478,0.782254784274913,0.234875553078342,1.3104244170515,-0.483065123798769,0.0456511976465796,-0.21976801530233,"Low",1,"Q2",2,"Below Median",78.47,">=70 kg",173,26.2187176317284,1.94188553845082,97.24,59.5545660222131,67.880560696051,15,36,17.1,38,"Y","","","",1
"CDISCPILOT01",1,"01-704-1332",1332,"1332",1332,"704",704,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-09,2014-02-14,68,80,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",78,"DAYS","CENSORED",2013-12-09,2014-02-24,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,19.0249197993457,3.69774700937295,0.792704991639405,0.5552165370569,4.25757379554292,2.94627517649991,-0.617509661699478,0.782254784274913,0.234875553078342,1.3104244170515,-0.483065123798769,0.0456511976465796,-0.21976801530233,"Low",1,"Q2",2,"Below Median",78.47,">=70 kg",173,26.2187176317284,1.94188553845082,97.24,59.5545660222131,67.880560696051,15,36,17.1,38,"","Y","","",2
"CDISCPILOT01",1,"01-704-1351",1351,"1351",1351,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-12,2014-04-18,189,70,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-12,2013-10-12,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,73.48,">=70 kg",175.26,23.9223330788607,1.89136229563067,106.08,59.6401583710407,65.0742578440118,14,18,15.39,45,"Y","","","",1
"CDISCPILOT01",1,"01-704-1351",1351,"1351",1351,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-12,2014-04-18,189,70,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",189,"DAYS","CENSORED",2013-10-12,2014-04-18,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,73.48,">=70 kg",175.26,23.9223330788607,1.89136229563067,106.08,59.6401583710407,65.0742578440118,14,18,15.39,45,"","Y","","",2
"CDISCPILOT01",1,"01-704-1388",1388,"1388",1388,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-12-07,2013-06-11,187,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-07,2012-12-07,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.51,"<70 kg",176.53,18.7755667680478,1.69384263174331,97.24,43.6658854380913,67.4597012197355,36,38,13.68,43,"Y","","","",1
"CDISCPILOT01",1,"01-704-1388",1388,"1388",1388,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-12-07,2013-06-11,187,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",195,"DAYS","CENSORED",2012-12-07,2013-06-19,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.51,"<70 kg",176.53,18.7755667680478,1.69384263174331,97.24,43.6658854380913,67.4597012197355,36,38,13.68,43,"","Y","","",2
"CDISCPILOT01",1,"01-704-1435",1435,"1435",1435,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-11-17,2013-01-09,54,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-11-17,2012-11-17,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,76.2,">=70 kg",167.64,27.1143792976291,1.8837144157223,97.24,63.6149321266968,70.4614322133439,13,17,10.26,41,"Y","","","",1
"CDISCPILOT01",1,"01-704-1435",1435,"1435",1435,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-11-17,2013-01-09,54,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",57,"DAYS","CENSORED",2012-11-17,2013-01-12,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,76.2,">=70 kg",167.64,27.1143792976291,1.8837144157223,97.24,63.6149321266968,70.4614322133439,13,17,10.26,41,"","Y","","",2
"CDISCPILOT01",1,"01-704-1445",1445,"1445",1445,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-05-11,2014-11-01,175,75,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",175,"DAYS","EVENT",2014-05-11,2014-11-01,0,1,"Death","ADRS","ADT",8,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,72.12,">=70 kg",177.8,22.8135150147851,1.8873067229962,88.4,65.2261764705882,78.5094041163344,34,31,6.84,38,"Y","","","",1
"CDISCPILOT01",1,"01-704-1445",1445,"1445",1445,"704",704,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-05-11,2014-11-01,175,75,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",175,"DAYS","EVENT",2014-05-11,2014-11-01,0,1,"Death","ADRS","ADT",8,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,72.12,">=70 kg",177.8,22.8135150147851,1.8873067229962,88.4,65.2261764705882,78.5094041163344,34,31,6.84,38,"","Y","","",2
"CDISCPILOT01",1,"01-705-1018",1018,"1018",1018,"705",705,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-07-05,,,69,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-07-05,2013-07-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,48.99,"<70 kg",147.32,22.5727264772009,1.41590242130829,88.4,40.9210588235294,61.0007080257338,12,23,6.84,41,"Y","","","",1
"CDISCPILOT01",1,"01-705-1018",1018,"1018",1018,"705",705,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-07-05,,,69,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-07-05,2013-07-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,48.99,"<70 kg",147.32,22.5727264772009,1.41590242130829,88.4,40.9210588235294,61.0007080257338,12,23,6.84,41,"","Y","","",2
"CDISCPILOT01",1,"01-705-1031",1031,"1031",1031,"705",705,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-11-27,2013-12-18,22,56,"<65",1,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-11-27,2013-11-27,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,11.7540799745272,1.81320591441202,0.489753332271968,0.293302549071097,4.59414944572656,2.46505081891135,-1.3726696359929,0.483296928018592,0.21766814767643,0.600596442917321,-1.31535842100177,0.0335778873039263,-0.693640637745983,"Low",1,"Q1",1,"Below Median",71.67,">=70 kg",157.48,28.8992513468898,1.77063952664943,88.4,70.8268235294118,66.1375304520839,18,16,5.13,38,"Y","","","",1
"CDISCPILOT01",1,"01-705-1031",1031,"1031",1031,"705",705,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-11-27,2013-12-18,22,56,"<65",1,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",166,"DAYS","CENSORED",2013-11-27,2014-05-11,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,11.7540799745272,1.81320591441202,0.489753332271968,0.293302549071097,4.59414944572656,2.46505081891135,-1.3726696359929,0.483296928018592,0.21766814767643,0.600596442917321,-1.31535842100177,0.0335778873039263,-0.693640637745983,"Low",1,"Q1",1,"Below Median",71.67,">=70 kg",157.48,28.8992513468898,1.77063952664943,88.4,70.8268235294118,66.1375304520839,18,16,5.13,38,"","Y","","",2
"CDISCPILOT01",1,"01-705-1059",1059,"1059",1059,"705",705,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-08-05,2013-12-05,123,66,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-05,2013-08-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,53.98,"<70 kg",162.6,20.4169938378351,1.56144057417075,88.4,46.9943529411765,62.149537143963,20,23,10.26,38,"Y","","","",1
"CDISCPILOT01",1,"01-705-1059",1059,"1059",1059,"705",705,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-08-05,2013-12-05,123,66,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",123,"DAYS","CENSORED",2013-08-05,2013-12-05,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,53.98,"<70 kg",162.6,20.4169938378351,1.56144057417075,88.4,46.9943529411765,62.149537143963,20,23,10.26,38,"","Y","","",2
"CDISCPILOT01",1,"01-705-1186",1186,"1186",1186,"705",705,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-08,2014-01-26,19,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-08,2014-01-08,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,39.92,"<70 kg",142.24,19.7309068087524,1.25589950057939,70.72,32.8752941176471,72.6292864744312,50,54,25.65,34,"Y","","","",1
"CDISCPILOT01",1,"01-705-1186",1186,"1186",1186,"705",705,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-08,2014-01-26,19,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",31,"DAYS","CENSORED",2014-01-08,2014-02-07,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,39.92,"<70 kg",142.24,19.7309068087524,1.25589950057939,70.72,32.8752941176471,72.6292864744312,50,54,25.65,34,"","Y","","",2
"CDISCPILOT01",1,"01-705-1199",1199,"1199",1199,"705",705,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-16,2013-09-28,13,87,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-16,2013-09-16,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,15.1263241842382,2.1095325894987,0.630263507676593,0.536247795734979,3.5699353882861,2.71709743017201,-1.02242345919996,0.621954761776216,0.28011711452293,0.751195587723815,-1.18448798993685,0.03906541832405,-0.445875456621587,"Low",1,"Q1",1,"Below Median",64.41,"<70 kg",161.29,24.7593030371131,1.69874863257242,114.92,36.5374860772711,53.1835798965913,12,15,10.26,35,"Y","","","",1
"CDISCPILOT01",1,"01-705-1199",1199,"1199",1199,"705",705,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-16,2013-09-28,13,87,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",14,"DAYS","CENSORED",2013-09-16,2013-09-29,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,15.1263241842382,2.1095325894987,0.630263507676593,0.536247795734979,3.5699353882861,2.71709743017201,-1.02242345919996,0.621954761776216,0.28011711452293,0.751195587723815,-1.18448798993685,0.03906541832405,-0.445875456621587,"Low",1,"Q1",1,"Below Median",64.41,"<70 kg",161.29,24.7593030371131,1.69874863257242,114.92,36.5374860772711,53.1835798965913,12,15,10.26,35,"","Y","","",2
"CDISCPILOT01",1,"01-705-1280",1280,"1280",1280,"705",705,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-17,2014-07-25,190,56,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-17,2014-01-17,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,18.2631082257401,3.15773914948621,0.76096284273917,0.822272418257024,4.43517056345526,2.90543048321822,-0.696632517133146,0.750931091221053,0.225470471922717,1.15301813138479,-0.721555503988642,0.0389844339442742,-0.260115100173969,"Low",1,"Q2",2,"Below Median",69.4,"<70 kg",157.48,27.9839269355958,1.74237322191442,88.4,68.5835294117647,66.1375304520839,12,19,6.84,42,"Y","","","",1
"CDISCPILOT01",1,"01-705-1280",1280,"1280",1280,"705",705,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-17,2014-07-25,190,56,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",190,"DAYS","CENSORED",2014-01-17,2014-07-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,18.2631082257401,3.15773914948621,0.76096284273917,0.822272418257024,4.43517056345526,2.90543048321822,-0.696632517133146,0.750931091221053,0.225470471922717,1.15301813138479,-0.721555503988642,0.0389844339442742,-0.260115100173969,"Low",1,"Q2",2,"Below Median",69.4,"<70 kg",157.48,27.9839269355958,1.74237322191442,88.4,68.5835294117647,66.1375304520839,12,19,6.84,42,"","Y","","",2
"CDISCPILOT01",1,"01-705-1281",1281,"1281",1281,"705",705,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-11-28,2014-02-27,92,73,"65-75",2,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-11-28,2013-11-28,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,22.5631279176754,5.48869430906302,0.940130329903142,0.86366509340524,3.58992779261543,3.11676016862964,-0.25002623254151,0.927736618496307,0.278557134786116,1.7045106657028,0.307893182794576,0.0677616581365805,-0.0511561144254238,"Medium",2,"Q2",2,"Below Median",73.03,">=70 kg",152.4,31.4435351092924,1.75829557621389,88.4,57.5648235294118,59.5019016074244,14,18,10.26,36,"Y","","","",1
"CDISCPILOT01",1,"01-705-1281",1281,"1281",1281,"705",705,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-11-28,2014-02-27,92,73,"65-75",2,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",110,"DAYS","CENSORED",2013-11-28,2014-03-17,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,22.5631279176754,5.48869430906302,0.940130329903142,0.86366509340524,3.58992779261543,3.11676016862964,-0.25002623254151,0.927736618496307,0.278557134786116,1.7045106657028,0.307893182794576,0.0677616581365805,-0.0511561144254238,"Medium",2,"Q2",2,"Below Median",73.03,">=70 kg",152.4,31.4435351092924,1.75829557621389,88.4,57.5648235294118,59.5019016074244,14,18,10.26,36,"","Y","","",2
"CDISCPILOT01",1,"01-705-1282",1282,"1282",1282,"705",705,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-12-26,2013-06-24,181,70,"65-75",2,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-26,2012-12-26,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,73.03,">=70 kg",154.94,30.4210498235562,1.77288749094678,106.08,50.1186274509804,48.7098029830653,29,24,5.13,41,"Y","","","",1
"CDISCPILOT01",1,"01-705-1282",1282,"1282",1282,"705",705,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-12-26,2013-06-24,181,70,"65-75",2,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",181,"DAYS","CENSORED",2012-12-26,2013-06-24,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,73.03,">=70 kg",154.94,30.4210498235562,1.77288749094678,106.08,50.1186274509804,48.7098029830653,29,24,5.13,41,"","Y","","",2
"CDISCPILOT01",1,"01-705-1292",1292,"1292",1292,"705",705,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-10-14,2014-05-13,212,60,"<65",1,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-14,2013-10-14,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,12.4487270746054,1.7971561982063,0.518696961441892,0.281027699172726,4.33779290656604,2.52242134719393,-1.30052258023636,0.511858994148171,0.230531982863063,0.591754448497615,-1.3224466565705,0.0332806703371537,-0.637339862982721,"Low",1,"Q1",1,"Below Median",75.3,">=70 kg",167.64,26.7941307232477,1.87255707523162,88.4,70.8705882352941,64.5125107049213,33,43,8.55,38,"Y","","","",1
"CDISCPILOT01",1,"01-705-1292",1292,"1292",1292,"705",705,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-10-14,2014-05-13,212,60,"<65",1,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",213,"DAYS","CENSORED",2013-10-14,2014-05-14,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,12.4487270746054,1.7971561982063,0.518696961441892,0.281027699172726,4.33779290656604,2.52242134719393,-1.30052258023636,0.511858994148171,0.230531982863063,0.591754448497615,-1.3224466565705,0.0332806703371537,-0.637339862982721,"Low",1,"Q1",1,"Below Median",75.3,">=70 kg",167.64,26.7941307232477,1.87255707523162,88.4,70.8705882352941,64.5125107049213,33,43,8.55,38,"","Y","","",2
"CDISCPILOT01",1,"01-705-1303",1303,"1303",1303,"705",705,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-16,2013-12-30,15,72,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-16,2013-12-16,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,26.944574451653,4.82593064243104,1.12269060215221,0.946790193772024,3.00617106220546,3.29415302141685,0.205037162016102,1.10789020386735,0.332649067304359,1.57607359072063,0.0151886305603763,0.0595793906472968,0.124595866334996,"Medium",2,"Q3",3,"Above Median",84.37,">=70 kg",175.26,27.4677087896499,2.02667531522277,114.92,61.4053846153846,58.3838433944817,17,19,11.97,39,"Y","","","",1
"CDISCPILOT01",1,"01-705-1303",1303,"1303",1303,"705",705,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-16,2013-12-30,15,72,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",113,"DAYS","CENSORED",2013-12-16,2014-04-07,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,26.944574451653,4.82593064243104,1.12269060215221,0.946790193772024,3.00617106220546,3.29415302141685,0.205037162016102,1.10789020386735,0.332649067304359,1.57607359072063,0.0151886305603763,0.0595793906472968,0.124595866334996,"Medium",2,"Q3",3,"Above Median",84.37,">=70 kg",175.26,27.4677087896499,2.02667531522277,114.92,61.4053846153846,58.3838433944817,17,19,11.97,39,"","Y","","",2
"CDISCPILOT01",1,"01-705-1310",1310,"1310",1310,"705",705,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-11-02,2014-01-23,83,74,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-11-02,2013-11-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,21.2480830704439,4.15151104319475,0.885336794601829,0.488453927331637,3.81210859028837,3.05673720282997,-0.386608698522986,0.873665424812837,0.262322013215357,1.42587823985777,-0.282663676002528,0.0512532227554908,-0.110555324675248,"Medium",2,"Q2",2,"Below Median",48.54,"<70 kg",146.05,22.7560379506392,1.40329641677492,88.4,37.6898823529412,59.1329898174584,10,20,17.1,37,"Y","","","",1
"CDISCPILOT01",1,"01-705-1310",1310,"1310",1310,"705",705,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-11-02,2014-01-23,83,74,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",83,"DAYS","CENSORED",2013-11-02,2014-01-23,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,21.2480830704439,4.15151104319475,0.885336794601829,0.488453927331637,3.81210859028837,3.05673720282997,-0.386608698522986,0.873665424812837,0.262322013215357,1.42587823985777,-0.282663676002528,0.0512532227554908,-0.110555324675248,"Medium",2,"Q2",2,"Below Median",48.54,"<70 kg",146.05,22.7560379506392,1.40329641677492,88.4,37.6898823529412,59.1329898174584,10,20,17.1,37,"","Y","","",2
"CDISCPILOT01",1,"01-705-1349",1349,"1349",1349,"705",705,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-10,2013-09-08,183,86,">75",3,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-10,2013-03-10,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,44.45,"<70 kg",144.78,21.205798028709,1.33702312370928,88.4,28.2388235294118,54.880460490736,21,40,27.36,34,"Y","","","",1
"CDISCPILOT01",1,"01-705-1349",1349,"1349",1349,"705",705,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-03-10,2013-09-08,183,86,">75",3,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-03-10,2013-09-08,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,44.45,"<70 kg",144.78,21.205798028709,1.33702312370928,88.4,28.2388235294118,54.880460490736,21,40,27.36,34,"","Y","","",2
"CDISCPILOT01",1,"01-705-1377",1377,"1377",1377,"705",705,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-04,2014-01-25,22,63,"<65",1,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-04,2014-01-04,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,39.5638201965197,5.36696675652909,1.64849250818832,0.793044931609521,2.04732504590458,3.67816779348491,1.51569033577568,1.62676047832718,0.488442224648391,1.68212441527711,0.254133131432564,0.0662588488460381,0.505909062173374,"High",3,"Q4",4,"Above Median",57.15,"<70 kg",165.1,20.9663141219774,1.61893869556571,97.24,47.0647058823529,56.4767502918193,18,23,3.42,42,"Y","","","",1
"CDISCPILOT01",1,"01-705-1377",1377,"1377",1377,"705",705,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-04,2014-01-25,22,63,"<65",1,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",35,"DAYS","CENSORED",2014-01-04,2014-02-07,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,39.5638201965197,5.36696675652909,1.64849250818832,0.793044931609521,2.04732504590458,3.67816779348491,1.51569033577568,1.62676047832718,0.488442224648391,1.68212441527711,0.254133131432564,0.0662588488460381,0.505909062173374,"High",3,"Q4",4,"Above Median",57.15,"<70 kg",165.1,20.9663141219774,1.61893869556571,97.24,47.0647058823529,56.4767502918193,18,23,3.42,42,"","Y","","",2
"CDISCPILOT01",1,"01-705-1382",1382,"1382",1382,"705",705,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-05-13,,,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-13,2013-05-13,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,36.128430779443,8.53213207761981,1.50535128247679,0.511253041576202,2.24200161071177,3.58735686361936,1.15888580612118,1.48550627932404,0.446030009622753,2.14501063444207,1.65200441602655,0.105334963921232,0.41564728170537,"High",3,"Q4",4,"Above Median",96.16,">=70 kg",170.18,33.2030069272881,2.13206399737177,106.08,64.6686877828054,60.3944642000474,13,21,11.97,41,"Y","","","",1
"CDISCPILOT01",1,"01-705-1382",1382,"1382",1382,"705",705,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-05-13,,,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-13,2013-05-13,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,36.128430779443,8.53213207761981,1.50535128247679,0.511253041576202,2.24200161071177,3.58735686361936,1.15888580612118,1.48550627932404,0.446030009622753,2.14501063444207,1.65200441602655,0.105334963921232,0.41564728170537,"High",3,"Q4",4,"Above Median",96.16,">=70 kg",170.18,33.2030069272881,2.13206399737177,106.08,64.6686877828054,60.3944642000474,13,21,11.97,41,"","Y","","",2
"CDISCPILOT01",1,"01-705-1393",1393,"1393",1393,"705",705,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-07,2013-02-01,148,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-07,2012-09-07,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,27.0449329451191,5.53594212190408,1.12687220604663,0.318636804442163,1.9966771635034,3.29786935262625,0.215460540769031,1.11201668179654,0.50083209157628,1.71306651113193,0.328759821383813,0.102517446701927,0.128280812714172,"Medium",2,"Q3",3,"Above Median",56.25,"<70 kg",144.78,26.8352337258691,1.50405701354703,123.76,26.4705882352941,37.1078779200745,12,18,5.13,32,"Y","","","",1
"CDISCPILOT01",1,"01-705-1393",1393,"1393",1393,"705",705,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-07,2013-02-01,148,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",167,"DAYS","CENSORED",2012-09-07,2013-02-20,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,27.0449329451191,5.53594212190408,1.12687220604663,0.318636804442163,1.9966771635034,3.29786935262625,0.215460540769031,1.11201668179654,0.50083209157628,1.71306651113193,0.328759821383813,0.102517446701927,0.128280812714172,"Medium",2,"Q3",3,"Above Median",56.25,"<70 kg",144.78,26.8352337258691,1.50405701354703,123.76,26.4705882352941,37.1078779200745,12,18,5.13,32,"","Y","","",2
"CDISCPILOT01",1,"01-705-1431",1431,"1431",1431,"705",705,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-06-23,2013-12-19,180,68,"65-75",2,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-06-23,2013-06-23,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,15.0944531987818,2.36048050658835,0.628935549949241,0.414627826817779,3.57747308159253,2.71498961416895,-1.02573362599471,0.620644310477823,0.279526911088551,0.8630926799929,-1.07365874354936,0.0437126019738584,-0.447951690490705,"Low",1,"Q1",1,"Below Median",54.43,"<70 kg",149.86,24.2363311500538,1.50525743460859,70.72,57.6317647058824,80.2283571238921,16,23,6.84,41,"Y","","","",1
"CDISCPILOT01",1,"01-705-1431",1431,"1431",1431,"705",705,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-06-23,2013-12-19,180,68,"65-75",2,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",180,"DAYS","CENSORED",2013-06-23,2013-12-19,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,15.0944531987818,2.36048050658835,0.628935549949241,0.414627826817779,3.57747308159253,2.71498961416895,-1.02573362599471,0.620644310477823,0.279526911088551,0.8630926799929,-1.07365874354936,0.0437126019738584,-0.447951690490705,"Low",1,"Q1",1,"Below Median",54.43,"<70 kg",149.86,24.2363311500538,1.50525743460859,70.72,57.6317647058824,80.2283571238921,16,23,6.84,41,"","Y","","",2
"CDISCPILOT01",1,"01-706-1041",1041,"1041",1041,"706",706,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-12-31,2014-07-28,210,64,"<65",1,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-31,2013-12-31,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.74,"<70 kg",167.64,20.9015569546291,1.65388209978825,70.72,65.6505882352941,82.2492467650512,15,21,6.84,37,"Y","","","",1
"CDISCPILOT01",1,"01-706-1041",1041,"1041",1041,"706",706,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-12-31,2014-07-28,210,64,"<65",1,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",211,"DAYS","CENSORED",2013-12-31,2014-07-29,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.74,"<70 kg",167.64,20.9015569546291,1.65388209978825,70.72,65.6505882352941,82.2492467650512,15,21,6.84,37,"","Y","","",2
"CDISCPILOT01",1,"01-706-1049",1049,"1049",1049,"706",706,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-14,2013-06-18,36,60,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-14,2013-05-14,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,53.743438671859,13.1502730753589,2.23930994466079,1.33620710095169,1.50716072513635,3.98440764025184,2.98840608544427,2.20978918533433,0.663499242862457,2.57720267608909,3.69157140038902,0.162349050313072,0.810623477915076,"High",3,"Q4",4,"Above Median",57.83,"<70 kg",167.64,20.5777500627545,1.64102112519411,106.08,45.356862745098,51.8353993633953,23,25,8.55,38,"Y","","","",1
"CDISCPILOT01",1,"01-706-1049",1049,"1049",1049,"706",706,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-14,2013-06-18,36,60,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",43,"DAYS","CENSORED",2013-05-14,2013-06-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,53.743438671859,13.1502730753589,2.23930994466079,1.33620710095169,1.50716072513635,3.98440764025184,2.98840608544427,2.20978918533433,0.663499242862457,2.57720267608909,3.69157140038902,0.162349050313072,0.810623477915076,"High",3,"Q4",4,"Above Median",57.83,"<70 kg",167.64,20.5777500627545,1.64102112519411,106.08,45.356862745098,51.8353993633953,23,25,8.55,38,"","Y","","",2
"CDISCPILOT01",1,"01-706-1384",1384,"1384",1384,"706",706,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-15,2012-09-24,10,74,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-15,2012-09-15,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,16.0403445538551,2.59297408606822,0.668347689743962,0.380331935650299,3.36651122541017,2.77573031687551,-0.927491977355532,0.659536881154301,0.297043417663983,0.956654670553045,-0.970979715556162,0.0480180386308929,-0.388095305755797,"Low",1,"Q1",1,"Below Median",75.98,">=70 kg",157.48,30.6371580485096,1.82310254480896,88.4,58.9962352941177,59.1329898174584,16,18,6.84,40,"Y","","","",1
"CDISCPILOT01",1,"01-706-1384",1384,"1384",1384,"706",706,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-15,2012-09-24,10,74,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",15,"DAYS","CENSORED",2012-09-15,2012-09-29,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,16.0403445538551,2.59297408606822,0.668347689743962,0.380331935650299,3.36651122541017,2.77573031687551,-0.927491977355532,0.659536881154301,0.297043417663983,0.956654670553045,-0.970979715556162,0.0480180386308929,-0.388095305755797,"Low",1,"Q1",1,"Below Median",75.98,">=70 kg",157.48,30.6371580485096,1.82310254480896,88.4,58.9962352941177,59.1329898174584,16,18,6.84,40,"","Y","","",2
"CDISCPILOT01",1,"01-707-1037",1037,"1037",1037,"707",707,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-12-20,2013-12-24,5,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-20,2013-12-20,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,36.3117695365614,9.11863916161053,1.51299039735672,0.936265150752864,1.48712113700845,3.59241727326658,1.17792763546254,1.49304468796973,0.672440176602989,2.21141663219539,1.91103082626128,0.168863688177973,0.420675768808922,"High",3,"Q4",4,"Above Median",55.34,"<70 kg",152.4,23.8269920984286,1.5305968334825,114.92,34.0553846153846,43.7018508294988,5,26,5.13,43,"Y","","","",1
"CDISCPILOT01",1,"01-707-1037",1037,"1037",1037,"707",707,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-12-20,2013-12-24,5,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",20,"DAYS","CENSORED",2013-12-20,2014-01-08,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,36.3117695365614,9.11863916161053,1.51299039735672,0.936265150752864,1.48712113700845,3.59241727326658,1.17792763546254,1.49304468796973,0.672440176602989,2.21141663219539,1.91103082626128,0.168863688177973,0.420675768808922,"High",3,"Q4",4,"Above Median",55.34,"<70 kg",152.4,23.8269920984286,1.5305968334825,114.92,34.0553846153846,43.7018508294988,5,26,5.13,43,"","Y","","",2
"CDISCPILOT01",1,"01-707-1206",1206,"1206",1206,"707",707,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-28,2014-04-26,181,65,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-28,2013-10-28,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,74.39,">=70 kg",173.99,24.5734414426898,1.8961302771112,114.92,59.7152584406544,60.9817290814098,18,20,5.13,37,"Y","","","",1
"CDISCPILOT01",1,"01-707-1206",1206,"1206",1206,"707",707,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-28,2014-04-26,181,65,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2013-10-28,2014-04-27,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,74.39,">=70 kg",173.99,24.5734414426898,1.8961302771112,114.92,59.7152584406544,60.9817290814098,18,20,5.13,37,"","Y","","",2
"CDISCPILOT01",1,"01-708-1019",1019,"1019",1019,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-12-20,2014-01-01,13,68,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-20,2013-12-20,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,10.1150726457807,1.90008329970606,0.421461360240863,0.214421934882893,5.3385676891332,2.31501478785879,-1.54289931537851,0.415905247112915,0.18731616010705,0.647146853519092,-1.27698968197449,0.0351867277723344,-0.840577319998139,"Low",1,"Q1",1,"Below Median",74.39,">=70 kg",182.88,22.2424248860843,1.94396810673426,123.76,53.2318875242405,54.7614692088909,14,19,6.84,40,"Y","","","",1
"CDISCPILOT01",1,"01-708-1019",1019,"1019",1019,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-12-20,2014-01-01,13,68,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",35,"DAYS","CENSORED",2013-12-20,2014-01-23,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,10.1150726457807,1.90008329970606,0.421461360240863,0.214421934882893,5.3385676891332,2.31501478785879,-1.54289931537851,0.415905247112915,0.18731616010705,0.647146853519092,-1.27698968197449,0.0351867277723344,-0.840577319998139,"Low",1,"Q1",1,"Below Median",74.39,">=70 kg",182.88,22.2424248860843,1.94396810673426,123.76,53.2318875242405,54.7614692088909,14,19,6.84,40,"","Y","","",2
"CDISCPILOT01",1,"01-708-1032",1032,"1032",1032,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-09,2013-03-01,21,62,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-09,2013-02-09,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,21.054616071332,2.79003340050805,0.877275669638835,0.657307276905956,2.56475823719846,3.04759466936088,-0.406702461774001,0.865710569431014,0.38990029761726,1.02963134586288,-0.883949962265966,0.0516672851945935,-0.119599556187559,"Medium",2,"Q2",2,"Below Median",82.56,">=70 kg",177.8,26.1159705992881,2.0192936058599,114.92,68.9245248868778,62.1302007683144,20,24,22.23,40,"Y","","","",1
"CDISCPILOT01",1,"01-708-1032",1032,"1032",1032,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-09,2013-03-01,21,62,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",29,"DAYS","CENSORED",2013-02-09,2013-03-09,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,21.054616071332,2.79003340050805,0.877275669638835,0.657307276905956,2.56475823719846,3.04759466936088,-0.406702461774001,0.865710569431014,0.38990029761726,1.02963134586288,-0.883949962265966,0.0516672851945935,-0.119599556187559,"Medium",2,"Q2",2,"Below Median",82.56,">=70 kg",177.8,26.1159705992881,2.0192936058599,114.92,68.9245248868778,62.1302007683144,20,24,22.23,40,"","Y","","",2
"CDISCPILOT01",1,"01-708-1084",1084,"1084",1084,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-05-09,2013-11-11,187,73,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-09,2013-05-09,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,27.538074244572,8.67593115681516,1.1474197601905,0.578746190567285,1.9609214326468,3.31593263277726,0.266678911684956,1.13229335811839,0.509964337862444,2.16170460831737,1.71551218992348,0.160665391792873,0.146193182925718,"Medium",2,"Q3",3,"Above Median",50.35,"<70 kg",167.64,17.9161285778954,1.53121901329192,70.72,49.6095588235294,77.7719272188965,12,15,6.84,38,"Y","","","",1
"CDISCPILOT01",1,"01-708-1084",1084,"1084",1084,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-05-09,2013-11-11,187,73,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",187,"DAYS","CENSORED",2013-05-09,2013-11-11,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,27.538074244572,8.67593115681516,1.1474197601905,0.578746190567285,1.9609214326468,3.31593263277726,0.266678911684956,1.13229335811839,0.509964337862444,2.16170460831737,1.71551218992348,0.160665391792873,0.146193182925718,"Medium",2,"Q3",3,"Above Median",50.35,"<70 kg",167.64,17.9161285778954,1.53121901329192,70.72,49.6095588235294,77.7719272188965,12,15,6.84,38,"","Y","","",2
"CDISCPILOT01",1,"01-708-1087",1087,"1087",1087,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-10-22,2013-04-28,189,74,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-10-22,2012-10-22,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,66.68,"<70 kg",157.48,26.8871505484946,1.70788745400731,70.72,64.7188235294118,77.2897412701394,9,12,8.55,37,"Y","","","",1
"CDISCPILOT01",1,"01-708-1087",1087,"1087",1087,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-10-22,2013-04-28,189,74,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",189,"DAYS","CENSORED",2012-10-22,2013-04-28,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,66.68,"<70 kg",157.48,26.8871505484946,1.70788745400731,70.72,64.7188235294118,77.2897412701394,9,12,8.55,37,"","Y","","",2
"CDISCPILOT01",1,"01-708-1158",1158,"1158",1158,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-02-08,2014-03-21,42,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-02-08,2014-02-08,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,73.48,">=70 kg",162.56,27.8062079561659,1.82154610763006,106.08,42.503137254902,45.4888847618858,14,13,6.84,41,"Y","","","",1
"CDISCPILOT01",1,"01-708-1158",1158,"1158",1158,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-02-08,2014-03-21,42,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",43,"DAYS","CENSORED",2014-02-08,2014-03-22,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,73.48,">=70 kg",162.56,27.8062079561659,1.82154610763006,106.08,42.503137254902,45.4888847618858,14,13,6.84,41,"","Y","","",2
"CDISCPILOT01",1,"01-708-1171",1171,"1171",1171,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-12-06,2013-06-04,181,77,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-06,2012-12-06,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.89,"<70 kg",162.56,20.7714038474952,1.57435334167538,88.4,40.6831764705882,58.0399213301922,13,27,8.55,42,"Y","","","",1
"CDISCPILOT01",1,"01-708-1171",1171,"1171",1171,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-12-06,2013-06-04,181,77,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",181,"DAYS","CENSORED",2012-12-06,2013-06-04,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.89,"<70 kg",162.56,20.7714038474952,1.57435334167538,88.4,40.6831764705882,58.0399213301922,13,27,8.55,42,"","Y","","",2
"CDISCPILOT01",1,"01-708-1178",1178,"1178",1178,"708",708,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-29,2014-04-06,99,77,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-29,2013-12-29,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,29.0609204163383,6.12712892790962,1.2108716840141,1.41312540044228,2.78724826466477,3.36973837613829,0.42484392475518,1.19490879703445,0.358776795263436,1.81435703148181,0.589852995392556,0.0756435670112299,0.199565098708586,"High",3,"Q3",3,"Above Median",62.82,"<70 kg",165.1,23.0464366254176,1.69734940421824,141.44,29.1004411764706,33.0204384750618,8,20,5.13,39,"Y","","","",1
"CDISCPILOT01",1,"01-708-1178",1178,"1178",1178,"708",708,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-29,2014-04-06,99,77,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",99,"DAYS","CENSORED",2013-12-29,2014-04-06,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,29.0609204163383,6.12712892790962,1.2108716840141,1.41312540044228,2.78724826466477,3.36973837613829,0.42484392475518,1.19490879703445,0.358776795263436,1.81435703148181,0.589852995392556,0.0756435670112299,0.199565098708586,"High",3,"Q3",3,"Above Median",62.82,"<70 kg",165.1,23.0464366254176,1.69734940421824,141.44,29.1004411764706,33.0204384750618,8,20,5.13,39,"","Y","","",2
"CDISCPILOT01",1,"01-708-1213",1213,"1213",1213,"708",708,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-02-09,2013-02-22,14,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-09,2013-02-09,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,41.4570333326089,9.60623023686441,1.72737638885871,0.844029582215734,1.95383011008382,3.72489873402414,1.712322199168,1.70460443504173,0.511815226328505,2.26345232060776,2.12637173063048,0.118595435023017,0.552376152823116,"High",3,"Q4",4,"Above Median",41.73,"<70 kg",165.1,15.3092613877535,1.38339588212003,88.4,31.4202352941176,58.4020138158505,12,15,11.97,42,"Y","","","",1
"CDISCPILOT01",1,"01-708-1213",1213,"1213",1213,"708",708,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-02-09,2013-02-22,14,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",14,"DAYS","CENSORED",2013-02-09,2013-02-22,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,41.4570333326089,9.60623023686441,1.72737638885871,0.844029582215734,1.95383011008382,3.72489873402414,1.712322199168,1.70460443504173,0.511815226328505,2.26345232060776,2.12637173063048,0.118595435023017,0.552376152823116,"High",3,"Q4",4,"Above Median",41.73,"<70 kg",165.1,15.3092613877535,1.38339588212003,88.4,31.4202352941176,58.4020138158505,12,15,11.97,42,"","Y","","",2
"CDISCPILOT01",1,"01-708-1216",1216,"1216",1216,"708",708,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-10-24,2012-11-29,37,78,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-10-24,2012-10-24,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,26.8545563065952,6.54896269302159,1.11893984610813,0.7891285311614,3.01624793480975,3.290807808377,0.19568774685284,1.10418889393356,0.331537732180188,1.88083246438897,0.776152681918562,0.0808513912718715,0.121279003064387,"Medium",2,"Q3",3,"Above Median",77.11,">=70 kg",172.72,25.8479106923612,1.92342570546524,106.08,55.4337160633484,61.9157535727906,17,19,18.81,39,"Y","","","",1
"CDISCPILOT01",1,"01-708-1216",1216,"1216",1216,"708",708,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-10-24,2012-11-29,37,78,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",51,"DAYS","CENSORED",2012-10-24,2012-12-13,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,26.8545563065952,6.54896269302159,1.11893984610813,0.7891285311614,3.01624793480975,3.290807808377,0.19568774685284,1.10418889393356,0.331537732180188,1.88083246438897,0.776152681918562,0.0808513912718715,0.121279003064387,"Medium",2,"Q3",3,"Above Median",77.11,">=70 kg",172.72,25.8479106923612,1.92342570546524,106.08,55.4337160633484,61.9157535727906,17,19,18.81,39,"","Y","","",2
"CDISCPILOT01",1,"01-708-1236",1236,"1236",1236,"708",708,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-09-21,2013-09-21,1,86,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-21,2013-09-21,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,34.0737008245948,6.95141396025695,1.41973753435812,0.881323666054913,2.37719995303631,3.52881928833638,0.945478571569457,1.40102117481242,0.420662973143146,1.94038260892244,0.95389223510023,0.085819925435271,0.357490885018936,"High",3,"Q4",4,"Above Median",54.43,"<70 kg",152.4,23.4351857592604,1.51796025420079,106.08,28.8158823529412,44.0961071844833,13,19,6.84,41,"Y","","","",1
"CDISCPILOT01",1,"01-708-1236",1236,"1236",1236,"708",708,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-09-21,2013-09-21,1,86,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-21,2013-09-21,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,34.0737008245948,6.95141396025695,1.41973753435812,0.881323666054913,2.37719995303631,3.52881928833638,0.945478571569457,1.40102117481242,0.420662973143146,1.94038260892244,0.95389223510023,0.085819925435271,0.357490885018936,"High",3,"Q4",4,"Above Median",54.43,"<70 kg",152.4,23.4351857592604,1.51796025420079,106.08,28.8158823529412,44.0961071844833,13,19,6.84,41,"","Y","","",2
"CDISCPILOT01",1,"01-708-1253",1253,"1253",1253,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-05-07,2013-11-05,183,61,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-07,2013-05-07,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,75.75,">=70 kg",185.42,22.0327894211803,1.975233108606,97.24,75.6954699712053,76.3949349037317,21,22,8.55,40,"Y","","","",1
"CDISCPILOT01",1,"01-708-1253",1253,"1253",1253,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-05-07,2013-11-05,183,61,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-05-07,2013-11-05,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,75.75,">=70 kg",185.42,22.0327894211803,1.975233108606,97.24,75.6954699712053,76.3949349037317,21,22,8.55,40,"","Y","","",2
"CDISCPILOT01",1,"01-708-1272",1272,"1272",1272,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-06,2013-03-22,45,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-06,2013-02-06,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,20.0256079264325,4.02228340801804,0.834400330268023,0.716824520297868,2.69654735069108,2.99751108684875,-0.513576740808117,0.823400454439982,0.370844591230232,1.39433281798588,-0.339736082042685,0.0744867297781119,-0.169128571880593,"Medium",2,"Q2",2,"Below Median",74.39,">=70 kg",172.72,24.9361441629458,1.88919741924683,150.28,35.3139645994144,39.7627051044991,16,21,11.97,40,"Y","","","",1
"CDISCPILOT01",1,"01-708-1272",1272,"1272",1272,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-06,2013-03-22,45,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",58,"DAYS","CENSORED",2013-02-06,2013-04-04,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,20.0256079264325,4.02228340801804,0.834400330268023,0.716824520297868,2.69654735069108,2.99751108684875,-0.513576740808117,0.823400454439982,0.370844591230232,1.39433281798588,-0.339736082042685,0.0744867297781119,-0.169128571880593,"Medium",2,"Q2",2,"Below Median",74.39,">=70 kg",172.72,24.9361441629458,1.88919741924683,150.28,35.3139645994144,39.7627051044991,16,21,11.97,40,"","Y","","",2
"CDISCPILOT01",1,"01-708-1286",1286,"1286",1286,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-10,2014-03-08,180,80,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-10,2013-09-10,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,76.2,">=70 kg",152.4,32.8083989501312,1.79605122421383,106.08,44.8235294117647,45.7726753490499,13,28,6.84,39,"Y","","","",1
"CDISCPILOT01",1,"01-708-1286",1286,"1286",1286,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-10,2014-03-08,180,80,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",180,"DAYS","CENSORED",2013-09-10,2014-03-08,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,76.2,">=70 kg",152.4,32.8083989501312,1.79605122421383,106.08,44.8235294117647,45.7726753490499,13,28,6.84,39,"","Y","","",2
"CDISCPILOT01",1,"01-708-1296",1296,"1296",1296,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-06-14,2013-12-12,182,57,"<65",1,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-06-14,2013-06-14,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,80.74,">=70 kg",170.18,27.8786478713523,1.95365278957706,114.92,71.7259537069265,64.0925860225862,16,19,10.26,41,"Y","","","",1
"CDISCPILOT01",1,"01-708-1296",1296,"1296",1296,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-06-14,2013-12-12,182,57,"<65",1,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2013-06-14,2013-12-12,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,80.74,">=70 kg",170.18,27.8786478713523,1.95365278957706,114.92,71.7259537069265,64.0925860225862,16,19,10.26,41,"","Y","","",2
"CDISCPILOT01",1,"01-708-1297",1297,"1297",1297,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-01-25,2013-05-03,99,61,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-25,2013-01-25,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,17.723665859915,4.1254269086563,0.738486077496459,0.428987731521439,3.04677375588139,2.87546485900265,-0.752659783985968,0.728750636535418,0.328216034442871,1.41959056586869,-0.294183536406606,0.0763967946047462,-0.289702675834578,"Low",1,"Q2",2,"Below Median",78.93,">=70 kg",185.42,22.95773028401,2.0162672193933,114.92,66.7388452836756,62.5178111977403,19,20,8.55,42,"Y","","","",1
"CDISCPILOT01",1,"01-708-1297",1297,"1297",1297,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-01-25,2013-05-03,99,61,"<65",1,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",104,"DAYS","CENSORED",2013-01-25,2013-05-08,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,17.723665859915,4.1254269086563,0.738486077496459,0.428987731521439,3.04677375588139,2.87546485900265,-0.752659783985968,0.728750636535418,0.328216034442871,1.41959056586869,-0.294183536406606,0.0763967946047462,-0.289702675834578,"Low",1,"Q2",2,"Below Median",78.93,">=70 kg",185.42,22.95773028401,2.0162672193933,114.92,66.7388452836756,62.5178111977403,19,20,8.55,42,"","Y","","",2
"CDISCPILOT01",1,"01-708-1316",1316,"1316",1316,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-08-23,2014-03-01,191,74,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-23,2013-08-23,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,59.88,"<70 kg",160.02,23.3847784400028,1.63146130815291,70.72,58.1188235294118,77.2897412701394,11,25,10.26,44,"Y","","","",1
"CDISCPILOT01",1,"01-708-1316",1316,"1316",1316,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-08-23,2014-03-01,191,74,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",191,"DAYS","CENSORED",2013-08-23,2014-03-01,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,59.88,"<70 kg",160.02,23.3847784400028,1.63146130815291,70.72,58.1188235294118,77.2897412701394,11,25,10.26,44,"","Y","","",2
"CDISCPILOT01",1,"01-708-1336",1336,"1336",1336,"708",708,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-12-07,2013-06-05,181,73,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-07,2012-12-07,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,29.5173459120209,4.7668108148063,1.22988941300087,0.532979841679604,2.74414916034212,3.38531681403359,0.472248939016391,1.21367581584076,0.364411677926184,1.56377313027553,-0.0109211934150372,0.0588495162321766,0.215022192576085,"High",3,"Q3",3,"Above Median",87.54,">=70 kg",190.5,24.1221815776965,2.15228367089471,106.08,68.0068947963801,63.87136550251,16,18,10.26,42,"Y","","","",1
"CDISCPILOT01",1,"01-708-1336",1336,"1336",1336,"708",708,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-12-07,2013-06-05,181,73,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",181,"DAYS","CENSORED",2012-12-07,2013-06-05,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,29.5173459120209,4.7668108148063,1.22988941300087,0.532979841679604,2.74414916034212,3.38531681403359,0.472248939016391,1.21367581584076,0.364411677926184,1.56377313027553,-0.0109211934150372,0.0588495162321766,0.215022192576085,"High",3,"Q3",3,"Above Median",87.54,">=70 kg",190.5,24.1221815776965,2.15228367089471,106.08,68.0068947963801,63.87136550251,16,18,10.26,42,"","Y","","",2
"CDISCPILOT01",1,"01-708-1342",1342,"1342",1342,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-12-29,2013-06-28,182,59,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-29,2012-12-29,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.97,"<70 kg",170.18,20.3617025634586,1.66962359364153,79.56,62.4388235294118,73.6637697940494,13,20,10.26,42,"Y","","","",1
"CDISCPILOT01",1,"01-708-1342",1342,"1342",1342,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-12-29,2013-06-28,182,59,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2012-12-29,2013-06-28,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.97,"<70 kg",170.18,20.3617025634586,1.66962359364153,79.56,62.4388235294118,73.6637697940494,13,20,10.26,42,"","Y","","",2
"CDISCPILOT01",1,"01-708-1347",1347,"1347",1347,"708",708,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-04-20,2013-06-18,60,61,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-20,2013-04-20,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,24.2176403434674,5.88948809690177,1.00906834764448,0.381506202252028,3.34466937534851,3.18749414434397,-0.0781861712786506,0.995765828309985,0.298983214116882,1.77486558391054,0.484900722757881,0.0727097295913798,0.0188888252439522,"Medium",2,"Q2",2,"Below Median",74.84,">=70 kg",160.02,29.227067776383,1.82390734413785,97.24,63.2337967914439,57.183629154632,21,25,8.55,42,"Y","","","",1
"CDISCPILOT01",1,"01-708-1347",1347,"1347",1347,"708",708,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-04-20,2013-06-18,60,61,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",67,"DAYS","CENSORED",2013-04-20,2013-06-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,24.2176403434674,5.88948809690177,1.00906834764448,0.381506202252028,3.34466937534851,3.18749414434397,-0.0781861712786506,0.995765828309985,0.298983214116882,1.77486558391054,0.484900722757881,0.0727097295913798,0.0188888252439522,"Medium",2,"Q2",2,"Below Median",74.84,">=70 kg",160.02,29.227067776383,1.82390734413785,97.24,63.2337967914439,57.183629154632,21,25,8.55,42,"","Y","","",2
"CDISCPILOT01",1,"01-708-1348",1348,"1348",1348,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-08-05,2014-02-13,193,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-05,2013-08-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,11.9941587975832,3.13825530628776,0.499756616565965,0.291145631436782,4.5021915176645,2.48525315621298,-1.34773470107267,0.493168339300181,0.222114051807096,1.14684842837457,-0.730160395726573,0.058115839005329,-0.673821889590301,"Low",1,"Q1",1,"Below Median",60.33,"<70 kg",160.02,23.5605157529287,1.63758007437804,88.4,43.2956470588235,57.3224573602738,15,15,5.13,38,"Y","","","",1
"CDISCPILOT01",1,"01-708-1348",1348,"1348",1348,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-08-05,2014-02-13,193,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",193,"DAYS","CENSORED",2013-08-05,2014-02-13,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,11.9941587975832,3.13825530628776,0.499756616565965,0.291145631436782,4.5021915176645,2.48525315621298,-1.34773470107267,0.493168339300181,0.222114051807096,1.14684842837457,-0.730160395726573,0.058115839005329,-0.673821889590301,"Low",1,"Q1",1,"Below Median",60.33,"<70 kg",160.02,23.5605157529287,1.63758007437804,88.4,43.2956470588235,57.3224573602738,15,15,5.13,38,"","Y","","",2
"CDISCPILOT01",1,"01-708-1353",1353,"1353",1353,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-04,2013-08-28,56,87,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-07-04,2013-07-04,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,30.6130994888034,4.36065356868029,1.27554581203347,0.723660420130406,1.76395075643191,3.42175460943078,0.586055495454411,1.25873032786314,0.566909249792655,1.47491255597522,-0.190297464097061,0.0807528438644498,0.251183384609984,"High",3,"Q3",3,"Above Median",50.35,"<70 kg",157.48,20.3024599597586,1.48409325103842,114.92,24.1497737556561,39.8093160725223,10,27,8.55,37,"Y","","","",1
"CDISCPILOT01",1,"01-708-1353",1353,"1353",1353,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-04,2013-08-28,56,87,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",69,"DAYS","CENSORED",2013-07-04,2013-09-10,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,30.6130994888034,4.36065356868029,1.27554581203347,0.723660420130406,1.76395075643191,3.42175460943078,0.586055495454411,1.25873032786314,0.566909249792655,1.47491255597522,-0.190297464097061,0.0807528438644498,0.251183384609984,"High",3,"Q3",3,"Above Median",50.35,"<70 kg",157.48,20.3024599597586,1.48409325103842,114.92,24.1497737556561,39.8093160725223,10,27,8.55,37,"","Y","","",2
"CDISCPILOT01",1,"01-708-1372",1372,"1372",1372,"708",708,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-04-12,2013-04-19,8,84,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-12,2013-04-12,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,24.100480425012,4.73777685806644,1.0041866843755,0.815062860412679,3.36092885168947,3.18264661837414,-0.090354570410071,0.990948519869075,0.297536795370518,1.55767647860563,-0.0237438204463504,0.058491072321808,0.0140869951025905,"Medium",2,"Q2",2,"Below Median",88.91,">=70 kg",170.18,30.6996604191471,2.05011543035454,132.6,46.1849230769231,45.6355303388078,14,13,8.55,38,"Y","","","",1
"CDISCPILOT01",1,"01-708-1372",1372,"1372",1372,"708",708,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-04-12,2013-04-19,8,84,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",8,"DAYS","CENSORED",2013-04-12,2013-04-19,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,24.100480425012,4.73777685806644,1.0041866843755,0.815062860412679,3.36092885168947,3.18264661837414,-0.090354570410071,0.990948519869075,0.297536795370518,1.55767647860563,-0.0237438204463504,0.058491072321808,0.0140869951025905,"Medium",2,"Q2",2,"Below Median",88.91,">=70 kg",170.18,30.6996604191471,2.05011543035454,132.6,46.1849230769231,45.6355303388078,14,13,8.55,38,"","Y","","",2
"CDISCPILOT01",1,"01-708-1378",1378,"1378",1378,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-03,2014-01-28,148,67,"65-75",2,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-03,2013-09-03,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,70.31,">=70 kg",170.18,24.2772817913647,1.82310447984871,114.92,54.935040898016,60.2278997784662,18,24,15.39,42,"Y","","","",1
"CDISCPILOT01",1,"01-708-1378",1378,"1378",1378,"708",708,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-03,2014-01-28,148,67,"65-75",2,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",148,"DAYS","CENSORED",2013-09-03,2014-01-28,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,70.31,">=70 kg",170.18,24.2772817913647,1.82310447984871,114.92,54.935040898016,60.2278997784662,18,24,15.39,42,"","Y","","",2
"CDISCPILOT01",1,"01-708-1406",1406,"1406",1406,"708",708,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-26,2014-07-02,189,71,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-26,2013-12-26,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,19.8403521014118,3.33605411833311,0.826681337558827,0.61494869260491,4.08258883642675,2.98822174508227,-0.532817679603496,0.815783220992184,0.244942618535949,1.20778177647242,-0.642804048921373,0.0411858533127544,-0.178312000747283,"Medium",2,"Q2",2,"Below Median",54.89,"<70 kg",157.48,22.1331087823466,1.5495588261036,61.88,63.6539495798319,92.4104308624746,13,18,18.81,35,"Y","","","",1
"CDISCPILOT01",1,"01-708-1406",1406,"1406",1406,"708",708,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-26,2014-07-02,189,71,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",189,"DAYS","CENSORED",2013-12-26,2014-07-02,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,19.8403521014118,3.33605411833311,0.826681337558827,0.61494869260491,4.08258883642675,2.98822174508227,-0.532817679603496,0.815783220992184,0.244942618535949,1.20778177647242,-0.642804048921373,0.0411858533127544,-0.178312000747283,"Medium",2,"Q2",2,"Below Median",54.89,"<70 kg",157.48,22.1331087823466,1.5495588261036,61.88,63.6539495798319,92.4104308624746,13,18,18.81,35,"","Y","","",2
"CDISCPILOT01",1,"01-708-1428",1428,"1428",1428,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-11-09,2013-12-14,36,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-11-09,2013-11-09,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,35.0075662948588,6.55346881221288,1.45864859561912,2.09720654229142,1.54252368031451,3.5558498297215,1.04247119436262,1.43941927265924,0.648288264719608,1.8815192455494,0.77814277532079,0.121360533559498,0.384342655246272,"High",3,"Q4",4,"Above Median",58.97,"<70 kg",157.48,23.7782733629983,1.60611639954547,88.4,38.8508235294118,55.5673597422312,11,25,8.55,43,"Y","","","",1
"CDISCPILOT01",1,"01-708-1428",1428,"1428",1428,"708",708,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-11-09,2013-12-14,36,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",84,"DAYS","CENSORED",2013-11-09,2014-01-31,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,35.0075662948588,6.55346881221288,1.45864859561912,2.09720654229142,1.54252368031451,3.5558498297215,1.04247119436262,1.43941927265924,0.648288264719608,1.8815192455494,0.77814277532079,0.121360533559498,0.384342655246272,"High",3,"Q4",4,"Above Median",58.97,"<70 kg",157.48,23.7782733629983,1.60611639954547,88.4,38.8508235294118,55.5673597422312,11,25,8.55,43,"","Y","","",2
"CDISCPILOT01",1,"01-709-1001",1001,"1001",1001,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-08,2014-04-08,183,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-08,2013-10-08,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,73.03,">=70 kg",170.18,25.2164683433844,1.85803401176859,123.76,39.2766386554622,39.0008596596687,24,23,6.84,39,"Y","","","",1
"CDISCPILOT01",1,"01-709-1001",1001,"1001",1001,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-08,2014-04-08,183,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-10-08,2014-04-08,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,73.03,">=70 kg",170.18,25.2164683433844,1.85803401176859,123.76,39.2766386554622,39.0008596596687,24,23,6.84,39,"","Y","","",2
"CDISCPILOT01",1,"01-709-1007",1007,"1007",1007,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-07-31,2012-08-28,29,54,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-07-31,2012-07-31,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,17.6976071208374,3.08995508466091,0.737400296701558,0.852787444195836,3.05125996024738,2.87399432808872,-0.755366282438157,0.727679169557862,0.327733465200693,1.13138762256708,-0.751491822682949,0.0572213904566836,-0.291154364952563,"Low",1,"Q2",2,"Below Median",59.88,"<70 kg",158.75,23.760431520863,1.62497435877206,106.08,50.4870588235294,53.8062214136656,18,20,8.55,42,"Y","","","",1
"CDISCPILOT01",1,"01-709-1007",1007,"1007",1007,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-07-31,2012-08-28,29,54,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",33,"DAYS","CENSORED",2012-07-31,2012-09-01,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,17.6976071208374,3.08995508466091,0.737400296701558,0.852787444195836,3.05125996024738,2.87399432808872,-0.755366282438157,0.727679169557862,0.327733465200693,1.13138762256708,-0.751491822682949,0.0572213904566836,-0.291154364952563,"Low",1,"Q2",2,"Below Median",59.88,"<70 kg",158.75,23.760431520863,1.62497435877206,106.08,50.4870588235294,53.8062214136656,18,20,8.55,42,"","Y","","",2
"CDISCPILOT01",1,"01-709-1020",1020,"1020",1020,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-12-01,2013-06-01,183,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-01,2012-12-01,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,13.1664418555297,1.91374147348207,0.548601743980403,0.302899789734473,4.1013358500741,2.57843052718932,-1.22597968167563,0.541369542788809,0.243822997324624,0.654271973923092,-1.27095765300138,0.0354396569163347,-0.582318503420074,"Low",1,"Q1",1,"Below Median",54.43,"<70 kg",144.78,25.9669648302054,1.47952464212891,70.72,54.43,78.2571213713992,10,13,11.97,39,"Y","","","",1
"CDISCPILOT01",1,"01-709-1020",1020,"1020",1020,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-12-01,2013-06-01,183,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2012-12-01,2013-06-01,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,13.1664418555297,1.91374147348207,0.548601743980403,0.302899789734473,4.1013358500741,2.57843052718932,-1.22597968167563,0.541369542788809,0.243822997324624,0.654271973923092,-1.27095765300138,0.0354396569163347,-0.582318503420074,"Low",1,"Q1",1,"Below Median",54.43,"<70 kg",144.78,25.9669648302054,1.47952464212891,70.72,54.43,78.2571213713992,10,13,11.97,39,"","Y","","",2
"CDISCPILOT01",1,"01-709-1029",1029,"1029",1029,"709",709,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-12-25,2013-06-26,184,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-25,2012-12-25,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,26.3473316754709,3.68819210420567,1.09780548647795,0.562150715870467,3.07431511462735,3.27174647823861,0.143006660674404,1.08333314796543,0.325275699697171,1.30784407975134,-0.487284975277413,0.045533235854391,0.102381019193475,"Medium",2,"Q3",3,"Above Median",68.95,"<70 kg",172.72,23.1126111041149,1.8188094396549,114.92,42.8027584406544,54.863385718363,17,18,23.94,43,"Y","","","",1
"CDISCPILOT01",1,"01-709-1029",1029,"1029",1029,"709",709,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-12-25,2013-06-26,184,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2012-12-25,2013-06-26,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,26.3473316754709,3.68819210420567,1.09780548647795,0.562150715870467,3.07431511462735,3.27174647823861,0.143006660674404,1.08333314796543,0.325275699697171,1.30784407975134,-0.487284975277413,0.045533235854391,0.102381019193475,"Medium",2,"Q3",3,"Above Median",68.95,"<70 kg",172.72,23.1126111041149,1.8188094396549,114.92,42.8027584406544,54.863385718363,17,18,23.94,43,"","Y","","",2
"CDISCPILOT01",1,"01-709-1081",1081,"1081",1081,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-01-18,2014-04-27,100,86,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-18,2014-01-18,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,25.9747162962696,3.72042194877622,1.0822798456779,0.505291964866676,2.07894474704062,3.25750853042003,0.10430628672056,1.06801218124658,0.481013264745733,1.31652135025411,-0.473050908597895,0.0688967027551153,0.0882671134272435,"Medium",2,"Q3",3,"Above Median",56.47,"<70 kg",154.94,23.5228903674685,1.5589759637517,97.24,32.6136898395722,48.9493044013051,14,17,8.55,38,"Y","","","",1
"CDISCPILOT01",1,"01-709-1081",1081,"1081",1081,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-01-18,2014-04-27,100,86,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",113,"DAYS","CENSORED",2014-01-18,2014-05-10,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,25.9747162962696,3.72042194877622,1.0822798456779,0.505291964866676,2.07894474704062,3.25750853042003,0.10430628672056,1.06801218124658,0.481013264745733,1.31652135025411,-0.473050908597895,0.0688967027551153,0.0882671134272435,"Medium",2,"Q3",3,"Above Median",56.47,"<70 kg",154.94,23.5228903674685,1.5589759637517,97.24,32.6136898395722,48.9493044013051,14,17,8.55,38,"","Y","","",2
"CDISCPILOT01",1,"01-709-1088",1088,"1088",1088,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-04-12,2014-10-09,181,69,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-04-12,2014-04-12,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,79.38,">=70 kg",179.07,24.7551423124576,1.9870816540847,106.08,65.3493156108597,65.4802353028897,15,20,10.26,44,"Y","","","",1
"CDISCPILOT01",1,"01-709-1088",1088,"1088",1088,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-04-12,2014-10-09,181,69,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",181,"DAYS","CENSORED",2014-04-12,2014-10-09,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,79.38,">=70 kg",179.07,24.7551423124576,1.9870816540847,106.08,65.3493156108597,65.4802353028897,15,20,10.26,44,"","Y","","",2
"CDISCPILOT01",1,"01-709-1099",1099,"1099",1099,"709",709,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-25,2014-04-25,183,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-25,2013-10-25,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,26.8710725285033,4.66967804548597,1.11962802202097,0.899551869543926,3.01439400731324,3.2914224154729,0.19740314562548,1.1048679976429,0.331741636154362,1.54322931386358,-0.0538191451021858,0.0576503462405675,0.121888394479049,"Medium",2,"Q3",3,"Above Median",53.52,"<70 kg",165.1,19.6345954822087,1.56668014178602,88.4,38.4084705882353,57.3224573602738,20,25,11.97,39,"Y","","","",1
"CDISCPILOT01",1,"01-709-1099",1099,"1099",1099,"709",709,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-25,2014-04-25,183,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-10-25,2014-04-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,26.8710725285033,4.66967804548597,1.11962802202097,0.899551869543926,3.01439400731324,3.2914224154729,0.19740314562548,1.1048679976429,0.331741636154362,1.54322931386358,-0.0538191451021858,0.0576503462405675,0.121888394479049,"Medium",2,"Q3",3,"Above Median",53.52,"<70 kg",165.1,19.6345954822087,1.56668014178602,88.4,38.4084705882353,57.3224573602738,20,25,11.97,39,"","Y","","",2
"CDISCPILOT01",1,"01-709-1102",1102,"1102",1102,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-01-15,2013-03-27,72,71,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-15,2013-01-15,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,12.467141762038,3.10560178642776,0.519464240084915,0.430964204547038,4.33138573625819,2.52389831123322,-1.29861000407966,0.512616157778661,0.230872995593296,1.13642232344511,-0.744581575387888,0.0575111441931067,-0.63588965147168,"Low",1,"Q1",1,"Below Median",88.91,">=70 kg",166.37,32.1218520183092,2.02703647256558,106.08,60.145,48.4078022045703,70,50,10.26,42,"Y","","","",1
"CDISCPILOT01",1,"01-709-1102",1102,"1102",1102,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-01-15,2013-03-27,72,71,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",76,"DAYS","CENSORED",2013-01-15,2013-03-31,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,12.467141762038,3.10560178642776,0.519464240084915,0.430964204547038,4.33138573625819,2.52389831123322,-1.29861000407966,0.512616157778661,0.230872995593296,1.13642232344511,-0.744581575387888,0.0575111441931067,-0.63588965147168,"Low",1,"Q1",1,"Below Median",88.91,">=70 kg",166.37,32.1218520183092,2.02703647256558,106.08,60.145,48.4078022045703,70,50,10.26,42,"","Y","","",2
"CDISCPILOT01",1,"01-709-1168",1168,"1168",1168,"709",709,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-08-02,2013-09-26,56,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-02,2013-08-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,20.6533054660724,3.69039963258872,0.860554394419682,0.718277156001173,3.9218903789062,3.02835944441143,-0.448383163543431,0.849209730307612,0.254979079828054,1.30844082262541,-0.486310037091395,0.0455604892912188,-0.138625035316344,"Medium",2,"Q2",2,"Below Median",62.14,"<70 kg",149.86,27.6694032273442,1.60833768565905,70.72,62.14,78.2571213713992,14,13,10.26,39,"Y","","","",1
"CDISCPILOT01",1,"01-709-1168",1168,"1168",1168,"709",709,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-08-02,2013-09-26,56,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",71,"DAYS","CENSORED",2013-08-02,2013-10-11,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,20.6533054660724,3.69039963258872,0.860554394419682,0.718277156001173,3.9218903789062,3.02835944441143,-0.448383163543431,0.849209730307612,0.254979079828054,1.30844082262541,-0.486310037091395,0.0455604892912188,-0.138625035316344,"Medium",2,"Q2",2,"Below Median",62.14,"<70 kg",149.86,27.6694032273442,1.60833768565905,70.72,62.14,78.2571213713992,14,13,10.26,39,"","Y","","",2
"CDISCPILOT01",1,"01-709-1217",1217,"1217",1217,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-03-04,2013-06-11,100,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-04,2013-03-04,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,25.8949616548469,2.66470812909314,1.07895673561862,0.532135515160927,2.08534774910132,3.25443452004357,0.0960228539373327,1.06473287965272,0.47953632694161,0.983840263775586,-0.939298918915243,0.0493464468350581,0.0852201146204142,"Medium",2,"Q3",3,"Above Median",68.04,"<70 kg",171.45,23.1467129600926,1.80011249648459,132.6,39.7618371040724,47.6661587488205,19,24,8.55,40,"Y","","","",1
"CDISCPILOT01",1,"01-709-1217",1217,"1217",1217,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-03-04,2013-06-11,100,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",114,"DAYS","CENSORED",2013-03-04,2013-06-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,25.8949616548469,2.66470812909314,1.07895673561862,0.532135515160927,2.08534774910132,3.25443452004357,0.0960228539373327,1.06473287965272,0.47953632694161,0.983840263775586,-0.939298918915243,0.0493464468350581,0.0852201146204142,"Medium",2,"Q3",3,"Above Median",68.04,"<70 kg",171.45,23.1467129600926,1.80011249648459,132.6,39.7618371040724,47.6661587488205,19,24,8.55,40,"","Y","","",2
"CDISCPILOT01",1,"01-709-1238",1238,"1238",1238,"709",709,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-15,2013-08-06,84,69,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-15,2013-05-15,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,19.531565420151,3.10445657029856,0.813815225839626,0.343461366418581,4.14713302582654,2.97254375702654,-0.564888712372932,0.803086722857934,0.241130437285815,1.13605468125734,-0.745087351415131,0.0383266243246736,-0.193809014704213,"Medium",2,"Q2",2,"Below Median",82.56,">=70 kg",170.18,28.5070741671891,1.975549206339,88.4,81.5606877828054,81.4943924965979,19,19,10.26,43,"Y","","","",1
"CDISCPILOT01",1,"01-709-1238",1238,"1238",1238,"709",709,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-15,2013-08-06,84,69,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",85,"DAYS","CENSORED",2013-05-15,2013-08-07,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,19.531565420151,3.10445657029856,0.813815225839626,0.343461366418581,4.14713302582654,2.97254375702654,-0.564888712372932,0.803086722857934,0.241130437285815,1.13605468125734,-0.745087351415131,0.0383266243246736,-0.193809014704213,"Medium",2,"Q2",2,"Below Median",82.56,">=70 kg",170.18,28.5070741671891,1.975549206339,88.4,81.5606877828054,81.4943924965979,19,19,10.26,43,"","Y","","",2
"CDISCPILOT01",1,"01-709-1259",1259,"1259",1259,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-01-26,2013-06-13,139,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-26,2013-01-26,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,65.32,"<70 kg",172.72,21.8958050372848,1.77028484839148,123.76,37.6529476405947,50.195060860829,13,15,11.97,39,"Y","","","",1
"CDISCPILOT01",1,"01-709-1259",1259,"1259",1259,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-01-26,2013-06-13,139,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",139,"DAYS","CENSORED",2013-01-26,2013-06-13,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,65.32,"<70 kg",172.72,21.8958050372848,1.77028484839148,123.76,37.6529476405947,50.195060860829,13,15,11.97,39,"","Y","","",2
"CDISCPILOT01",1,"01-709-1285",1285,"1285",1285,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-03-24,2013-05-23,61,87,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-24,2013-03-24,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,33.6004634269334,5.32116347488679,1.40001930945556,0.989997812377006,1.60712069098174,3.51483743000653,0.896327448774428,1.38156289470807,0.622230804202471,1.67356950232766,0.233904459103413,0.0985400643497554,0.34360339894564,"High",3,"Q4",4,"Above Median",64.86,"<70 kg",167.64,23.0792472604229,1.73790506069808,114.92,36.7927549599722,53.1835798965913,14,19,15.39,40,"Y","","","",1
"CDISCPILOT01",1,"01-709-1285",1285,"1285",1285,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-03-24,2013-05-23,61,87,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",69,"DAYS","CENSORED",2013-03-24,2013-05-31,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,33.6004634269334,5.32116347488679,1.40001930945556,0.989997812377006,1.60712069098174,3.51483743000653,0.896327448774428,1.38156289470807,0.622230804202471,1.67356950232766,0.233904459103413,0.0985400643497554,0.34360339894564,"High",3,"Q4",4,"Above Median",64.86,"<70 kg",167.64,23.0792472604229,1.73790506069808,114.92,36.7927549599722,53.1835798965913,14,19,15.39,40,"","Y","","",2
"CDISCPILOT01",1,"01-709-1301",1301,"1301",1301,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-07-19,2014-01-17,183,62,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-07-19,2013-07-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,50.35,"<70 kg",146.05,23.6045840711719,1.42922060150901,79.56,51.3372549019608,72.3021010256738,55,36,10.26,40,"Y","","","",1
"CDISCPILOT01",1,"01-709-1301",1301,"1301",1301,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-07-19,2014-01-17,183,62,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-07-19,2014-01-17,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,50.35,"<70 kg",146.05,23.6045840711719,1.42922060150901,79.56,51.3372549019608,72.3021010256738,55,36,10.26,40,"","Y","","",2
"CDISCPILOT01",1,"01-709-1306",1306,"1306",1306,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-02-03,2014-06-16,134,60,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-02-03,2014-02-03,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,44.45,"<70 kg",154.94,18.5158929844869,1.38314085006232,97.24,38.0320855614973,57.540379507579,13,17,8.55,44,"Y","","","",1
"CDISCPILOT01",1,"01-709-1306",1306,"1306",1306,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-02-03,2014-06-16,134,60,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",143,"DAYS","CENSORED",2014-02-03,2014-06-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,44.45,"<70 kg",154.94,18.5158929844869,1.38314085006232,97.24,38.0320855614973,57.540379507579,13,17,8.55,44,"","Y","","",2
"CDISCPILOT01",1,"01-709-1309",1309,"1309",1309,"709",709,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-06-19,2013-12-19,184,65,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-06-19,2013-06-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,14.1456306166143,2.53095957287404,0.589401275692261,0.310269512196513,5.72614980521719,2.65011246837435,-1.12427971613314,0.581631215434229,0.174637415019929,0.93254179428389,-0.998367955483026,0.0312464144799264,-0.511823995819789,"Low",1,"Q1",1,"Below Median",78.47,">=70 kg",177.8,24.8221925015279,1.96864067597698,114.92,62.9904063696485,60.9817290814098,38,26,27.36,40,"Y","","","",1
"CDISCPILOT01",1,"01-709-1309",1309,"1309",1309,"709",709,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-06-19,2013-12-19,184,65,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2013-06-19,2013-12-19,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,14.1456306166143,2.53095957287404,0.589401275692261,0.310269512196513,5.72614980521719,2.65011246837435,-1.12427971613314,0.581631215434229,0.174637415019929,0.93254179428389,-0.998367955483026,0.0312464144799264,-0.511823995819789,"Low",1,"Q1",1,"Below Median",78.47,">=70 kg",177.8,24.8221925015279,1.96864067597698,114.92,62.9904063696485,60.9817290814098,38,26,27.36,40,"","Y","","",2
"CDISCPILOT01",1,"01-709-1312",1312,"1312",1312,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-04-20,2014-10-19,183,68,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-04-20,2014-04-20,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,53.52,"<70 kg",160.02,20.9010244173172,1.54238905597777,70.72,56.6682352941177,80.2283571238921,14,25,20.52,42,"Y","","","",1
"CDISCPILOT01",1,"01-709-1312",1312,"1312",1312,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-04-20,2014-10-19,183,68,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2014-04-20,2014-10-19,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,53.52,"<70 kg",160.02,20.9010244173172,1.54238905597777,70.72,56.6682352941177,80.2283571238921,14,25,20.52,42,"","Y","","",2
"CDISCPILOT01",1,"01-709-1326",1326,"1326",1326,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-04-05,2013-10-02,181,75,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-05,2013-04-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,37.7644945655982,6.57713691155329,1.57352060689992,1.26900853695633,1.42991454330734,3.63163412793952,1.32880976490213,1.55277692948167,0.699342491955522,1.88511879455767,0.788595612083667,0.121798831695431,0.459650600426201,"High",3,"Q4",4,"Above Median",74.84,">=70 kg",161.29,28.7686110743292,1.83113076782869,97.24,52.027807486631,52.4152435485389,16,21,5.13,38,"Y","","","",1
"CDISCPILOT01",1,"01-709-1326",1326,"1326",1326,"709",709,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-04-05,2013-10-02,181,75,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",181,"DAYS","CENSORED",2013-04-05,2013-10-02,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,37.7644945655982,6.57713691155329,1.57352060689992,1.26900853695633,1.42991454330734,3.63163412793952,1.32880976490213,1.55277692948167,0.699342491955522,1.88511879455767,0.788595612083667,0.121798831695431,0.459650600426201,"High",3,"Q4",4,"Above Median",74.84,">=70 kg",161.29,28.7686110743292,1.83113076782869,97.24,52.027807486631,52.4152435485389,16,21,5.13,38,"","Y","","",2
"CDISCPILOT01",1,"01-709-1329",1329,"1329",1329,"709",709,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-08-15,2013-08-25,11,70,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-15,2013-08-15,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,28.3330694571165,5.71255731981619,1.18054456071319,1.03829563478771,2.8588501546787,3.34438253669389,0.349248268008732,1.16498147533768,0.349790980952056,1.74441578936343,0.406760585495288,0.0705253990100764,0.174410816494759,"High",3,"Q3",3,"Above Median",76.66,">=70 kg",170.18,26.4698680433226,1.90365137447894,114.92,57.4349634528367,59.1145919699943,36,28,6.84,43,"Y","","","",1
"CDISCPILOT01",1,"01-709-1329",1329,"1329",1329,"709",709,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-08-15,2013-08-25,11,70,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",15,"DAYS","CENSORED",2013-08-15,2013-08-29,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,28.3330694571165,5.71255731981619,1.18054456071319,1.03829563478771,2.8588501546787,3.34438253669389,0.349248268008732,1.16498147533768,0.349790980952056,1.74441578936343,0.406760585495288,0.0705253990100764,0.174410816494759,"High",3,"Q3",3,"Above Median",76.66,">=70 kg",170.18,26.4698680433226,1.90365137447894,114.92,57.4349634528367,59.1145919699943,36,28,6.84,43,"","Y","","",2
"CDISCPILOT01",1,"01-709-1339",1339,"1339",1339,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-12-23,2013-06-24,184,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-23,2012-12-23,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,78.02,">=70 kg",175.26,25.4003868646259,1.94891602350298,106.08,53.3739762443439,60.771245924781,25,24,8.55,36,"Y","","","",1
"CDISCPILOT01",1,"01-709-1339",1339,"1339",1339,"709",709,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-12-23,2013-06-24,184,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2012-12-23,2013-06-24,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,78.02,">=70 kg",175.26,25.4003868646259,1.94891602350298,106.08,53.3739762443439,60.771245924781,25,24,8.55,36,"","Y","","",2
"CDISCPILOT01",1,"01-709-1424",1424,"1424",1424,"709",709,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-03-03,2013-03-07,5,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-03-03,2013-03-03,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,17.6344429177387,3.34607575325959,0.73476845490578,0.633818034159104,4.59328374464957,2.87042088495067,-0.761926608224106,0.725082023257642,0.217709171823935,1.21077236083518,-0.63837806978055,0.0413095772007356,-0.294681907694718,"Low",1,"Q2",2,"Below Median",68.49,"<70 kg",173.99,22.6244791559326,1.81938444260689,123.76,42.8837273755656,51.7804741711431,18,26,6.84,35,"Y","","","",1
"CDISCPILOT01",1,"01-709-1424",1424,"1424",1424,"709",709,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-03-03,2013-03-07,5,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",15,"DAYS","CENSORED",2013-03-03,2013-03-17,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,17.6344429177387,3.34607575325959,0.73476845490578,0.633818034159104,4.59328374464957,2.87042088495067,-0.761926608224106,0.725082023257642,0.217709171823935,1.21077236083518,-0.63837806978055,0.0413095772007356,-0.294681907694718,"Low",1,"Q2",2,"Below Median",68.49,"<70 kg",173.99,22.6244791559326,1.81938444260689,123.76,42.8837273755656,51.7804741711431,18,26,6.84,35,"","Y","","",2
"CDISCPILOT01",1,"01-710-1002",1002,"1002",1002,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-01-14,2014-01-18,5,88,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-14,2014-01-14,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,17.5733905334254,3.81778896754061,0.732224605559391,0.595843265751799,3.07282763091673,2.86695473676858,-0.768267597446731,0.722571709404853,0.325433158026396,1.34228734342441,-0.430049502418469,0.0706997956951965,-0.298103378709809,"Low",1,"Q2",2,"Below Median",70.31,">=70 kg",165.1,25.7942527719375,1.79568781312962,123.76,36.3366806722689,48.3565089209216,14,20,11.97,39,"Y","","","",1
"CDISCPILOT01",1,"01-710-1002",1002,"1002",1002,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-01-14,2014-01-18,5,88,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",7,"DAYS","CENSORED",2014-01-14,2014-01-20,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,17.5733905334254,3.81778896754061,0.732224605559391,0.595843265751799,3.07282763091673,2.86695473676858,-0.768267597446731,0.722571709404853,0.325433158026396,1.34228734342441,-0.430049502418469,0.0706997956951965,-0.298103378709809,"Low",1,"Q2",2,"Below Median",70.31,">=70 kg",165.1,25.7942527719375,1.79568781312962,123.76,36.3366806722689,48.3565089209216,14,20,11.97,39,"","Y","","",2
"CDISCPILOT01",1,"01-710-1006",1006,"1006",1006,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-10,2013-08-09,181,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-10,2013-02-10,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,32.168959290076,5.99423664840393,1.34037330375317,0.645667638882914,2.5179552521299,3.47131280077018,0.747649351988385,1.32270320060284,0.397147645556494,1.79246532811837,0.53116212694805,0.0740029215852337,0.300381075524013,"High",3,"Q4",4,"Above Median",72.58,">=70 kg",170.18,25.0610882152929,1.8523007015301,141.44,39.7640285633484,44.1139236016938,14,28,8.55,37,"Y","","","",1
"CDISCPILOT01",1,"01-710-1006",1006,"1006",1006,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-10,2013-08-09,181,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2013-02-10,2013-08-10,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,32.168959290076,5.99423664840393,1.34037330375317,0.645667638882914,2.5179552521299,3.47131280077018,0.747649351988385,1.32270320060284,0.397147645556494,1.79246532811837,0.53116212694805,0.0740029215852337,0.300381075524013,"High",3,"Q4",4,"Above Median",72.58,">=70 kg",170.18,25.0610882152929,1.8523007015301,141.44,39.7640285633484,44.1139236016938,14,28,8.55,37,"","Y","","",2
"CDISCPILOT01",1,"01-710-1021",1021,"1021",1021,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-09-27,2013-10-29,33,79,">75",3,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-27,2013-09-27,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,30.4348379418098,5.70138719172175,1.26811824757541,0.886223262203656,2.66142373272592,3.41591645406426,0.567540992523721,1.25140068077612,0.375738740022343,1.74246193491947,0.401827383047881,0.0703874961940957,0.245388877164489,"High",3,"Q3",3,"Above Median",56.25,"<70 kg",162.56,21.2860533142941,1.59373774505092,123.76,34.1017897543633,51.1403867328481,11,16,8.55,41,"Y","","","",1
"CDISCPILOT01",1,"01-710-1021",1021,"1021",1021,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-09-27,2013-10-29,33,79,">75",3,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",47,"DAYS","CENSORED",2013-09-27,2013-11-12,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,30.4348379418098,5.70138719172175,1.26811824757541,0.886223262203656,2.66142373272592,3.41591645406426,0.567540992523721,1.25140068077612,0.375738740022343,1.74246193491947,0.401827383047881,0.0703874961940957,0.245388877164489,"High",3,"Q3",3,"Above Median",56.25,"<70 kg",162.56,21.2860533142941,1.59373774505092,123.76,34.1017897543633,51.1403867328481,11,16,8.55,41,"","Y","","",2
"CDISCPILOT01",1,"01-710-1027",1027,"1027",1027,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-02-28,2014-08-29,183,83,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-02-28,2014-02-28,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,70.76,">=70 kg",170.18,24.4326619194562,1.8289293164156,132.6,37.413149321267,45.9202358007726,16,21,8.55,35,"Y","","","",1
"CDISCPILOT01",1,"01-710-1027",1027,"1027",1027,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-02-28,2014-08-29,183,83,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2014-02-28,2014-08-29,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,70.76,">=70 kg",170.18,24.4326619194562,1.8289293164156,132.6,37.413149321267,45.9202358007726,16,21,8.55,35,"","Y","","",2
"CDISCPILOT01",1,"01-710-1045",1045,"1045",1045,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-06-03,2013-08-13,72,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-06-03,2013-06-03,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,26.70633747417,3.59450589170373,1.11276406142375,0.43015025919561,2.02199197296253,3.28527526869594,0.180293523849606,1.09809452444306,0.494561805077222,1.28218469940235,-0.52866078125702,0.0665649239204395,0.1157935569988,"Medium",2,"Q3",3,"Above Median",58.06,"<70 kg",162.56,21.9709912076074,1.61917619657515,88.4,38.9343529411765,55.9140267078197,15,20,10.26,43,"Y","","","",1
"CDISCPILOT01",1,"01-710-1045",1045,"1045",1045,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-06-03,2013-08-13,72,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",76,"DAYS","CENSORED",2013-06-03,2013-08-17,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,26.70633747417,3.59450589170373,1.11276406142375,0.43015025919561,2.02199197296253,3.28527526869594,0.180293523849606,1.09809452444306,0.494561805077222,1.28218469940235,-0.52866078125702,0.0665649239204395,0.1157935569988,"Medium",2,"Q3",3,"Above Median",58.06,"<70 kg",162.56,21.9709912076074,1.61917619657515,88.4,38.9343529411765,55.9140267078197,15,20,10.26,43,"","Y","","",2
"CDISCPILOT01",1,"01-710-1053",1053,"1053",1053,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-12-26,2013-02-10,47,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-26,2012-12-26,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,27.9704193034381,6.23397206364401,1.16543413764325,0.756174963324223,1.93061102925126,3.331504954952,0.311582896837371,1.15007025254542,0.517970727841446,1.83161652853107,0.637039456840204,0.115443927104519,0.161637558200944,"High",3,"Q3",3,"Above Median",51.71,"<70 kg",157.48,20.8508481533092,1.50400306589522,114.92,26.2059728506787,40.5590467389533,13,22,11.97,39,"Y","","","",1
"CDISCPILOT01",1,"01-710-1053",1053,"1053",1053,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-12-26,2013-02-10,47,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",63,"DAYS","CENSORED",2012-12-26,2013-02-26,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,27.9704193034381,6.23397206364401,1.16543413764325,0.756174963324223,1.93061102925126,3.331504954952,0.311582896837371,1.15007025254542,0.517970727841446,1.83161652853107,0.637039456840204,0.115443927104519,0.161637558200944,"High",3,"Q3",3,"Above Median",51.71,"<70 kg",157.48,20.8508481533092,1.50400306589522,114.92,26.2059728506787,40.5590467389533,13,22,11.97,39,"","Y","","",2
"CDISCPILOT01",1,"01-710-1060",1060,"1060",1060,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-01-01,2013-07-05,186,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-01,2013-01-01,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,70.31,">=70 kg",182.88,21.0225150388572,1.88990687601268,132.6,37.8274162895928,46.2067174489562,27,30,10.26,36,"Y","","","",1
"CDISCPILOT01",1,"01-710-1060",1060,"1060",1060,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-01-01,2013-07-05,186,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",186,"DAYS","CENSORED",2013-01-01,2013-07-05,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,70.31,">=70 kg",182.88,21.0225150388572,1.88990687601268,132.6,37.8274162895928,46.2067174489562,27,30,10.26,36,"","Y","","",2
"CDISCPILOT01",1,"01-710-1070",1070,"1070",1070,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-09-08,2013-01-22,137,85,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-08,2012-09-08,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,36.2580514325621,3.94269374546129,1.51075214302342,1.90167889404991,2.23398657124902,3.59093722790793,1.17234839523547,1.49083594047965,0.447630264599532,1.37439730735965,-0.374886253535234,0.048675231425448,0.419205043406191,"High",3,"Q4",4,"Above Median",48.99,"<70 kg",149.86,21.8140338607595,1.42805631308199,79.56,35.221568627451,62.6653894509272,8,16,13.68,37,"Y","","","",1
"CDISCPILOT01",1,"01-710-1070",1070,"1070",1070,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-09-08,2013-01-22,137,85,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",156,"DAYS","CENSORED",2012-09-08,2013-02-10,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,36.2580514325621,3.94269374546129,1.51075214302342,1.90167889404991,2.23398657124902,3.59093722790793,1.17234839523547,1.49083594047965,0.447630264599532,1.37439730735965,-0.374886253535234,0.048675231425448,0.419205043406191,"High",3,"Q4",4,"Above Median",48.99,"<70 kg",149.86,21.8140338607595,1.42805631308199,79.56,35.221568627451,62.6653894509272,8,16,13.68,37,"","Y","","",2
"CDISCPILOT01",1,"01-710-1077",1077,"1077",1077,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-11-17,2014-05-18,183,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-11-17,2013-11-17,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,48.99,"<70 kg",162.56,18.5387333665292,1.48733676975548,79.56,40.9850980392157,66.2730276192129,12,20,8.55,36,"Y","","","",1
"CDISCPILOT01",1,"01-710-1077",1077,"1077",1077,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-11-17,2014-05-18,183,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-11-17,2014-05-18,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,48.99,"<70 kg",162.56,18.5387333665292,1.48733676975548,79.56,40.9850980392157,66.2730276192129,12,20,8.55,36,"","Y","","",2
"CDISCPILOT01",1,"01-710-1078",1078,"1078",1078,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-17,2014-03-23,188,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-17,2013-09-17,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,41.73,"<70 kg",152.4,17.9671192675719,1.32912377151265,97.24,26.3322994652406,50.4953704364397,22,23,6.84,36,"Y","","","",1
"CDISCPILOT01",1,"01-710-1078",1078,"1078",1078,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-17,2014-03-23,188,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",188,"DAYS","CENSORED",2013-09-17,2014-03-23,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,41.73,"<70 kg",152.4,17.9671192675719,1.32912377151265,97.24,26.3322994652406,50.4953704364397,22,23,6.84,36,"","Y","","",2
"CDISCPILOT01",1,"01-710-1083",1083,"1083",1083,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-07-22,2013-08-01,11,89,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",12,"DAYS","EVENT",2013-07-22,2013-08-02,0,1,"Death","ADRS","ADT",8,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,47.17,"<70 kg",157.48,19.0201993307212,1.43646282389919,106.08,23.585,43.2809942445954,12,18,8.55,37,"Y","","","",1
"CDISCPILOT01",1,"01-710-1083",1083,"1083",1083,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-07-22,2013-08-01,11,89,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",12,"DAYS","EVENT",2013-07-22,2013-08-02,0,1,"Death","ADRS","ADT",8,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,47.17,"<70 kg",157.48,19.0201993307212,1.43646282389919,106.08,23.585,43.2809942445954,12,18,8.55,37,"","Y","","",2
"CDISCPILOT01",1,"01-710-1137",1137,"1137",1137,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-11,2013-11-13,34,79,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-11,2013-10-11,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,35.5872603410636,6.22967755774202,1.48280251421098,1.05545053585349,2.27609541233876,3.57226867818497,1.10267905914541,1.46325477082911,0.439348893099551,1.83092850760744,0.635142820844004,0.0769095994782966,0.400655235334459,"High",3,"Q4",4,"Above Median",65.32,"<70 kg",165.1,23.9635982230544,1.73079397323245,88.4,46.8767058823529,57.3224573602738,13,21,10.26,35,"Y","","","",1
"CDISCPILOT01",1,"01-710-1137",1137,"1137",1137,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-10-11,2013-11-13,34,79,">75",3,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",34,"DAYS","CENSORED",2013-10-11,2013-11-13,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,35.5872603410636,6.22967755774202,1.48280251421098,1.05545053585349,2.27609541233876,3.57226867818497,1.10267905914541,1.46325477082911,0.439348893099551,1.83092850760744,0.635142820844004,0.0769095994782966,0.400655235334459,"High",3,"Q4",4,"Above Median",65.32,"<70 kg",165.1,23.9635982230544,1.73079397323245,88.4,46.8767058823529,57.3224573602738,13,21,10.26,35,"","Y","","",2
"CDISCPILOT01",1,"01-710-1142",1142,"1142",1142,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-10-02,2012-10-20,19,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-10-02,2012-10-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,33.9371598405265,5.65088252652493,1.4140483266886,1.23664457321189,2.38676425430489,3.5248051933779,0.931297226841292,1.39540696780584,0.418977281981809,1.7335798034746,0.379522380289812,0.0697639818089497,0.353503749695251,"High",3,"Q4",4,"Above Median",57.61,"<70 kg",152.4,24.8043551642659,1.5616732479406,97.24,39.4335828877005,52.0902690385379,22,21,6.84,41,"Y","","","",1
"CDISCPILOT01",1,"01-710-1142",1142,"1142",1142,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-10-02,2012-10-20,19,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",22,"DAYS","CENSORED",2012-10-02,2012-10-23,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,33.9371598405265,5.65088252652493,1.4140483266886,1.23664457321189,2.38676425430489,3.5248051933779,0.931297226841292,1.39540696780584,0.418977281981809,1.7335798034746,0.379522380289812,0.0697639818089497,0.353503749695251,"High",3,"Q4",4,"Above Median",57.61,"<70 kg",152.4,24.8043551642659,1.5616732479406,97.24,39.4335828877005,52.0902690385379,22,21,6.84,41,"","Y","","",2
"CDISCPILOT01",1,"01-710-1154",1154,"1154",1154,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-03-29,2014-04-27,30,84,">75",3,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-03-29,2014-03-29,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,24.2391773717831,2.3547560500426,1.0099657238243,0.343471075122655,2.22779837664217,3.18838269399503,-0.0759493042672584,0.996651374405144,0.448873655033021,0.860674866535864,-1.076186906414,0.0436065935193074,0.019769022637723,"Medium",2,"Q2",2,"Below Median",82.56,">=70 kg",160.02,32.2419390114668,1.91567011773948,114.92,49.4842742777584,54.1851886840024,18,28,27.36,39,"Y","","","",1
"CDISCPILOT01",1,"01-710-1154",1154,"1154",1154,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-03-29,2014-04-27,30,84,">75",3,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",42,"DAYS","CENSORED",2014-03-29,2014-05-09,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,24.2391773717831,2.3547560500426,1.0099657238243,0.343471075122655,2.22779837664217,3.18838269399503,-0.0759493042672584,0.996651374405144,0.448873655033021,0.860674866535864,-1.076186906414,0.0436065935193074,0.019769022637723,"Medium",2,"Q2",2,"Below Median",82.56,">=70 kg",160.02,32.2419390114668,1.91567011773948,114.92,49.4842742777584,54.1851886840024,18,28,27.36,39,"","Y","","",2
"CDISCPILOT01",1,"01-710-1166",1166,"1166",1166,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-11-30,2013-03-19,110,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-11-30,2012-11-30,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,27.0511052114146,5.49648278109942,1.12712938380894,1.00305208138175,1.99622158052211,3.29809746490248,0.216101601302521,1.11227046919172,0.500946392803974,1.70592608560434,0.311332902463558,0.101786718168508,0.128507002321563,"Medium",2,"Q3",3,"Above Median",54.89,"<70 kg",157.48,22.1331087823466,1.5495588261036,88.4,38.1001176470588,56.6138623642673,19,21,5.13,39,"Y","","","",1
"CDISCPILOT01",1,"01-710-1166",1166,"1166",1166,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-11-30,2013-03-19,110,81,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",121,"DAYS","CENSORED",2012-11-30,2013-03-30,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,27.0511052114146,5.49648278109942,1.12712938380894,1.00305208138175,1.99622158052211,3.29809746490248,0.216101601302521,1.11227046919172,0.500946392803974,1.70592608560434,0.311332902463558,0.101786718168508,0.128507002321563,"Medium",2,"Q3",3,"Above Median",54.89,"<70 kg",157.48,22.1331087823466,1.5495588261036,88.4,38.1001176470588,56.6138623642673,19,21,5.13,39,"","Y","","",2
"CDISCPILOT01",1,"01-710-1183",1183,"1183",1183,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-11-16,2014-05-17,183,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-11-16,2013-11-16,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,47.63,"<70 kg",149.86,21.2084595384359,1.40809483187588,79.56,37.356862745098,64.6446786644013,7,26,11.97,37,"Y","","","",1
"CDISCPILOT01",1,"01-710-1183",1183,"1183",1183,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-11-16,2014-05-17,183,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-11-16,2014-05-17,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,47.63,"<70 kg",149.86,21.2084595384359,1.40809483187588,79.56,37.356862745098,64.6446786644013,7,26,11.97,37,"","Y","","",2
"CDISCPILOT01",1,"01-710-1187",1187,"1187",1187,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-11-10,2013-05-12,184,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-11-10,2012-11-10,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,31.852024855388,13.1837611063496,1.32716770230783,0.614477332387211,2.54300944344197,3.46141485724543,0.714732081725499,1.30967168822586,0.393234874757877,2.57974407440283,3.7063611355689,0.162762482794439,0.29055372204734,"High",3,"Q3",3,"Above Median",49.9,"<70 kg",154.94,20.7861205832597,1.46548304512729,106.08,30.3313725490196,46.3455790046506,11,18,10.26,40,"Y","","","",1
"CDISCPILOT01",1,"01-710-1187",1187,"1187",1187,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-11-10,2013-05-12,184,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2012-11-10,2013-05-12,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,31.852024855388,13.1837611063496,1.32716770230783,0.614477332387211,2.54300944344197,3.46141485724543,0.714732081725499,1.30967168822586,0.393234874757877,2.57974407440283,3.7063611355689,0.162762482794439,0.29055372204734,"High",3,"Q3",3,"Above Median",49.9,"<70 kg",154.94,20.7861205832597,1.46548304512729,106.08,30.3313725490196,46.3455790046506,11,18,10.26,40,"","Y","","",2
"CDISCPILOT01",1,"01-710-1235",1235,"1235",1235,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-26,2013-03-27,183,56,"<65",1,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-26,2012-09-26,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,12.2252798384914,2.11270925687315,0.509386659937142,0.333866302821533,4.41707680424463,2.50432356859805,-1.32373013440415,0.502671430083423,0.226394071083174,0.752693224154379,-1.18308503885753,0.0391242454976509,-0.655106663685278,"Low",1,"Q1",1,"Below Median",95.71,">=70 kg",170.18,33.0476267991966,2.12706943678125,88.4,94.584,66.1375304520839,19,13,5.13,42,"Y","","","",1
"CDISCPILOT01",1,"01-710-1235",1235,"1235",1235,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-26,2013-03-27,183,56,"<65",1,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2012-09-26,2013-03-27,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,12.2252798384914,2.11270925687315,0.509386659937142,0.333866302821533,4.41707680424463,2.50432356859805,-1.32373013440415,0.502671430083423,0.226394071083174,0.752693224154379,-1.18308503885753,0.0391242454976509,-0.655106663685278,"Low",1,"Q1",1,"Below Median",95.71,">=70 kg",170.18,33.0476267991966,2.12706943678125,88.4,94.584,66.1375304520839,19,13,5.13,42,"","Y","","",2
"CDISCPILOT01",1,"01-710-1249",1249,"1249",1249,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-28,2014-06-28,183,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-28,2013-12-28,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,19.6914710898348,3.74529775257591,0.820477962076451,0.437515537146896,4.11345600491037,2.98069330756684,-0.548280677494263,0.809661624432402,0.243104581355986,1.32316757703271,-0.462064698310215,0.0462382438589618,-0.185753886010606,"Medium",2,"Q2",2,"Below Median",80.29,">=70 kg",177.8,25.397907938673,1.99133972211898,132.6,45.4310610859729,47.0769306674774,14,20,8.55,42,"Y","","","",1
"CDISCPILOT01",1,"01-710-1249",1249,"1249",1249,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-28,2014-06-28,183,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-12-28,2014-06-28,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,19.6914710898348,3.74529775257591,0.820477962076451,0.437515537146896,4.11345600491037,2.98069330756684,-0.548280677494263,0.809661624432402,0.243104581355986,1.32316757703271,-0.462064698310215,0.0462382438589618,-0.185753886010606,"Medium",2,"Q2",2,"Below Median",80.29,">=70 kg",177.8,25.397907938673,1.99133972211898,132.6,45.4310610859729,47.0769306674774,14,20,8.55,42,"","Y","","",2
"CDISCPILOT01",1,"01-710-1264",1264,"1264",1264,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-06-13,2013-10-11,121,78,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-06-13,2013-06-13,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,81.65,">=70 kg",167.64,29.0536623313834,1.94991495541045,114.92,54.1822920292377,56.2453515450587,14,18,10.26,42,"Y","","","",1
"CDISCPILOT01",1,"01-710-1264",1264,"1264",1264,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-06-13,2013-10-11,121,78,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",122,"DAYS","CENSORED",2013-06-13,2013-10-12,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,81.65,">=70 kg",167.64,29.0536623313834,1.94991495541045,114.92,54.1822920292377,56.2453515450587,14,18,10.26,42,"","Y","","",2
"CDISCPILOT01",1,"01-710-1270",1270,"1270",1270,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-02-12,2014-03-01,18,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-02-12,2014-02-12,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,35.1081655821159,5.96075693064978,1.46284023258816,1.11474213071353,1.53810371760089,3.55871853454726,1.05291958230807,1.4435556513973,0.650151214483628,1.78687370842102,0.516376063246104,0.110384387604625,0.387192667638696,"High",3,"Q4",4,"Above Median",57.61,"<70 kg",149.86,25.6523064037223,1.54860462280654,114.92,29.7173755656109,40.8120816451533,24,36,6.84,41,"Y","","","",1
"CDISCPILOT01",1,"01-710-1270",1270,"1270",1270,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-02-12,2014-03-01,18,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",18,"DAYS","CENSORED",2014-02-12,2014-03-01,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,35.1081655821159,5.96075693064978,1.46284023258816,1.11474213071353,1.53810371760089,3.55871853454726,1.05291958230807,1.4435556513973,0.650151214483628,1.78687370842102,0.516376063246104,0.110384387604625,0.387192667638696,"High",3,"Q4",4,"Above Median",57.61,"<70 kg",149.86,25.6523064037223,1.54860462280654,114.92,29.7173755656109,40.8120816451533,24,36,6.84,41,"","Y","","",2
"CDISCPILOT01",1,"01-710-1271",1271,"1271",1271,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-09-27,2012-11-21,56,86,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-27,2012-09-27,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,47.63,"<70 kg",149.86,21.2084595384359,1.40809483187588,70.72,37.8238235294118,71.7314751919203,11,13,10.26,35,"Y","","","",1
"CDISCPILOT01",1,"01-710-1271",1271,"1271",1271,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-09-27,2012-11-21,56,86,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",61,"DAYS","CENSORED",2012-09-27,2012-11-26,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,47.63,"<70 kg",149.86,21.2084595384359,1.40809483187588,70.72,37.8238235294118,71.7314751919203,11,13,10.26,35,"","Y","","",2
"CDISCPILOT01",1,"01-710-1278",1278,"1278",1278,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-12-24,2013-02-26,65,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-24,2012-12-24,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,37.272431315837,4.92714847746051,1.55301797149321,1.12305575656072,2.1731879874867,3.6185222053903,1.27770336179145,1.53254457973454,0.460153473035024,1.59678793325442,0.0598907205692852,0.0608289935488952,0.446618549449505,"High",3,"Q4",4,"Above Median",71.67,">=70 kg",177.8,22.6711677913152,1.8814094893634,150.28,34.6093418951291,40.0107718902185,16,25,10.26,40,"Y","","","",1
"CDISCPILOT01",1,"01-710-1278",1278,"1278",1278,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-12-24,2013-02-26,65,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",74,"DAYS","CENSORED",2012-12-24,2013-03-07,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,37.272431315837,4.92714847746051,1.55301797149321,1.12305575656072,2.1731879874867,3.6185222053903,1.27770336179145,1.53254457973454,0.460153473035024,1.59678793325442,0.0598907205692852,0.0608289935488952,0.446618549449505,"High",3,"Q4",4,"Above Median",71.67,">=70 kg",177.8,22.6711677913152,1.8814094893634,150.28,34.6093418951291,40.0107718902185,16,25,10.26,40,"","Y","","",2
"CDISCPILOT01",1,"01-710-1300",1300,"1300",1300,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-12-15,2013-02-15,63,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-15,2012-12-15,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,11.9929278755463,2.66737444235953,0.499705328147761,0.407340024891117,4.50265361055883,2.48515060965623,-1.3478625464215,0.493117727015736,0.22209125695456,0.98483662863034,-0.938121361861278,0.0493958230066579,-0.673922508193112,"Low",1,"Q1",1,"Below Median",46.72,"<70 kg",152.4,20.1155957867471,1.40634751513747,79.56,37.8645751633987,65.4537896119163,14,18,11.97,36,"Y","","","",1
"CDISCPILOT01",1,"01-710-1300",1300,"1300",1300,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-12-15,2013-02-15,63,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",67,"DAYS","CENSORED",2012-12-15,2013-02-19,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,11.9929278755463,2.66737444235953,0.499705328147761,0.407340024891117,4.50265361055883,2.48515060965623,-1.3478625464215,0.493117727015736,0.22209125695456,0.98483662863034,-0.938121361861278,0.0493958230066579,-0.673922508193112,"Low",1,"Q1",1,"Below Median",46.72,"<70 kg",152.4,20.1155957867471,1.40634751513747,79.56,37.8645751633987,65.4537896119163,14,18,11.97,36,"","Y","","",2
"CDISCPILOT01",1,"01-710-1314",1314,"1314",1314,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-04-24,2013-05-23,30,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-24,2013-04-24,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,42.64,"<70 kg",137.16,22.6653402552347,1.27459169932963,70.72,38.8776470588235,75.3907082255345,14,26,8.55,38,"Y","","","",1
"CDISCPILOT01",1,"01-710-1314",1314,"1314",1314,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-04-24,2013-05-23,30,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",31,"DAYS","CENSORED",2013-04-24,2013-05-24,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,42.64,"<70 kg",137.16,22.6653402552347,1.27459169932963,70.72,38.8776470588235,75.3907082255345,14,26,8.55,38,"","Y","","",2
"CDISCPILOT01",1,"01-710-1315",1315,"1315",1315,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-27,2013-07-06,130,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-27,2013-02-27,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,56.25,"<70 kg",152.4,24.2187984375969,1.5431299362011,88.4,37.7205882352941,55.9140267078197,15,20,10.26,42,"Y","","","",1
"CDISCPILOT01",1,"01-710-1315",1315,"1315",1315,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-27,2013-07-06,130,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",140,"DAYS","CENSORED",2013-02-27,2013-07-16,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,56.25,"<70 kg",152.4,24.2187984375969,1.5431299362011,88.4,37.7205882352941,55.9140267078197,15,20,10.26,42,"","Y","","",2
"CDISCPILOT01",1,"01-710-1354",1354,"1354",1354,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-11-11,2013-05-01,172,73,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-11-11,2012-11-11,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,32.375785463588,7.23830981765165,1.34899106098283,0.602713720081176,2.5018698030075,3.47771960627276,0.76913061847694,1.33120735018399,0.399701055106025,1.98076831308812,1.08059761697988,0.0893618496006377,0.306742557504132,"High",3,"Q4",4,"Above Median",89.36,">=70 kg",182.88,26.7184176343661,2.13060742512552,114.92,64.0807309432649,58.0218635654359,34,36,10.26,43,"Y","","","",1
"CDISCPILOT01",1,"01-710-1354",1354,"1354",1354,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-11-11,2013-05-01,172,73,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",172,"DAYS","CENSORED",2012-11-11,2013-05-01,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,32.375785463588,7.23830981765165,1.34899106098283,0.602713720081176,2.5018698030075,3.47771960627276,0.76913061847694,1.33120735018399,0.399701055106025,1.98076831308812,1.08059761697988,0.0893618496006377,0.306742557504132,"High",3,"Q4",4,"Above Median",89.36,">=70 kg",182.88,26.7184176343661,2.13060742512552,114.92,64.0807309432649,58.0218635654359,34,36,10.26,43,"","Y","","",2
"CDISCPILOT01",1,"01-710-1358",1358,"1358",1358,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-17,2013-02-09,146,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-17,2012-09-17,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,14.3987301280348,1.89401005155223,0.599947088668115,0.823482716739403,3.75033072498945,2.66783428177258,-1.09799243362616,0.592038003257489,0.266643150519162,0.643962215531831,-1.27967188601036,0.0350742602139302,-0.494383065465238,"Low",1,"Q1",1,"Below Median",82.1,">=70 kg",162.56,31.0681773707297,1.92542751385533,114.92,50.9660111381831,54.863385718363,14,22,5.13,42,"Y","","","",1
"CDISCPILOT01",1,"01-710-1358",1358,"1358",1358,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-17,2013-02-09,146,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",146,"DAYS","CENSORED",2012-09-17,2013-02-09,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,14.3987301280348,1.89401005155223,0.599947088668115,0.823482716739403,3.75033072498945,2.66783428177258,-1.09799243362616,0.592038003257489,0.266643150519162,0.643962215531831,-1.27967188601036,0.0350742602139302,-0.494383065465238,"Low",1,"Q1",1,"Below Median",82.1,">=70 kg",162.56,31.0681773707297,1.92542751385533,114.92,50.9660111381831,54.863385718363,14,22,5.13,42,"","Y","","",2
"CDISCPILOT01",1,"01-710-1368",1368,"1368",1368,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-23,2014-04-24,184,88,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-23,2013-10-23,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,34.02,"<70 kg",147.32,15.6751205297892,1.17990423340202,79.56,23.1247058823529,61.5070248449345,23,26,11.97,39,"Y","","","",1
"CDISCPILOT01",1,"01-710-1368",1368,"1368",1368,"710",710,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-10-23,2014-04-24,184,88,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2013-10-23,2014-04-24,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,34.02,"<70 kg",147.32,15.6751205297892,1.17990423340202,79.56,23.1247058823529,61.5070248449345,23,26,11.97,39,"","Y","","",2
"CDISCPILOT01",1,"01-710-1385",1385,"1385",1385,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-10-29,2013-02-18,113,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-10-29,2012-10-29,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,17.884087292806,3.70682967613087,0.745170303866918,0.383623633209347,3.01944399598865,2.88447033944177,-0.735998181192222,0.735346744939698,0.33118680171863,1.3128710673249,-0.479053832835914,0.0686449940024235,-0.280811987134104,"Low",1,"Q2",2,"Below Median",84.37,">=70 kg",182.88,25.2264200516055,2.07026471737312,106.08,61.6311397058824,62.3020261348266,15,18,6.84,40,"Y","","","",1
"CDISCPILOT01",1,"01-710-1385",1385,"1385",1385,"710",710,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-10-29,2013-02-18,113,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",113,"DAYS","CENSORED",2012-10-29,2013-02-18,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,17.884087292806,3.70682967613087,0.745170303866918,0.383623633209347,3.01944399598865,2.88447033944177,-0.735998181192222,0.735346744939698,0.33118680171863,1.3128710673249,-0.479053832835914,0.0686449940024235,-0.280811987134104,"Low",1,"Q2",2,"Below Median",84.37,">=70 kg",182.88,25.2264200516055,2.07026471737312,106.08,61.6311397058824,62.3020261348266,15,18,6.84,40,"","Y","","",2
"CDISCPILOT01",1,"01-710-1408",1408,"1408",1408,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-01-05,2013-07-12,189,80,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-05,2013-01-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,32.2480136854011,6.95996544912535,1.34366723689171,0.626815149070118,2.51178261055717,3.47376649874318,0.755860056195851,1.32595370991448,0.398123625745692,1.94161026767627,0.95766893537241,0.0859254993719179,0.302817381280763,"High",3,"Q4",4,"Above Median",107.96,">=70 kg",177.8,34.150680546259,2.30911767661253,132.6,60.086334841629,46.785053697339,23,21,8.55,40,"Y","","","",1
"CDISCPILOT01",1,"01-710-1408",1408,"1408",1408,"710",710,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-01-05,2013-07-12,189,80,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",189,"DAYS","CENSORED",2013-01-05,2013-07-12,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,32.2480136854011,6.95996544912535,1.34366723689171,0.626815149070118,2.51178261055717,3.47376649874318,0.755860056195851,1.32595370991448,0.398123625745692,1.94161026767627,0.95766893537241,0.0859254993719179,0.302817381280763,"High",3,"Q4",4,"Above Median",107.96,">=70 kg",177.8,34.150680546259,2.30911767661253,132.6,60.086334841629,46.785053697339,23,21,8.55,40,"","Y","","",2
"CDISCPILOT01",1,"01-711-1012",1012,"1012",1012,"711",711,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-04-03,2013-04-29,27,67,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-03,2013-04-03,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,13.3327435133069,2.42499224128641,0.55553097972112,0.456240449838359,6.07526874863806,2.5909726800099,-1.20870735019292,0.548207430611786,0.164601771769221,0.889943570199458,-1.0451676246644,0.0299381758183507,-0.569990202042104,"Low",1,"Q1",1,"Below Median",80.97,">=70 kg",170.18,27.9580643812658,1.95643344720267,106.08,57.9491176470588,49.6271569256875,12,20,8.55,43,"Y","","","",1
"CDISCPILOT01",1,"01-711-1012",1012,"1012",1012,"711",711,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-04-03,2013-04-29,27,67,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",30,"DAYS","CENSORED",2013-04-03,2013-05-02,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,13.3327435133069,2.42499224128641,0.55553097972112,0.456240449838359,6.07526874863806,2.5909726800099,-1.20870735019292,0.548207430611786,0.164601771769221,0.889943570199458,-1.0451676246644,0.0299381758183507,-0.569990202042104,"Low",1,"Q1",1,"Below Median",80.97,">=70 kg",170.18,27.9580643812658,1.95643344720267,106.08,57.9491176470588,49.6271569256875,12,20,8.55,43,"","Y","","",2
"CDISCPILOT01",1,"01-711-1036",1036,"1036",1036,"711",711,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-07-29,2013-02-10,197,70,"65-75",2,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-07-29,2012-07-29,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,69.17,"<70 kg",171.96,23.3917601809516,1.81769643596871,159.12,37.4279600301659,40.0036586611768,22,21,5.13,37,"Y","","","",1
"CDISCPILOT01",1,"01-711-1036",1036,"1036",1036,"711",711,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-07-29,2013-02-10,197,70,"65-75",2,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",197,"DAYS","CENSORED",2012-07-29,2013-02-10,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,69.17,"<70 kg",171.96,23.3917601809516,1.81769643596871,159.12,37.4279600301659,40.0036586611768,22,21,5.13,37,"","Y","","",2
"CDISCPILOT01",1,"01-711-1143",1143,"1143",1143,"711",711,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-04-03,2013-05-30,58,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-03,2013-04-03,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,9.14032672927727,1.48002206228265,0.380846947053219,0.30754137635802,5.90788508982215,2.21378958676764,-1.64413784063618,0.375826252579467,0.169265309801431,0.398790926748854,-1.46250654507561,0.0274078159681972,-0.9394392353909,"Low",1,"Q1",1,"Below Median",64.64,"<70 kg",163.07,24.3082226372512,1.71114360719504,88.4,48.6701176470588,58.4020138158505,19,24,13.68,42,"Y","","","",1
"CDISCPILOT01",1,"01-711-1143",1143,"1143",1143,"711",711,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-04-03,2013-05-30,58,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",60,"DAYS","CENSORED",2013-04-03,2013-06-01,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,9.14032672927727,1.48002206228265,0.380846947053219,0.30754137635802,5.90788508982215,2.21378958676764,-1.64413784063618,0.375826252579467,0.169265309801431,0.398790926748854,-1.46250654507561,0.0274078159681972,-0.9394392353909,"Low",1,"Q1",1,"Below Median",64.64,"<70 kg",163.07,24.3082226372512,1.71114360719504,88.4,48.6701176470588,58.4020138158505,19,24,13.68,42,"","Y","","",2
"CDISCPILOT01",1,"01-711-1433",1433,"1433",1433,"711",711,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-01-27,2013-02-05,10,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-27,2013-01-27,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,34.3940191497686,7.27495059771706,1.43308413124036,0.584438227341967,2.35506061816405,3.53817339330367,0.978747297608263,1.41419182388746,0.424617520367513,1.98581065825383,1.09677973990321,0.0898142049100872,0.36678258110005,"High",3,"Q4",4,"Above Median",51.94,"<70 kg",157.48,20.9435902742773,1.5073441692077,88.4,34.2192941176471,55.5673597422312,13,21,8.55,37,"Y","","","",1
"CDISCPILOT01",1,"01-711-1433",1433,"1433",1433,"711",711,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-01-27,2013-02-05,10,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",11,"DAYS","CENSORED",2013-01-27,2013-02-06,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,34.3940191497686,7.27495059771706,1.43308413124036,0.584438227341967,2.35506061816405,3.53817339330367,0.978747297608263,1.41419182388746,0.424617520367513,1.98581065825383,1.09677973990321,0.0898142049100872,0.36678258110005,"High",3,"Q4",4,"Above Median",51.94,"<70 kg",157.48,20.9435902742773,1.5073441692077,88.4,34.2192941176471,55.5673597422312,13,21,8.55,37,"","Y","","",2
"CDISCPILOT01",1,"01-713-1043",1043,"1043",1043,"713",713,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-15,2014-03-24,191,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-15,2013-09-15,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,22.977055956122,3.82522670155754,0.957377331505083,0.516693667101875,2.3501705398255,3.13493127299007,-0.207035065853216,0.944756253366542,0.425501036224481,1.34422854690715,-0.426764683538572,0.0708375315103248,-0.0331666512586559,"Medium",2,"Q2",2,"Below Median",51.26,"<70 kg",165.1,18.805481397945,1.53324510615738,97.24,33.9905882352941,51.4463520524019,16,26,6.84,39,"Y","","","",1
"CDISCPILOT01",1,"01-713-1043",1043,"1043",1043,"713",713,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-15,2014-03-24,191,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",191,"DAYS","CENSORED",2013-09-15,2014-03-24,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,22.977055956122,3.82522670155754,0.957377331505083,0.516693667101875,2.3501705398255,3.13493127299007,-0.207035065853216,0.944756253366542,0.425501036224481,1.34422854690715,-0.426764683538572,0.0708375315103248,-0.0331666512586559,"Medium",2,"Q2",2,"Below Median",51.26,"<70 kg",165.1,18.805481397945,1.53324510615738,97.24,33.9905882352941,51.4463520524019,16,26,6.84,39,"","Y","","",2
"CDISCPILOT01",1,"01-713-1073",1073,"1073",1073,"713",713,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-03-30,2014-10-05,190,74,"65-75",2,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-03-30,2014-03-30,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,16.0842485345362,3.89387218883914,0.67017702227234,0.538369252257499,3.35732190932334,2.77846197428745,-0.922932046216722,0.661342097643974,0.297856454343262,1.36196892950036,-0.396447924142621,0.0721087442377618,-0.385402187820057,"Low",1,"Q1",1,"Below Median",56.93,"<70 kg",167.64,20.257501488373,1.62820156409866,97.24,40.1858823529412,52.7422454704557,10,19,6.84,38,"Y","","","",1
"CDISCPILOT01",1,"01-713-1073",1073,"1073",1073,"713",713,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-03-30,2014-10-05,190,74,"65-75",2,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",190,"DAYS","CENSORED",2014-03-30,2014-10-05,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,16.0842485345362,3.89387218883914,0.67017702227234,0.538369252257499,3.35732190932334,2.77846197428745,-0.922932046216722,0.661342097643974,0.297856454343262,1.36196892950036,-0.396447924142621,0.0721087442377618,-0.385402187820057,"Low",1,"Q1",1,"Below Median",56.93,"<70 kg",167.64,20.257501488373,1.62820156409866,97.24,40.1858823529412,52.7422454704557,10,19,6.84,38,"","Y","","",2
"CDISCPILOT01",1,"01-713-1106",1106,"1106",1106,"713",713,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-10-31,2013-05-06,188,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-10-31,2012-10-31,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,27.2438924875497,5.63209045700924,1.13516218698124,0.293057700164288,2.97314343157889,3.30519635448789,0.236124767538886,1.12019737614821,0.336344351698145,1.73025464524271,0.371223005157954,0.0695319809507313,0.135546274993619,"Medium",2,"Q3",3,"Above Median",53.07,"<70 kg",164.8,19.5404550381751,1.55866181921117,88.4,48.7355497737557,78.999199151071,20,23,8.55,43,"Y","","","",1
"CDISCPILOT01",1,"01-713-1106",1106,"1106",1106,"713",713,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-10-31,2013-05-06,188,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",188,"DAYS","CENSORED",2012-10-31,2013-05-06,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,27.2438924875497,5.63209045700924,1.13516218698124,0.293057700164288,2.97314343157889,3.30519635448789,0.236124767538886,1.12019737614821,0.336344351698145,1.73025464524271,0.371223005157954,0.0695319809507313,0.135546274993619,"Medium",2,"Q3",3,"Above Median",53.07,"<70 kg",164.8,19.5404550381751,1.55866181921117,88.4,48.7355497737557,78.999199151071,20,23,8.55,43,"","Y","","",2
"CDISCPILOT01",1,"01-713-1141",1141,"1141",1141,"713",713,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-31,2013-07-01,32,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-31,2013-05-31,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,33.8404451064714,6.00997010992525,1.41001854610298,0.925783908314682,2.39358553781286,3.5219521486506,0.921252294227934,1.39143031170309,0.4177832729194,1.79508229417971,0.538110691031377,0.074197161850929,0.350669932163779,"High",3,"Q4",4,"Above Median",68.04,"<70 kg",170,23.5432525951557,1.79248430955476,123.76,41.2495248868778,51.1403867328481,23,31,8.55,39,"Y","","","",1
"CDISCPILOT01",1,"01-713-1141",1141,"1141",1141,"713",713,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-31,2013-07-01,32,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",68,"DAYS","CENSORED",2013-05-31,2013-08-06,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,33.8404451064714,6.00997010992525,1.41001854610298,0.925783908314682,2.39358553781286,3.5219521486506,0.921252294227934,1.39143031170309,0.4177832729194,1.79508229417971,0.538110691031377,0.074197161850929,0.350669932163779,"High",3,"Q4",4,"Above Median",68.04,"<70 kg",170,23.5432525951557,1.79248430955476,123.76,41.2495248868778,51.1403867328481,23,31,8.55,39,"","Y","","",2
"CDISCPILOT01",1,"01-713-1179",1179,"1179",1179,"713",713,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-08-09,2014-02-05,181,64,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-09,2013-08-09,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,55.34,"<70 kg",165.1,20.3022891252883,1.59309569357553,88.4,49.4804705882353,62.9274181996834,21,25,5.13,40,"Y","","","",1
"CDISCPILOT01",1,"01-713-1179",1179,"1179",1179,"713",713,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-08-09,2014-02-05,181,64,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",181,"DAYS","CENSORED",2013-08-09,2014-02-05,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,55.34,"<70 kg",165.1,20.3022891252883,1.59309569357553,88.4,49.4804705882353,62.9274181996834,21,25,5.13,40,"","Y","","",2
"CDISCPILOT01",1,"01-713-1209",1209,"1209",1209,"713",713,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-27,2013-11-22,180,77,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-27,2013-05-27,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,24.6519896288722,4.23393814904919,1.02716623453634,0.62197016479824,3.28573884783456,3.20526317691756,-0.0330740242497751,1.01362513127356,0.30434555097373,1.44549164690595,-0.246260369174182,0.0522708413462863,0.0364922197139187,"Medium",2,"Q3",3,"Above Median",52.16,"<70 kg",165.1,19.1356595730943,1.54664655159334,79.56,42.9552941176471,65.8621348479738,13,24,6.84,40,"Y","","","",1
"CDISCPILOT01",1,"01-713-1209",1209,"1209",1209,"713",713,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-27,2013-11-22,180,77,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",180,"DAYS","CENSORED",2013-05-27,2013-11-22,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,24.6519896288722,4.23393814904919,1.02716623453634,0.62197016479824,3.28573884783456,3.20526317691756,-0.0330740242497751,1.01362513127356,0.30434555097373,1.44549164690595,-0.246260369174182,0.0522708413462863,0.0364922197139187,"Medium",2,"Q3",3,"Above Median",52.16,"<70 kg",165.1,19.1356595730943,1.54664655159334,79.56,42.9552941176471,65.8621348479738,13,24,6.84,40,"","Y","","",2
"CDISCPILOT01",1,"01-713-1256",1256,"1256",1256,"713",713,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-09-19,2013-03-25,188,71,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-19,2012-09-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,77.11,">=70 kg",180.34,23.7097280383809,1.9653962987426,97.24,67.300757918552,71.7884355819716,11,16,6.84,37,"Y","","","",1
"CDISCPILOT01",1,"01-713-1256",1256,"1256",1256,"713",713,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-09-19,2013-03-25,188,71,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",188,"DAYS","CENSORED",2012-09-19,2013-03-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,77.11,">=70 kg",180.34,23.7097280383809,1.9653962987426,97.24,67.300757918552,71.7884355819716,11,16,6.84,37,"","Y","","",2
"CDISCPILOT01",1,"01-713-1269",1269,"1269",1269,"713",713,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-27,2014-07-28,183,73,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-27,2014-01-27,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,75.3,">=70 kg",185.42,21.9019015632327,1.96935734018317,106.08,58.4980486425339,63.87136550251,15,18,8.55,39,"Y","","","",1
"CDISCPILOT01",1,"01-713-1269",1269,"1269",1269,"713",713,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-27,2014-07-28,183,73,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2014-01-27,2014-07-28,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,75.3,">=70 kg",185.42,21.9019015632327,1.96935734018317,106.08,58.4980486425339,63.87136550251,15,18,8.55,39,"","Y","","",2
"CDISCPILOT01",1,"01-713-1448",1448,"1448",1448,"713",713,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-01-19,2014-05-16,118,71,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-19,2014-01-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,17.3854125288661,4.69358646541504,0.724392188702754,0.476676816090362,3.10605226711419,2.85620652369298,-0.787791265758908,0.714842547076925,0.321952083867891,1.54832529546809,-0.0432601725720102,0.0869182678780563,-0.308712076030415,"Low",1,"Q2",2,"Below Median",78.47,">=70 kg",175.26,25.5468899931709,1.95452837448492,79.56,70.7768627450981,68.3662642504749,14,20,8.55,40,"Y","","","",1
"CDISCPILOT01",1,"01-713-1448",1448,"1448",1448,"713",713,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-01-19,2014-05-16,118,71,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",125,"DAYS","CENSORED",2014-01-19,2014-05-23,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,17.3854125288661,4.69358646541504,0.724392188702754,0.476676816090362,3.10605226711419,2.85620652369298,-0.787791265758908,0.714842547076925,0.321952083867891,1.54832529546809,-0.0432601725720102,0.0869182678780563,-0.308712076030415,"Low",1,"Q2",2,"Below Median",78.47,">=70 kg",175.26,25.5468899931709,1.95452837448492,79.56,70.7768627450981,68.3662642504749,14,20,8.55,40,"","Y","","",2
"CDISCPILOT01",1,"01-714-1035",1035,"1035",1035,"714",714,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-04-17,2014-10-16,183,88,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-04-17,2014-04-17,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.43,"<70 kg",148.59,24.6523979058624,1.49886565442003,114.92,25.6141176470588,39.5624983128726,37,31,6.84,39,"Y","","","",1
"CDISCPILOT01",1,"01-714-1035",1035,"1035",1035,"714",714,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-04-17,2014-10-16,183,88,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2014-04-17,2014-10-16,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.43,"<70 kg",148.59,24.6523979058624,1.49886565442003,114.92,25.6141176470588,39.5624983128726,37,31,6.84,39,"","Y","","",2
"CDISCPILOT01",1,"01-714-1068",1068,"1068",1068,"714",714,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-08-08,2013-10-08,62,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-08,2013-08-08,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,15.3732984763415,2.32745344841397,0.640554103180894,0.319071717275418,3.5125838533027,2.73328240638489,-0.996772350859057,0.632109696652593,0.284690712524842,0.84906206686538,-1.08824489357727,0.043100989785444,-0.429930812803455,"Low",1,"Q1",1,"Below Median",54.43,"<70 kg",153.67,23.0494279716788,1.52427196647376,79.56,43.4016993464052,65.0479761163224,12,15,6.84,42,"Y","","","",1
"CDISCPILOT01",1,"01-714-1068",1068,"1068",1068,"714",714,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-08-08,2013-10-08,62,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",70,"DAYS","CENSORED",2013-08-08,2013-10-16,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,15.3732984763415,2.32745344841397,0.640554103180894,0.319071717275418,3.5125838533027,2.73328240638489,-0.996772350859057,0.632109696652593,0.284690712524842,0.84906206686538,-1.08824489357727,0.043100989785444,-0.429930812803455,"Low",1,"Q1",1,"Below Median",54.43,"<70 kg",153.67,23.0494279716788,1.52427196647376,79.56,43.4016993464052,65.0479761163224,12,15,6.84,42,"","Y","","",2
"CDISCPILOT01",1,"01-714-1195",1195,"1195",1195,"714",714,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-04-26,2013-10-23,181,75,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-26,2013-04-26,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,14.1201685978458,1.43477238017448,0.588340358243574,0.31905807419133,3.82431694252139,2.64831212853224,-1.12692423834817,0.580584284030102,0.26148460366381,0.367951786785841,-1.48249072436461,0.02656985889212,-0.513595525999731,"Low",1,"Q1",1,"Below Median",85.73,">=70 kg",172.72,28.7374060907291,2.02808650922215,114.92,59.6424773755656,57.30462281766,28,26,10.26,40,"Y","","","",1
"CDISCPILOT01",1,"01-714-1195",1195,"1195",1195,"714",714,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-04-26,2013-10-23,181,75,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",181,"DAYS","CENSORED",2013-04-26,2013-10-23,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,14.1201685978458,1.43477238017448,0.588340358243574,0.31905807419133,3.82431694252139,2.64831212853224,-1.12692423834817,0.580584284030102,0.26148460366381,0.367951786785841,-1.48249072436461,0.02656985889212,-0.513595525999731,"Low",1,"Q1",1,"Below Median",85.73,">=70 kg",172.72,28.7374060907291,2.02808650922215,114.92,59.6424773755656,57.30462281766,28,26,10.26,40,"","Y","","",2
"CDISCPILOT01",1,"01-714-1288",1288,"1288",1288,"714",714,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-04,2014-06-17,196,77,">75",3,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-04,2013-12-04,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,29.47376247237,3.50714253405442,1.22807343634875,1.66213714041953,2.74820698836577,3.38383968714108,0.467722299734087,1.2118837791572,0.36387361077,1.25764887983994,-0.567244146293259,0.0432980559759805,0.213556491040085,"High",3,"Q3",3,"Above Median",49.44,"<70 kg",162.56,18.7090217930436,1.49415215646422,106.08,36.1152488687783,62.3020261348266,14,24,6.84,41,"Y","","","",1
"CDISCPILOT01",1,"01-714-1288",1288,"1288",1288,"714",714,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-04,2014-06-17,196,77,">75",3,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",196,"DAYS","CENSORED",2013-12-04,2014-06-17,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,29.47376247237,3.50714253405442,1.22807343634875,1.66213714041953,2.74820698836577,3.38383968714108,0.467722299734087,1.2118837791572,0.36387361077,1.25764887983994,-0.567244146293259,0.0432980559759805,0.213556491040085,"High",3,"Q3",3,"Above Median",49.44,"<70 kg",162.56,18.7090217930436,1.49415215646422,106.08,36.1152488687783,62.3020261348266,14,24,6.84,41,"","Y","","",2
"CDISCPILOT01",1,"01-714-1375",1375,"1375",1375,"714",714,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-26,2013-09-07,194,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-26,2013-02-26,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,57.61,"<70 kg",149.86,25.6523064037223,1.54860462280654,97.24,38.2012834224599,51.4463520524019,18,26,6.84,43,"Y","","","",1
"CDISCPILOT01",1,"01-714-1375",1375,"1375",1375,"714",714,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-26,2013-09-07,194,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",194,"DAYS","CENSORED",2013-02-26,2013-09-07,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,57.61,"<70 kg",149.86,25.6523064037223,1.54860462280654,97.24,38.2012834224599,51.4463520524019,18,26,6.84,43,"","Y","","",2
"CDISCPILOT01",1,"01-714-1425",1425,"1425",1425,"714",714,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-08-15,2013-08-19,5,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-15,2013-08-15,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,23.824311368632,3.81180362929886,0.992679640359665,0.44626942234608,3.39988840586796,3.17112619663598,-0.119037889330769,0.979593172887303,0.294127300847308,1.34072246545545,-0.432692881707687,0.047059304065418,0.00267605652426853,"Medium",2,"Q2",2,"Below Median",91.63,">=70 kg",177.8,28.9850579701159,2.12732317452918,106.08,62.6846634615385,60.771245924781,22,26,10.26,42,"Y","","","",1
"CDISCPILOT01",1,"01-714-1425",1425,"1425",1425,"714",714,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-08-15,2013-08-19,5,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",8,"DAYS","CENSORED",2013-08-15,2013-08-22,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,23.824311368632,3.81180362929886,0.992679640359665,0.44626942234608,3.39988840586796,3.17112619663598,-0.119037889330769,0.979593172887303,0.294127300847308,1.34072246545545,-0.432692881707687,0.047059304065418,0.00267605652426853,"Medium",2,"Q2",2,"Below Median",91.63,">=70 kg",177.8,28.9850579701159,2.12732317452918,106.08,62.6846634615385,60.771245924781,22,26,10.26,42,"","Y","","",2
"CDISCPILOT01",1,"01-715-1085",1085,"1085",1085,"715",715,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-16,2013-08-18,184,77,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-16,2013-02-16,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,26.3614584319238,4.70583010623639,1.09839410133016,0.81703467543478,2.04844508658163,3.2722823053176,0.144473886097718,1.08391400312477,0.488175156146736,1.55092495705513,-0.037852861361755,0.0871450019673405,0.102912212204504,"Medium",2,"Q3",3,"Above Median",57.61,"<70 kg",162.56,21.8007027810931,1.61288919506442,97.24,38.8174331550802,51.767309370499,12,18,8.55,41,"Y","","","",1
"CDISCPILOT01",1,"01-715-1085",1085,"1085",1085,"715",715,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-16,2013-08-18,184,77,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2013-02-16,2013-08-18,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,26.3614584319238,4.70583010623639,1.09839410133016,0.81703467543478,2.04844508658163,3.2722823053176,0.144473886097718,1.08391400312477,0.488175156146736,1.55092495705513,-0.037852861361755,0.0871450019673405,0.102912212204504,"Medium",2,"Q3",3,"Above Median",57.61,"<70 kg",162.56,21.8007027810931,1.61288919506442,97.24,38.8174331550802,51.767309370499,12,18,8.55,41,"","Y","","",2
"CDISCPILOT01",1,"01-715-1107",1107,"1107",1107,"715",715,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-26,2013-05-07,71,65,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-26,2013-02-26,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,38.1062402732282,7.53773240140236,1.58776001138451,0.954720064799715,1.4170907340323,3.64064044520278,1.36430396997427,1.56682861630183,0.705671116170892,2.02124717396347,1.21283533265149,0.139587637063007,0.4686026554554,"High",3,"Q4",4,"Above Median",69.4,"<70 kg",172.72,23.2634548314079,1.82473498836894,114.92,55.7096240863209,60.9817290814098,23,26,8.55,40,"Y","","","",1
"CDISCPILOT01",1,"01-715-1107",1107,"1107",1107,"715",715,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-26,2013-05-07,71,65,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",170,"DAYS","CENSORED",2013-02-26,2013-08-14,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,38.1062402732282,7.53773240140236,1.58776001138451,0.954720064799715,1.4170907340323,3.64064044520278,1.36430396997427,1.56682861630183,0.705671116170892,2.02124717396347,1.21283533265149,0.139587637063007,0.4686026554554,"High",3,"Q4",4,"Above Median",69.4,"<70 kg",172.72,23.2634548314079,1.82473498836894,114.92,55.7096240863209,60.9817290814098,23,26,8.55,40,"","Y","","",2
"CDISCPILOT01",1,"01-715-1155",1155,"1155",1155,"715",715,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-12-13,2014-01-25,44,59,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-13,2013-12-13,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,63.5,"<70 kg",165.1,23.2959045799748,1.70651122338986,97.24,55.0106951871658,57.8993555117518,12,22,5.13,38,"Y","","","",1
"CDISCPILOT01",1,"01-715-1155",1155,"1155",1155,"715",715,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-12-13,2014-01-25,44,59,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",44,"DAYS","CENSORED",2013-12-13,2014-01-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,63.5,"<70 kg",165.1,23.2959045799748,1.70651122338986,97.24,55.0106951871658,57.8993555117518,12,22,5.13,38,"","Y","","",2
"CDISCPILOT01",1,"01-715-1207",1207,"1207",1207,"715",715,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-11-18,2013-05-27,191,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-11-18,2012-11-18,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,49.44,"<70 kg",152.4,21.2867092400851,1.44670660467145,97.24,32.783743315508,51.4463520524019,10,24,6.84,38,"Y","","","",1
"CDISCPILOT01",1,"01-715-1207",1207,"1207",1207,"715",715,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-11-18,2013-05-27,191,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",196,"DAYS","CENSORED",2012-11-18,2013-06-01,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,49.44,"<70 kg",152.4,21.2867092400851,1.44670660467145,97.24,32.783743315508,51.4463520524019,10,24,6.84,38,"","Y","","",2
"CDISCPILOT01",1,"01-715-1319",1319,"1319",1319,"715",715,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-17,2013-03-05,17,65,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-17,2013-02-17,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,30.5129210802312,7.44364132444202,1.2713717116763,0.635473216507735,2.6546130993823,3.41847791219775,0.575650820579862,1.25461125455228,0.37670272938557,2.00870268136459,1.17128072135111,0.0918968064745929,0.247931153871953,"High",3,"Q3",3,"Above Median",75.75,">=70 kg",172.72,25.3920274276535,1.90638838295523,106.08,65.8742222850679,67.1296312766838,11,16,6.84,40,"Y","","","",1
"CDISCPILOT01",1,"01-715-1319",1319,"1319",1319,"715",715,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-17,2013-03-05,17,65,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",30,"DAYS","CENSORED",2013-02-17,2013-03-18,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,30.5129210802312,7.44364132444202,1.2713717116763,0.635473216507735,2.6546130993823,3.41847791219775,0.575650820579862,1.25461125455228,0.37670272938557,2.00870268136459,1.17128072135111,0.0918968064745929,0.247931153871953,"High",3,"Q3",3,"Above Median",75.75,">=70 kg",172.72,25.3920274276535,1.90638838295523,106.08,65.8742222850679,67.1296312766838,11,16,6.84,40,"","Y","","",2
"CDISCPILOT01",1,"01-715-1321",1321,"1321",1321,"715",715,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-02-11,2014-04-21,70,75,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-02-11,2014-02-11,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,34.4700271314034,7.34924851908557,1.43625113047514,0.575002454584923,2.34986760211181,3.54038023266883,0.986641596869478,1.41731707266139,0.425555890511153,1.99595782414277,1.12959285399049,0.0907314631985873,0.368974781185007,"High",3,"Q4",4,"Above Median",59.88,"<70 kg",162.56,22.6597132881766,1.64435843618922,97.24,41.627807486631,52.4152435485389,14,19,8.55,41,"Y","","","",1
"CDISCPILOT01",1,"01-715-1321",1321,"1321",1321,"715",715,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-02-11,2014-04-21,70,75,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",71,"DAYS","CENSORED",2014-02-11,2014-04-22,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,34.4700271314034,7.34924851908557,1.43625113047514,0.575002454584923,2.34986760211181,3.54038023266883,0.986641596869478,1.41731707266139,0.425555890511153,1.99595782414277,1.12959285399049,0.0907314631985873,0.368974781185007,"High",3,"Q4",4,"Above Median",59.88,"<70 kg",162.56,22.6597132881766,1.64435843618922,97.24,41.627807486631,52.4152435485389,14,19,8.55,41,"","Y","","",2
"CDISCPILOT01",1,"01-715-1397",1397,"1397",1397,"715",715,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-04-03,2013-10-02,183,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-03,2013-04-03,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,67.13,"<70 kg",152.4,28.9032522509489,1.6857747971383,88.4,50.5449411764706,58.4020138158505,12,19,6.84,38,"Y","","","",1
"CDISCPILOT01",1,"01-715-1397",1397,"1397",1397,"715",715,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-04-03,2013-10-02,183,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2013-04-03,2013-10-03,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,67.13,"<70 kg",152.4,28.9032522509489,1.6857747971383,88.4,50.5449411764706,58.4020138158505,12,19,6.84,38,"","Y","","",2
"CDISCPILOT01",1,"01-715-1405",1405,"1405",1405,"715",715,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-06,2013-07-07,2,69,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-07-06,2013-07-06,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,22.2455789330201,4.07002138944589,0.926899122209172,0.541153098058095,2.42744862530169,3.10259271574529,-0.283007330855714,0.914679837437142,0.411955165426299,1.40610223091358,-0.318652964210636,0.0753707664712202,-0.0651796629352719,"Medium",2,"Q2",2,"Below Median",69.85,"<70 kg",180.34,21.4774283942537,1.87058732606752,123.76,49.2889503878474,54.4219480997958,15,16,6.84,39,"Y","","","",1
"CDISCPILOT01",1,"01-715-1405",1405,"1405",1405,"715",715,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-06,2013-07-07,2,69,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",8,"DAYS","CENSORED",2013-07-06,2013-07-13,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,22.2455789330201,4.07002138944589,0.926899122209172,0.541153098058095,2.42744862530169,3.10259271574529,-0.283007330855714,0.914679837437142,0.411955165426299,1.40610223091358,-0.318652964210636,0.0753707664712202,-0.0651796629352719,"Medium",2,"Q2",2,"Below Median",69.85,"<70 kg",180.34,21.4774283942537,1.87058732606752,123.76,49.2889503878474,54.4219480997958,15,16,6.84,39,"","Y","","",2
"CDISCPILOT01",1,"01-716-1024",1024,"1024",1024,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-07-09,2013-01-20,196,87,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-07-09,2012-07-09,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.43,"<70 kg",154.94,22.6731171011388,1.5305576507346,88.4,33.9387058823529,54.5402016356934,17,26,11.97,41,"Y","","","",1
"CDISCPILOT01",1,"01-716-1024",1024,"1024",1024,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-07-09,2013-01-20,196,87,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",196,"DAYS","CENSORED",2012-07-09,2013-01-20,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.43,"<70 kg",154.94,22.6731171011388,1.5305576507346,88.4,33.9387058823529,54.5402016356934,17,26,11.97,41,"","Y","","",2
"CDISCPILOT01",1,"01-716-1026",1026,"1026",1026,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-04-02,2014-10-16,198,73,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-04-02,2014-04-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,79.83,">=70 kg",154.94,33.2536273779884,1.85358962556441,97.24,57.204385026738,53.0712874526622,21,21,6.84,46,"Y","","","",1
"CDISCPILOT01",1,"01-716-1026",1026,"1026",1026,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-04-02,2014-10-16,198,73,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",198,"DAYS","CENSORED",2014-04-02,2014-10-16,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,79.83,">=70 kg",154.94,33.2536273779884,1.85358962556441,97.24,57.204385026738,53.0712874526622,21,21,6.84,46,"","Y","","",2
"CDISCPILOT01",1,"01-716-1030",1030,"1030",1030,"716",716,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-12-28,2014-01-02,6,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-28,2013-12-28,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,36.6156091754391,6.52986011485951,1.52565038230996,1.32829398374157,2.21217130682979,3.6007476999754,1.20948486123184,1.50553777670131,0.452044557721471,1.87791577607514,0.767716172995457,0.0806155569735742,0.428953993133482,"High",3,"Q4",4,"Above Median",75.3,">=70 kg",150.62,33.1917147626221,1.77495586799597,97.24,45.9048128342246,49.8711688850674,15,22,11.97,40,"Y","","","",1
"CDISCPILOT01",1,"01-716-1030",1030,"1030",1030,"716",716,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,"Xanomeline High Dose",2,"Xanomeline Low Dose",1,2013-12-28,2014-01-02,6,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",14,"DAYS","CENSORED",2013-12-28,2014-01-10,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,36.6156091754391,6.52986011485951,1.52565038230996,1.32829398374157,2.21217130682979,3.6007476999754,1.20948486123184,1.50553777670131,0.452044557721471,1.87791577607514,0.767716172995457,0.0806155569735742,0.428953993133482,"High",3,"Q4",4,"Above Median",75.3,">=70 kg",150.62,33.1917147626221,1.77495586799597,97.24,45.9048128342246,49.8711688850674,15,22,11.97,40,"","Y","","",2
"CDISCPILOT01",1,"01-716-1044",1044,"1044",1044,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-04-27,2013-11-03,191,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-27,2013-04-27,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,86.18,">=70 kg",172.72,28.8882498180221,2.03340229391257,114.92,60.8779359554473,57.6621280113302,12,15,13.68,42,"Y","","","",1
"CDISCPILOT01",1,"01-716-1044",1044,"1044",1044,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-04-27,2013-11-03,191,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",191,"DAYS","CENSORED",2013-04-27,2013-11-03,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,86.18,">=70 kg",172.72,28.8882498180221,2.03340229391257,114.92,60.8779359554473,57.6621280113302,12,15,13.68,42,"","Y","","",2
"CDISCPILOT01",1,"01-716-1063",1063,"1063",1063,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-05-09,2013-08-25,109,80,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-09,2013-05-09,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,14.604272949868,3.7288710554819,0.608511372911167,0.224582134462444,3.69754798375554,2.68199865048132,-1.07664445790512,0.600489384784888,0.27044949907163,1.31878370903548,-0.469319424632229,0.0690531676941092,-0.480439699426706,"Low",1,"Q1",1,"Below Median",72.58,">=70 kg",160.02,28.344475938133,1.79615728709932,97.24,55.0843685726039,67.880560696051,22,38,8.55,40,"Y","","","",1
"CDISCPILOT01",1,"01-716-1063",1063,"1063",1063,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-05-09,2013-08-25,109,80,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",112,"DAYS","CENSORED",2013-05-09,2013-08-28,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,14.604272949868,3.7288710554819,0.608511372911167,0.224582134462444,3.69754798375554,2.68199865048132,-1.07664445790512,0.600489384784888,0.27044949907163,1.31878370903548,-0.469319424632229,0.0690531676941092,-0.480439699426706,"Low",1,"Q1",1,"Below Median",72.58,">=70 kg",160.02,28.344475938133,1.79615728709932,97.24,55.0843685726039,67.880560696051,22,38,8.55,40,"","Y","","",2
"CDISCPILOT01",1,"01-716-1071",1071,"1071",1071,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-06-08,2013-08-01,55,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-06-08,2013-06-08,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,59.5342179242481,13.2093560709875,2.48059241351034,1.65894672268435,1.36056209057899,4.08671919493685,3.58984482109709,2.44789083425781,0.734990344743804,2.58168212453735,3.7176649577924,0.163078470012192,0.912520599251262,"High",3,"Q4",4,"Above Median",76.66,">=70 kg",154.94,31.9331463709958,1.81641438615263,150.28,32.8921799307958,30.5131540658282,16,26,6.84,45,"Y","","","",1
"CDISCPILOT01",1,"01-716-1071",1071,"1071",1071,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-06-08,2013-08-01,55,78,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",55,"DAYS","CENSORED",2013-06-08,2013-08-01,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,59.5342179242481,13.2093560709875,2.48059241351034,1.65894672268435,1.36056209057899,4.08671919493685,3.58984482109709,2.44789083425781,0.734990344743804,2.58168212453735,3.7176649577924,0.163078470012192,0.912520599251262,"High",3,"Q4",4,"Above Median",76.66,">=70 kg",154.94,31.9331463709958,1.81641438615263,150.28,32.8921799307958,30.5131540658282,16,26,6.84,45,"","Y","","",2
"CDISCPILOT01",1,"01-716-1094",1094,"1094",1094,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-12-19,2013-01-24,37,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-19,2012-12-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,19.921830804396,3.30205057461207,0.830076283516498,0.532301977781312,2.7105942486011,2.99231799174155,-0.524355183284857,0.81913341147383,0.368922792673999,1.19756750651877,-0.657821456393061,0.0611490847150384,-0.174262577557976,"Medium",2,"Q2",2,"Below Median",80.74,">=70 kg",168.91,28.2994517032055,1.94634938909859,132.6,43.438850678733,46.2067174489562,19,24,10.26,39,"Y","","","",1
"CDISCPILOT01",1,"01-716-1094",1094,"1094",1094,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-12-19,2013-01-24,37,82,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",39,"DAYS","CENSORED",2012-12-19,2013-01-26,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,19.921830804396,3.30205057461207,0.830076283516498,0.532301977781312,2.7105942486011,2.99231799174155,-0.524355183284857,0.81913341147383,0.368922792673999,1.19756750651877,-0.657821456393061,0.0611490847150384,-0.174262577557976,"Medium",2,"Q2",2,"Below Median",80.74,">=70 kg",168.91,28.2994517032055,1.94634938909859,132.6,43.438850678733,46.2067174489562,19,24,10.26,39,"","Y","","",2
"CDISCPILOT01",1,"01-716-1103",1103,"1103",1103,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-03-20,2014-09-20,185,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-03-20,2014-03-20,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,23.0145896302748,4.7352308647181,0.958941234594785,0.543305906577703,2.34633773043535,3.13656275919318,-0.203136763993828,0.946299539566281,0.426196104264349,1.55714008519192,-0.0248682391200598,0.0876894604577427,-0.0315513143433971,"Medium",2,"Q2",2,"Below Median",69.85,"<70 kg",165.1,25.6254950379723,1.78980407059295,141.44,37.0534891119909,43.568606688256,14,28,6.84,41,"Y","","","",1
"CDISCPILOT01",1,"01-716-1103",1103,"1103",1103,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-03-20,2014-09-20,185,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",185,"DAYS","CENSORED",2014-03-20,2014-09-20,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,23.0145896302748,4.7352308647181,0.958941234594785,0.543305906577703,2.34633773043535,3.13656275919318,-0.203136763993828,0.946299539566281,0.426196104264349,1.55714008519192,-0.0248682391200598,0.0876894604577427,-0.0315513143433971,"Medium",2,"Q2",2,"Below Median",69.85,"<70 kg",165.1,25.6254950379723,1.78980407059295,141.44,37.0534891119909,43.568606688256,14,28,6.84,41,"","Y","","",2
"CDISCPILOT01",1,"01-716-1108",1108,"1108",1108,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-12,2013-08-10,180,86,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-12,2013-02-12,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,52.62,"<70 kg",142.24,26.0080239548234,1.44189967288528,79.56,37.1435294117647,62.2768640363314,16,24,11.97,41,"Y","","","",1
"CDISCPILOT01",1,"01-716-1108",1108,"1108",1108,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-12,2013-08-10,180,86,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",180,"DAYS","CENSORED",2013-02-12,2013-08-10,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,52.62,"<70 kg",142.24,26.0080239548234,1.44189967288528,79.56,37.1435294117647,62.2768640363314,16,24,11.97,41,"","Y","","",2
"CDISCPILOT01",1,"01-716-1151",1151,"1151",1151,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-01,2013-05-11,100,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-01,2013-02-01,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,17.746587312047,3.73813428992414,0.73944113800196,0.607956151427019,3.04283854977249,2.87675656324652,-0.750279128708198,0.729693106505431,0.328640505778649,1.32125819348995,-0.465228387319583,0.0692247090726693,-0.288427499544255,"Low",1,"Q2",2,"Below Median",45.81,"<70 kg",152.4,19.7237894475789,1.39258392924807,97.24,27.9269518716578,49.8711688850674,18,29,6.84,36,"Y","","","",1
"CDISCPILOT01",1,"01-716-1151",1151,"1151",1151,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-02-01,2013-05-11,100,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",127,"DAYS","CENSORED",2013-02-01,2013-06-07,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,17.746587312047,3.73813428992414,0.73944113800196,0.607956151427019,3.04283854977249,2.87675656324652,-0.750279128708198,0.729693106505431,0.328640505778649,1.32125819348995,-0.465228387319583,0.0692247090726693,-0.288427499544255,"Low",1,"Q2",2,"Below Median",45.81,"<70 kg",152.4,19.7237894475789,1.39258392924807,97.24,27.9269518716578,49.8711688850674,18,29,6.84,36,"","Y","","",2
"CDISCPILOT01",1,"01-716-1157",1157,"1157",1157,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-10-02,2014-04-04,185,85,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-10-02,2013-10-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,18.677676972051,3.88285932273635,0.778236540502127,0.48694916197958,2.89115183225434,2.92786432118237,-0.653574805596383,0.767977070317572,0.345882906889834,1.35914393202275,-0.401311673022844,0.0719048022728953,-0.237957055866559,"Low",1,"Q2",2,"Below Median",59.42,"<70 kg",160.02,23.2051358534564,1.62518275895359,114.92,34.9787939436129,53.8492405141616,17,23,8.55,36,"Y","","","",1
"CDISCPILOT01",1,"01-716-1157",1157,"1157",1157,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-10-02,2014-04-04,185,85,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",186,"DAYS","CENSORED",2013-10-02,2014-04-05,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,18.677676972051,3.88285932273635,0.778236540502127,0.48694916197958,2.89115183225434,2.92786432118237,-0.653574805596383,0.767977070317572,0.345882906889834,1.35914393202275,-0.401311673022844,0.0719048022728953,-0.237957055866559,"Low",1,"Q2",2,"Below Median",59.42,"<70 kg",160.02,23.2051358534564,1.62518275895359,114.92,34.9787939436129,53.8492405141616,17,23,8.55,36,"","Y","","",2
"CDISCPILOT01",1,"01-716-1160",1160,"1160",1160,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-04-05,2013-10-11,190,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-05,2013-04-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,59.88,"<70 kg",157.48,24.1452095807417,1.61846140928146,114.92,30.8883257918552,40.8120816451533,13,19,8.55,40,"Y","","","",1
"CDISCPILOT01",1,"01-716-1160",1160,"1160",1160,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-04-05,2013-10-11,190,83,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",190,"DAYS","CENSORED",2013-04-05,2013-10-11,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,59.88,"<70 kg",157.48,24.1452095807417,1.61846140928146,114.92,30.8883257918552,40.8120816451533,13,19,8.55,40,"","Y","","",2
"CDISCPILOT01",1,"01-716-1167",1167,"1167",1167,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-10-08,2013-04-12,187,68,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-10-08,2012-10-08,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,12.9676113026613,2.62883633949364,0.540317137610888,0.388289767766536,4.16422105348868,2.56322566526974,-1.24663051140238,0.533194152149494,0.240140950049284,0.970338039491112,-0.955141423025222,0.0486821544350673,-0.597260553095523,"Low",1,"Q1",1,"Below Median",62.6,"<70 kg",158.75,24.8397296794594,1.66147106839424,97.24,57.0120937885644,73.140430465603,17,20,6.84,38,"Y","","","",1
"CDISCPILOT01",1,"01-716-1167",1167,"1167",1167,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-10-08,2013-04-12,187,68,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",188,"DAYS","CENSORED",2012-10-08,2013-04-13,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,12.9676113026613,2.62883633949364,0.540317137610888,0.388289767766536,4.16422105348868,2.56322566526974,-1.24663051140238,0.533194152149494,0.240140950049284,0.970338039491112,-0.955141423025222,0.0486821544350673,-0.597260553095523,"Low",1,"Q1",1,"Below Median",62.6,"<70 kg",158.75,24.8397296794594,1.66147106839424,97.24,57.0120937885644,73.140430465603,17,20,6.84,38,"","Y","","",2
"CDISCPILOT01",1,"01-716-1177",1177,"1177",1177,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-09-02,2015-03-05,185,72,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-09-02,2014-09-02,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,86.18,">=70 kg",177.8,27.2610749303131,2.06308856921957,114.92,62.7227218934911,58.3838433944817,17,18,13.68,43,"Y","","","",1
"CDISCPILOT01",1,"01-716-1177",1177,"1177",1177,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-09-02,2015-03-05,185,72,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",185,"DAYS","CENSORED",2014-09-02,2015-03-05,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,86.18,">=70 kg",177.8,27.2610749303131,2.06308856921957,114.92,62.7227218934911,58.3838433944817,17,18,13.68,43,"","Y","","",2
"CDISCPILOT01",1,"01-716-1189",1189,"1189",1189,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-10-09,2013-02-27,142,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-10-09,2012-10-09,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,14.5714737495943,2.65949042812234,0.607144739566428,0.477361232543307,5.55880629454212,2.67975180169134,-1.08005103043764,0.599140767728673,0.179894737649312,0.9818876033073,-0.941603277019408,0.0328332151620042,-0.482651696580567,"Low",1,"Q1",1,"Below Median",73.48,">=70 kg",163.83,27.3767749025793,1.82864767884175,106.08,50.2681334841629,60.771245924781,18,20,6.84,40,"Y","","","",1
"CDISCPILOT01",1,"01-716-1189",1189,"1189",1189,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-10-09,2013-02-27,142,81,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",146,"DAYS","CENSORED",2012-10-09,2013-03-03,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,14.5714737495943,2.65949042812234,0.607144739566428,0.477361232543307,5.55880629454212,2.67975180169134,-1.08005103043764,0.599140767728673,0.179894737649312,0.9818876033073,-0.941603277019408,0.0328332151620042,-0.482651696580567,"Low",1,"Q1",1,"Below Median",73.48,">=70 kg",163.83,27.3767749025793,1.82864767884175,106.08,50.2681334841629,60.771245924781,18,20,6.84,40,"","Y","","",2
"CDISCPILOT01",1,"01-716-1229",1229,"1229",1229,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-20,2013-03-31,40,73,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-20,2013-02-20,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,28.6277924473166,6.10797384038995,1.19282468530486,0.928446298661113,2.82941830562253,3.35472725976821,0.37985862541799,1.17709971139604,0.353429536386624,1.81123096987615,0.581393296109486,0.0754070844492587,0.184672695121553,"High",3,"Q3",3,"Above Median",63.96,"<70 kg",161.29,24.586322345191,1.69280408395853,88.4,50.4155294117647,59.5019016074244,20,20,5.13,41,"Y","","","",1
"CDISCPILOT01",1,"01-716-1229",1229,"1229",1229,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-20,2013-03-31,40,73,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",42,"DAYS","CENSORED",2013-02-20,2013-04-02,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,28.6277924473166,6.10797384038995,1.19282468530486,0.928446298661113,2.82941830562253,3.35472725976821,0.37985862541799,1.17709971139604,0.353429536386624,1.81123096987615,0.581393296109486,0.0754070844492587,0.184672695121553,"High",3,"Q3",3,"Above Median",63.96,"<70 kg",161.29,24.586322345191,1.69280408395853,88.4,50.4155294117647,59.5019016074244,20,20,5.13,41,"","Y","","",2
"CDISCPILOT01",1,"01-716-1298",1298,"1298",1298,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-04-08,2013-06-28,82,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-08,2013-04-08,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,18.6158002769714,3.56259025640117,0.775658344873807,0.579457077228672,2.90076167538178,2.92454773123361,-0.660001408931287,0.76543286296891,0.344737042166136,1.27329089471581,-0.542756079793798,0.0659738936370586,-0.241233256784882,"Low",1,"Q2",2,"Below Median",71.67,">=70 kg",156.21,29.3710680619854,1.76348539829509,97.24,49.0575401069519,52.0902690385379,14,19,6.84,39,"Y","","","",1
"CDISCPILOT01",1,"01-716-1298",1298,"1298",1298,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-04-08,2013-06-28,82,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",90,"DAYS","CENSORED",2013-04-08,2013-07-06,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,18.6158002769714,3.56259025640117,0.775658344873807,0.579457077228672,2.90076167538178,2.92454773123361,-0.660001408931287,0.76543286296891,0.344737042166136,1.27329089471581,-0.542756079793798,0.0659738936370586,-0.241233256784882,"Low",1,"Q2",2,"Below Median",71.67,">=70 kg",156.21,29.3710680619854,1.76348539829509,97.24,49.0575401069519,52.0902690385379,14,19,6.84,39,"","Y","","",2
"CDISCPILOT01",1,"01-716-1308",1308,"1308",1308,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-08-28,2013-10-07,41,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-08-28,2013-08-28,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.51,"<70 kg",157.48,23.5927891210621,1.59983981837072,79.56,48.9495424836601,66.2730276192129,7,18,5.13,38,"Y","","","",1
"CDISCPILOT01",1,"01-716-1308",1308,"1308",1308,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-08-28,2013-10-07,41,76,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",41,"DAYS","CENSORED",2013-08-28,2013-10-07,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.51,"<70 kg",157.48,23.5927891210621,1.59983981837072,79.56,48.9495424836601,66.2730276192129,7,18,5.13,38,"","Y","","",2
"CDISCPILOT01",1,"01-716-1311",1311,"1311",1311,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-05-14,2014-09-21,131,78,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-05-14,2014-05-14,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,18.1738224036209,3.44019877327565,0.757242600150871,0.494211970359898,2.97130668500652,2.90053231987369,-0.705905872173391,0.747259892485011,0.33655226673372,1.23843184482578,-0.596809351071605,0.0637073846902899,-0.264952230167615,"Low",1,"Q2",2,"Below Median",80.74,">=70 kg",172.72,27.0647167591913,1.96817828912367,97.24,63.3199547511312,68.730172851566,20,25,10.26,39,"Y","","","",1
"CDISCPILOT01",1,"01-716-1311",1311,"1311",1311,"716",716,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-05-14,2014-09-21,131,78,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",140,"DAYS","CENSORED",2014-05-14,2014-09-30,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,18.1738224036209,3.44019877327565,0.757242600150871,0.494211970359898,2.97130668500652,2.90053231987369,-0.705905872173391,0.747259892485011,0.33655226673372,1.23843184482578,-0.596809351071605,0.0637073846902899,-0.264952230167615,"Low",1,"Q2",2,"Below Median",80.74,">=70 kg",172.72,27.0647167591913,1.96817828912367,97.24,63.3199547511312,68.730172851566,20,25,10.26,39,"","Y","","",2
"CDISCPILOT01",1,"01-716-1364",1364,"1364",1364,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-07-04,2014-01-09,190,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-07-04,2013-07-04,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,31.9987504722872,5.7937695263156,1.33328126967863,0.395627830266501,2.53134884345408,3.46600931767745,0.729971217197524,1.31570466061185,0.395046302127003,1.75850762477719,0.442627341227631,0.0715280188434025,0.295115329476356,"High",3,"Q4",4,"Above Median",53.98,"<70 kg",162.56,20.4270428072106,1.56124850324632,79.56,39.5147712418301,63.0563387511845,16,43,10.26,46,"Y","","","",1
"CDISCPILOT01",1,"01-716-1364",1364,"1364",1364,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-07-04,2014-01-09,190,84,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",190,"DAYS","CENSORED",2013-07-04,2014-01-09,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,31.9987504722872,5.7937695263156,1.33328126967863,0.395627830266501,2.53134884345408,3.46600931767745,0.729971217197524,1.31570466061185,0.395046302127003,1.75850762477719,0.442627341227631,0.0715280188434025,0.295115329476356,"High",3,"Q4",4,"Above Median",53.98,"<70 kg",162.56,20.4270428072106,1.56124850324632,79.56,39.5147712418301,63.0563387511845,16,43,10.26,46,"","Y","","",2
"CDISCPILOT01",1,"01-716-1373",1373,"1373",1373,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-12-14,2013-02-27,76,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-14,2012-12-14,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,21.2474643578945,4.67322500972901,0.885311014912271,0.46606835677942,3.81221959644819,3.05670809759262,-0.386672958906127,0.873639984976193,0.262314374788821,1.54398697724892,-0.0522526552162416,0.0576941359225804,-0.110584118377084,"Medium",2,"Q2",2,"Below Median",69.4,"<70 kg",147.32,31.9768772712337,1.68523061395829,114.92,49.0244691959624,57.6621280113302,38,31,8.55,39,"Y","","","",1
"CDISCPILOT01",1,"01-716-1373",1373,"1373",1373,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-12-14,2013-02-27,76,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",77,"DAYS","CENSORED",2012-12-14,2013-02-28,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,21.2474643578945,4.67322500972901,0.885311014912271,0.46606835677942,3.81221959644819,3.05670809759262,-0.386672958906127,0.873639984976193,0.262314374788821,1.54398697724892,-0.0522526552162416,0.0576941359225804,-0.110584118377084,"Medium",2,"Q2",2,"Below Median",69.4,"<70 kg",147.32,31.9768772712337,1.68523061395829,114.92,49.0244691959624,57.6621280113302,38,31,8.55,39,"","Y","","",2
"CDISCPILOT01",1,"01-716-1418",1418,"1418",1418,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-05,2013-11-20,200,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-05,2013-05-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,47.9800655184258,4.55889537190229,1.99916939660107,0.846112076967453,1.68820111279118,3.87099402112085,2.38981378699562,1.97281440329137,0.592346487881799,1.51927146275717,-0.102745473594817,0.056282658912374,0.697721401143803,"High",3,"Q4",4,"Above Median",68.95,"<70 kg",165.1,25.2953168628231,1.7782360954359,97.24,44.2459893048128,50.810394884725,10,23,8.55,42,"Y","","","",1
"CDISCPILOT01",1,"01-716-1418",1418,"1418",1418,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-05,2013-11-20,200,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",200,"DAYS","CENSORED",2013-05-05,2013-11-20,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,47.9800655184258,4.55889537190229,1.99916939660107,0.846112076967453,1.68820111279118,3.87099402112085,2.38981378699562,1.97281440329137,0.592346487881799,1.51927146275717,-0.102745473594817,0.056282658912374,0.697721401143803,"High",3,"Q4",4,"Above Median",68.95,"<70 kg",165.1,25.2953168628231,1.7782360954359,97.24,44.2459893048128,50.810394884725,10,23,8.55,42,"","Y","","",2
"CDISCPILOT01",1,"01-716-1441",1441,"1441",1441,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-22,2014-07-22,182,85,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-22,2014-01-22,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,57.61,"<70 kg",144.78,27.4840500435079,1.52213079814669,106.08,36.7394089366516,59.2780774618462,15,27,15.39,41,"Y","","","",1
"CDISCPILOT01",1,"01-716-1441",1441,"1441",1441,"716",716,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-22,2014-07-22,182,85,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2014-01-22,2014-07-22,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,57.61,"<70 kg",144.78,27.4840500435079,1.52213079814669,106.08,36.7394089366516,59.2780774618462,15,27,15.39,41,"","Y","","",2
"CDISCPILOT01",1,"01-716-1447",1447,"1447",1447,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-16,2014-06-17,184,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-16,2013-12-16,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,33.9320005748834,4.39885987547585,1.41383335728681,0.852827791349753,2.38712715512437,3.5246532025263,0.930761378025433,1.39519483233955,0.418913587344239,1.48361612439556,-0.173423938153875,0.0543069120429117,0.353352781764656,"High",3,"Q4",4,"Above Median",54.43,"<70 kg",149.86,24.2363311500538,1.50525743460859,97.24,39.5854545454545,53.4023822224413,18,29,6.84,41,"Y","","","",1
"CDISCPILOT01",1,"01-716-1447",1447,"1447",1447,"716",716,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-12-16,2014-06-17,184,72,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2013-12-16,2014-06-17,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,33.9320005748834,4.39885987547585,1.41383335728681,0.852827791349753,2.38712715512437,3.5246532025263,0.930761378025433,1.39519483233955,0.418913587344239,1.48361612439556,-0.173423938153875,0.0543069120429117,0.353352781764656,"High",3,"Q4",4,"Above Median",54.43,"<70 kg",149.86,24.2363311500538,1.50525743460859,97.24,39.5854545454545,53.4023822224413,18,29,6.84,41,"","Y","","",2
"CDISCPILOT01",1,"01-717-1004",1004,"1004",1004,"717",717,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-01-14,2014-07-16,184,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-14,2014-01-14,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,21.167152756508,4.65465358593954,0.881964698187832,0.609490455966629,2.55112251615406,3.05292290037686,-0.395014238359361,0.870337782649981,0.391984310305703,1.5400135734369,-0.0604545838347362,0.0861972886285101,-0.114328723207889,"Medium",2,"Q2",2,"Below Median",55.79,"<70 kg",135.89,30.2121313474874,1.45117797935945,88.4,39.3811764705882,56.9670581246401,24,24,6.84,40,"Y","","","",1
"CDISCPILOT01",1,"01-717-1004",1004,"1004",1004,"717",717,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-01-14,2014-07-16,184,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2014-01-14,2014-07-16,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,21.167152756508,4.65465358593954,0.881964698187832,0.609490455966629,2.55112251615406,3.05292290037686,-0.395014238359361,0.870337782649981,0.391984310305703,1.5400135734369,-0.0604545838347362,0.0861972886285101,-0.114328723207889,"Medium",2,"Q2",2,"Below Median",55.79,"<70 kg",135.89,30.2121313474874,1.45117797935945,88.4,39.3811764705882,56.9670581246401,24,24,6.84,40,"","Y","","",2
"CDISCPILOT01",1,"01-717-1109",1109,"1109",1109,"717",717,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-27,2014-07-28,183,84,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-27,2014-01-27,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,29.9902788979873,6.45174125865545,1.24959495408281,0.620375808656733,2.70087518277251,3.40120667821852,0.521368445171081,1.23312157933493,0.370250356765276,1.86589882615738,0.733215571985666,0.0796511266500673,0.230790204268786,"High",3,"Q3",3,"Above Median",44.45,"<70 kg",180.34,13.6674544327069,1.49221246997723,106.08,28.8623303167421,59.6478944071706,16,19,20.52,42,"Y","","","",1
"CDISCPILOT01",1,"01-717-1109",1109,"1109",1109,"717",717,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-01-27,2014-07-28,183,84,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2014-01-27,2014-07-28,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,29.9902788979873,6.45174125865545,1.24959495408281,0.620375808656733,2.70087518277251,3.40120667821852,0.521368445171081,1.23312157933493,0.370250356765276,1.86589882615738,0.733215571985666,0.0796511266500673,0.230790204268786,"High",3,"Q3",3,"Above Median",44.45,"<70 kg",180.34,13.6674544327069,1.49221246997723,106.08,28.8623303167421,59.6478944071706,16,19,20.52,42,"","Y","","",2
"CDISCPILOT01",1,"01-717-1174",1174,"1174",1174,"717",717,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-01-22,2013-07-24,184,73,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-22,2013-01-22,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,38.99060648238,9.08387664923502,1.6246086034325,0.740625604259253,2.07742344394166,3.66357719683899,1.45615552768422,1.60319143440863,0.481365512128148,2.20760129133843,1.89567822603333,0.112146625299198,0.491403389411932,"High",3,"Q4",4,"Above Median",68.04,"<70 kg",167.64,24.2107922232373,1.77999887640414,123.76,45.3068552036199,53.0847838643501,22,23,13.68,42,"Y","","","",1
"CDISCPILOT01",1,"01-717-1174",1174,"1174",1174,"717",717,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-01-22,2013-07-24,184,73,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2013-01-22,2013-07-24,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,38.99060648238,9.08387664923502,1.6246086034325,0.740625604259253,2.07742344394166,3.66357719683899,1.45615552768422,1.60319143440863,0.481365512128148,2.20760129133843,1.89567822603333,0.112146625299198,0.491403389411932,"High",3,"Q4",4,"Above Median",68.04,"<70 kg",167.64,24.2107922232373,1.77999887640414,123.76,45.3068552036199,53.0847838643501,22,23,13.68,42,"","Y","","",2
"CDISCPILOT01",1,"01-717-1201",1201,"1201",1201,"717",717,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-12-19,2014-02-21,65,85,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-12-19,2013-12-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,68.04,"<70 kg",160.02,26.571481714392,1.73907389147213,97.24,40.0235294117647,49.2546834386245,23,32,8.55,40,"Y","","","",1
"CDISCPILOT01",1,"01-717-1201",1201,"1201",1201,"717",717,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-12-19,2014-02-21,65,85,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",65,"DAYS","CENSORED",2013-12-19,2014-02-21,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,68.04,"<70 kg",160.02,26.571481714392,1.73907389147213,97.24,40.0235294117647,49.2546834386245,23,32,8.55,40,"","Y","","",2
"CDISCPILOT01",1,"01-717-1344",1344,"1344",1344,"717",717,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-11,2014-03-14,63,64,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-01-11,2014-01-11,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.06,"<70 kg",163.5,21.7190846262473,1.62385087574773,106.08,43.2603921568627,50.5617874369777,12,19,10.26,45,"Y","","","",1
"CDISCPILOT01",1,"01-717-1344",1344,"1344",1344,"717",717,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-11,2014-03-14,63,64,"<65",1,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",63,"DAYS","CENSORED",2014-01-11,2014-03-14,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.06,"<70 kg",163.5,21.7190846262473,1.62385087574773,106.08,43.2603921568627,50.5617874369777,12,19,10.26,45,"","Y","","",2
"CDISCPILOT01",1,"01-717-1357",1357,"1357",1357,"717",717,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-01,2013-10-14,167,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-01,2013-05-01,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,18.7998911227742,3.22060874333867,0.783328796782259,0.611131498780566,4.30853559050012,2.93438285503325,-0.640881466567873,0.77300219552796,0.232097421268818,1.17267058490712,-0.693789624167186,0.0397606017696132,-0.231517519342766,"Low",1,"Q2",2,"Below Median",81.29,">=70 kg",181.61,24.6466334783127,2.02505671388345,97.24,64.779536199095,69.1589583936064,11,20,17.1,44,"Y","","","",1
"CDISCPILOT01",1,"01-717-1357",1357,"1357",1357,"717",717,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-05-01,2013-10-14,167,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",173,"DAYS","CENSORED",2013-05-01,2013-10-20,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,18.7998911227742,3.22060874333867,0.783328796782259,0.611131498780566,4.30853559050012,2.93438285503325,-0.640881466567873,0.77300219552796,0.232097421268818,1.17267058490712,-0.693789624167186,0.0397606017696132,-0.231517519342766,"Low",1,"Q2",2,"Below Median",81.29,">=70 kg",181.61,24.6466334783127,2.02505671388345,97.24,64.779536199095,69.1589583936064,11,20,17.1,44,"","Y","","",2
"CDISCPILOT01",1,"01-717-1446",1446,"1446",1446,"717",717,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-01,2014-03-03,184,75,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-01,2013-09-01,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,21.3272653942944,4.98340531017816,0.888636058095599,0.50977784671825,2.53197018003286,3.06045509306512,-0.378384707473244,0.876921194209781,0.394949359153599,1.60811810390549,0.084736124534188,0.0922852835218177,-0.106877156180746,"Medium",2,"Q2",2,"Below Median",47.17,"<70 kg",156.21,19.3307280659112,1.43065890996655,97.24,32.7919786096257,52.4152435485389,20,28,10.26,45,"Y","","","",1
"CDISCPILOT01",1,"01-717-1446",1446,"1446",1446,"717",717,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-01,2014-03-03,184,75,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",198,"DAYS","CENSORED",2013-09-01,2014-03-17,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,21.3272653942944,4.98340531017816,0.888636058095599,0.50977784671825,2.53197018003286,3.06045509306512,-0.378384707473244,0.876921194209781,0.394949359153599,1.60811810390549,0.084736124534188,0.0922852835218177,-0.106877156180746,"Medium",2,"Q2",2,"Below Median",47.17,"<70 kg",156.21,19.3307280659112,1.43065890996655,97.24,32.7919786096257,52.4152435485389,20,28,10.26,45,"","Y","","",2
"CDISCPILOT01",1,"01-718-1066",1066,"1066",1066,"718",718,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-07,2013-07-16,10,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-07-07,2013-07-07,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,20.353145659266,3.28052251414915,0.848047735802748,0.428957543938165,2.65315253494567,3.01372668167671,-0.47955819661432,0.836867946615602,0.376910104801221,1.19104637105721,-0.667329161198748,0.0607504169286879,-0.153095544908068,"Medium",2,"Q2",2,"Below Median",50.35,"<70 kg",158.75,19.9789199578399,1.49006548140976,70.72,45.1669117647059,74.9232858345362,19,28,6.84,38,"Y","","","",1
"CDISCPILOT01",1,"01-718-1066",1066,"1066",1066,"718",718,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-07,2013-07-16,10,79,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",24,"DAYS","CENSORED",2013-07-07,2013-07-30,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,20.353145659266,3.28052251414915,0.848047735802748,0.428957543938165,2.65315253494567,3.01372668167671,-0.47955819661432,0.836867946615602,0.376910104801221,1.19104637105721,-0.667329161198748,0.0607504169286879,-0.153095544908068,"Medium",2,"Q2",2,"Below Median",50.35,"<70 kg",158.75,19.9789199578399,1.49006548140976,70.72,45.1669117647059,74.9232858345362,19,28,6.84,38,"","Y","","",2
"CDISCPILOT01",1,"01-718-1079",1079,"1079",1079,"718",718,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-19,2012-10-31,43,67,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-09-19,2012-09-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,12.8529152580141,1.53666571881435,0.535538135750587,0.441651984170245,4.20138146996105,2.55434838503275,-1.25854300902497,0.528478151734827,0.238016949222483,0.436101464734316,-1.43749030330382,0.0284567725706361,-0.60598256643565,"Low",1,"Q1",1,"Below Median",50.35,"<70 kg",158.75,19.9789199578399,1.49006548140976,79.56,48.0464052287582,70.0883570388785,23,36,8.55,45,"Y","","","",1
"CDISCPILOT01",1,"01-718-1079",1079,"1079",1079,"718",718,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2012-09-19,2012-10-31,43,67,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",43,"DAYS","CENSORED",2012-09-19,2012-10-31,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,12.8529152580141,1.53666571881435,0.535538135750587,0.441651984170245,4.20138146996105,2.55434838503275,-1.25854300902497,0.528478151734827,0.238016949222483,0.436101464734316,-1.43749030330382,0.0284567725706361,-0.60598256643565,"Low",1,"Q1",1,"Below Median",50.35,"<70 kg",158.75,19.9789199578399,1.49006548140976,79.56,48.0464052287582,70.0883570388785,23,36,8.55,45,"","Y","","",2
"CDISCPILOT01",1,"01-718-1101",1101,"1101",1101,"718",718,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-17,2013-07-31,165,82,">75",3,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-17,2013-02-17,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,24.5294563721086,4.65511640324558,1.02206068217119,0.320662147613246,3.30215226832755,3.20028228631158,-0.045800506094669,1.00858688526007,0.30283279471739,1.54011278645222,-0.0602501840778543,0.0574705728795751,0.0315574658841651,"Medium",2,"Q3",3,"Above Median",80.29,">=70 kg",186.18,23.1630319371965,2.03772696077435,88.4,64.7951199095023,75.1648210696517,6,17,11.97,36,"Y","","","",1
"CDISCPILOT01",1,"01-718-1101",1101,"1101",1101,"718",718,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-17,2013-07-31,165,82,">75",3,"M",1,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",167,"DAYS","CENSORED",2013-02-17,2013-08-02,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,24.5294563721086,4.65511640324558,1.02206068217119,0.320662147613246,3.30215226832755,3.20028228631158,-0.045800506094669,1.00858688526007,0.30283279471739,1.54011278645222,-0.0602501840778543,0.0574705728795751,0.0315574658841651,"Medium",2,"Q3",3,"Above Median",80.29,">=70 kg",186.18,23.1630319371965,2.03772696077435,88.4,64.7951199095023,75.1648210696517,6,17,11.97,36,"","Y","","",2
"CDISCPILOT01",1,"01-718-1139",1139,"1139",1139,"718",718,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-05-19,2013-11-17,183,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-05-19,2013-05-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,65.77,"<70 kg",171.45,22.3744754759743,1.76982944093492,114.92,44.3483927949878,56.5962482844221,17,22,11.97,43,"Y","","","",1
"CDISCPILOT01",1,"01-718-1139",1139,"1139",1139,"718",718,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-05-19,2013-11-17,183,77,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-05-19,2013-11-17,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,65.77,"<70 kg",171.45,22.3744754759743,1.76982944093492,114.92,44.3483927949878,56.5962482844221,17,22,11.97,43,"","Y","","",2
"CDISCPILOT01",1,"01-718-1150",1150,"1150",1150,"718",718,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-01-19,2013-07-29,192,73,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-01-19,2013-01-19,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.89,"<70 kg",156.21,22.4944596891639,1.54329795675797,79.56,48.0735947712418,67.5211505729668,30,27,8.55,41,"Y","","","",1
"CDISCPILOT01",1,"01-718-1150",1150,"1150",1150,"718",718,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-01-19,2013-07-29,192,73,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",194,"DAYS","CENSORED",2013-01-19,2013-07-31,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.89,"<70 kg",156.21,22.4944596891639,1.54329795675797,79.56,48.0735947712418,67.5211505729668,30,27,8.55,41,"","Y","","",2
"CDISCPILOT01",1,"01-718-1170",1170,"1170",1170,"718",718,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-16,2013-10-12,27,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-16,2013-09-16,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,18.4081090137741,3.20513575722481,0.767004542240589,0.464011821126923,2.93348979841404,2.9133343661531,-0.681572524889806,0.756893143169739,0.340890907662484,1.16786958299554,-0.700623151260183,0.0593543658745336,-0.252309082762092,"Low",1,"Q2",2,"Below Median",57.61,"<70 kg",162.56,21.8007027810931,1.61288919506442,106.08,33.8882352941176,45.7726753490499,11,19,10.26,39,"Y","","","",1
"CDISCPILOT01",1,"01-718-1170",1170,"1170",1170,"718",718,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-16,2013-10-12,27,80,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",49,"DAYS","CENSORED",2013-09-16,2013-11-03,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,18.4081090137741,3.20513575722481,0.767004542240589,0.464011821126923,2.93348979841404,2.9133343661531,-0.681572524889806,0.756893143169739,0.340890907662484,1.16786958299554,-0.700623151260183,0.0593543658745336,-0.252309082762092,"Low",1,"Q2",2,"Below Median",57.61,"<70 kg",162.56,21.8007027810931,1.61288919506442,106.08,33.8882352941176,45.7726753490499,11,19,10.26,39,"","Y","","",2
"CDISCPILOT01",1,"01-718-1172",1172,"1172",1172,"718",718,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-21,2013-11-29,70,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-21,2013-09-21,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,66.23,"<70 kg",173.99,21.8779275003273,1.78911505902903,114.92,46.7851670727463,57.6621280113302,13,19,10.26,40,"Y","","","",1
"CDISCPILOT01",1,"01-718-1172",1172,"1172",1172,"718",718,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-09-21,2013-11-29,70,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",70,"DAYS","CENSORED",2013-09-21,2013-11-29,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,66.23,"<70 kg",173.99,21.8779275003273,1.78911505902903,114.92,46.7851670727463,57.6621280113302,13,19,10.26,40,"","Y","","",2
"CDISCPILOT01",1,"01-718-1250",1250,"1250",1250,"718",718,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-21,2014-01-31,133,82,">75",3,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-09-21,2013-09-21,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,27.571513656164,5.05894464347907,1.14881306900683,0.568026069051498,1.95854317878292,3.31714575324365,0.270151977493943,1.13366829898421,0.510583586225258,1.62313263883068,0.118097498796415,0.0936841600644273,0.147396264901611,"Medium",2,"Q3",3,"Above Median",58.51,"<70 kg",157.48,23.5927891210621,1.59983981837072,106.08,33.2703921568627,45.2068536763621,15,25,5.13,40,"Y","","","",1
"CDISCPILOT01",1,"01-718-1250",1250,"1250",1250,"718",718,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-09-21,2014-01-31,133,82,">75",3,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",152,"DAYS","CENSORED",2013-09-21,2014-02-19,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,27.571513656164,5.05894464347907,1.14881306900683,0.568026069051498,1.95854317878292,3.31714575324365,0.270151977493943,1.13366829898421,0.510583586225258,1.62313263883068,0.118097498796415,0.0936841600644273,0.147396264901611,"Medium",2,"Q3",3,"Above Median",58.51,"<70 kg",157.48,23.5927891210621,1.59983981837072,106.08,33.2703921568627,45.2068536763621,15,25,5.13,40,"","Y","","",2
"CDISCPILOT01",1,"01-718-1254",1254,"1254",1254,"718",718,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-10,2014-01-09,184,78,">75",3,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-07-10,2013-07-10,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,15.6824817790554,2.56381948056986,0.653436740793973,0.483177559775669,3.44333255161944,2.75318173008448,-0.964660124410001,0.644822502820332,0.290416329241766,0.94539097484584,-0.983855626197625,0.0474781385290715,-0.410321771437212,"Low",1,"Q1",1,"Below Median",82.1,">=70 kg",170.18,28.3482411473622,1.9700379296969,97.24,64.3865281777046,68.730172851566,14,20,10.26,42,"Y","","","",1
"CDISCPILOT01",1,"01-718-1254",1254,"1254",1254,"718",718,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2013-07-10,2014-01-09,184,78,">75",3,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",184,"DAYS","CENSORED",2013-07-10,2014-01-09,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,15.6824817790554,2.56381948056986,0.653436740793973,0.483177559775669,3.44333255161944,2.75318173008448,-0.964660124410001,0.644822502820332,0.290416329241766,0.94539097484584,-0.983855626197625,0.0474781385290715,-0.410321771437212,"Low",1,"Q1",1,"Below Median",82.1,">=70 kg",170.18,28.3482411473622,1.9700379296969,97.24,64.3865281777046,68.730172851566,14,20,10.26,42,"","Y","","",2
"CDISCPILOT01",1,"01-718-1328",1328,"1328",1328,"718",718,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-01,2013-04-18,77,86,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-01,2013-02-01,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,27.6668167074212,6.31079667992708,1.15278402947588,0.877826399281006,2.92769496601584,3.32059512079147,0.280050290683549,1.13758691039431,0.341565638363225,1.84384525716474,0.670968466594125,0.0779110701225566,0.1508171550674,"Medium",2,"Q3",3,"Above Median",63.5,"<70 kg",170.18,21.9258625195798,1.732566336713,106.08,39.7593325791855,58.9105533815827,18,26,10.26,38,"Y","","","",1
"CDISCPILOT01",1,"01-718-1328",1328,"1328",1328,"718",718,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-02-01,2013-04-18,77,86,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",90,"DAYS","CENSORED",2013-02-01,2013-05-01,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,27.6668167074212,6.31079667992708,1.15278402947588,0.877826399281006,2.92769496601584,3.32059512079147,0.280050290683549,1.13758691039431,0.341565638363225,1.84384525716474,0.670968466594125,0.0779110701225566,0.1508171550674,"Medium",2,"Q3",3,"Above Median",63.5,"<70 kg",170.18,21.9258625195798,1.732566336713,106.08,39.7593325791855,58.9105533815827,18,26,10.26,38,"","Y","","",2
"CDISCPILOT01",1,"01-718-1355",1355,"1355",1355,"718",718,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-28,2013-08-29,183,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-02-28,2013-02-28,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.51,"<70 kg",167.64,20.8197156522871,1.65064098660692,114.92,38.2005334145492,55.8966303654793,12,25,8.55,41,"Y","","","",1
"CDISCPILOT01",1,"01-718-1355",1355,"1355",1355,"718",718,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2013-02-28,2013-08-29,183,79,">75",3,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2013-02-28,2013-08-29,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,58.51,"<70 kg",167.64,20.8197156522871,1.65064098660692,114.92,38.2005334145492,55.8966303654793,12,25,8.55,41,"","Y","","",2
"CDISCPILOT01",1,"01-718-1371",1371,"1371",1371,"718",718,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-04-26,2013-08-01,98,69,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2013-04-26,2013-04-26,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,20.271031893277,3.25379151557828,0.844626328886544,0.4713901260542,3.99584986232812,3.00968605974001,-0.488086651498123,0.833491644009488,0.25025965300342,1.18288956115812,-0.679134704202063,0.0401702656244232,-0.157090947814131,"Medium",2,"Q2",2,"Below Median",66.68,"<70 kg",154.94,27.7759222543438,1.69405817819552,70.72,69.6217647058824,79.730941309724,23,23,8.55,37,"Y","","","",1
"CDISCPILOT01",1,"01-718-1371",1371,"1371",1371,"718",718,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-04-26,2013-08-01,98,69,"65-75",2,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",98,"DAYS","CENSORED",2013-04-26,2013-08-01,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,20.271031893277,3.25379151557828,0.844626328886544,0.4713901260542,3.99584986232812,3.00968605974001,-0.488086651498123,0.833491644009488,0.25025965300342,1.18288956115812,-0.679134704202063,0.0401702656244232,-0.157090947814131,"Medium",2,"Q2",2,"Below Median",66.68,"<70 kg",154.94,27.7759222543438,1.69405817819552,70.72,69.6217647058824,79.730941309724,23,23,8.55,37,"","Y","","",2
"CDISCPILOT01",1,"01-718-1427",1427,"1427",1427,"718",718,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-12-17,2013-02-11,57,74,"65-75",2,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-12-17,2012-12-17,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,81,27.8304129388685,5.30445228356811,1.15960053911952,0.901087533753831,2.91048502147354,3.32648866793052,0.297041632662024,1.14431355818514,0.343585344924302,1.67042995541476,0.226524088062419,0.065487065229236,0.156662270956772,"Medium",2,"Q3",3,"Above Median",51.71,"<70 kg",158.75,20.5185690371381,1.51005541656957,79.56,44.6125490196079,67.1025194394144,14,29,8.55,43,"Y","","","",1
"CDISCPILOT01",1,"01-718-1427",1427,"1427",1427,"718",718,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2012-12-17,2013-02-11,57,74,"65-75",2,"F",2,"BLACK OR AFRICAN AMERICAN",3,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",71,"DAYS","CENSORED",2012-12-17,2013-02-25,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,27.8304129388685,5.30445228356811,1.15960053911952,0.901087533753831,2.91048502147354,3.32648866793052,0.297041632662024,1.14431355818514,0.343585344924302,1.67042995541476,0.226524088062419,0.065487065229236,0.156662270956772,"Medium",2,"Q3",3,"Above Median",51.71,"<70 kg",158.75,20.5185690371381,1.51005541656957,79.56,44.6125490196079,67.1025194394144,14,29,8.55,43,"","Y","","",2
